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ABSTRACT 
Neisseria meningitidis causes meningococcal disease, a global life threatening 
illness with annual incidences of between 1 and 1000 per 100,000 population. 
Humans are the only known host with approximately 10% of people having 
asymptomatic nasopharyngeal carriage at any one time. Thus, the ability of 
meningococci to attach, invade, and grow in the epithelium is crucial for both its 
commensal and pathogenic properties. In the rare event that meningococci 
cross the epithelium into the bloodstream, disease may occur. In order to better 
understand the mechanisms of meningococcal pathogenesis, transposon 
mutagenesis was used to identify bacterial genes involved in epithelial cell 
adherence and internalization as well as traversal of the epithelial barrier.   
Three epithelial cell lines of respiratory origin, A549 cells, 16HBE14o-  cells and 
Detroit 562 cells were used to examine N. meningitidis L91543 (C:2a:P1.2, ST-
11; ET-37) pathogenesis. First, adhesion, invasion and traversal assays were 
optimized for bacterial uptake to enable the maximum number of mutants to be 
tested and to avoid stochastic loss from the transposon library. Since the 
highest level of meningococci adherence and invasion was observed using 
16HBE14o- cells, this cell line was chosen for subsequent traversal assays, 
where an intact epithelial barrier was established on Transwell® membrane 
inserts. Epithelial barrier integrity was assessed by measuring transepithelial 
electrical resistance (TEER), permeability of the marker protein, 70 kDa 
Dextran, and by examining the distribution of the tight junction proteins, occludin 
and ZO-1, by immunofluorescence.   
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Next, transposon mutagenesis libraries comprising of approx. 14,500 N. 
meningitidis L91543 mutants, were used to probe meningococcal interactions 
with 16HBE14o-  epithelial cells. Illumina sequencing of amplified transposon 
junctions was performed on DNA extracted from both input and output pools 
obtained from the various assays. Comparative analysis of input/output pools 
showed reduced fitness, not only of genes associated with type IV pili, but 
mainly of genes involved in metabolism especially nucleotide and amino acid 
metabolism. Genes involved in membrane transport, regulatory functions and 
cellular processes also showed reduced fitness. The function of putative genes 
of interest was validated by generating insertion knockout mutants and testing 
them independently for their ability to alter meningococcal-epithelial cell 
interactions. The knockout mutant assays showed 67-100% agreement to the 
Tn-Seq analysis prediction. Based on the knock out mutant assays as well the 
Tn-Seq prediction we can conclude that type IV pili, nucleotide biosynthesis, 
glucose and amino acid metabolism, as well as resistance to antimicrobial 
peptide are critical for meningococcal interaction with epithelial cells. 
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1    INTRODUCTION 
1.1  Overview 
Neisseria meningitidis is one of the two pathogenic species of the Neisseria genus. 
N. meningitidis is the etiological agent of meningococcal disease which has a high 
disease burden of 1-1000 cases per 100,000 (Caugant, 2008) and a 10% fatality rate  
(Caugant and Maiden, 2009). However, in the vast majority of exposures, N. 
meningitidis exists as a harmless colonizer of the human upper respiratory system, 
primarily in the nasopharynx. What determines whether the bacterium remains in the 
nasopharynx resulting in asymptomatic carriage or crosses into the bloodstream and 
on occasion the cerebral spinal fluid (csf) leading to septicaemia, meningitis and/or 
septic shock, is not clear although several risk factors have been identified 
(Hadjichristodoulou et al., 2016, Olea et al., 2017). Infections must start with the 
attachment and invasion of the upper respiratory epithelial cells. Thus the primary 
aim of this PhD is to identify the genes involved in the interaction between N. 
meningitidis and the epithelial cells, i.e. the processes of adhesion, invasion and 
traversal across the epithelial barrier. This chapter will describe the microbiology, 
disease, epidemiology and the virulence factors of the bacterium with special regard 
for the process of colonization of the nasopharynx. In addition, genes essential for 
virulence or those that have a fitness phenotype identified elsewhere by individual 
mutant analysis or transposon mutagenesis screens will be briefly discussed.   
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1.2  Microbiology of Neisseria meningitidis  
N. meningitidis, also known as meningococcus, is a Gram-negative diplococci 
pathogenic bacterium of the Neisseriaceae family. The bacterium was first isolated 
by Anton Wechselbaum from the csf of  meningitis patients in 1887 and he befittingly 
called the organism,  Diplococcus intracellularis meningitidis (Branham, 1940).  
Meningococcus is a strict human pathogen/commensal: humans are the only natural 
reservoir of this bacterium.  The bacterium colonizes the mucosal surface of the 
nasopharynx and is transmitted between individuals via respiratory and salivary 
droplets (Caugant, 2008, Taha et al., 2002). Of late, urogenital and rectal 
meningococcal infections have also been reported with evidence of transmission 
between sexual partners (Harrison et al., 2017, Hayakawa et al., 2014, Kanemitsu et 
al., 2003). Approximately, 10% of the population are reported to be asymptomatic 
carriers during endemic periods (Taha et al., 2002), although higher carriage rates of 
up to 35% have been reported (Stephens et al., 2007, Trivedi et al., 2011). Carriage 
rates are typically higher, almost 100% in closed and semi-closed populations such 
as in military installations, prisons and dormitories (Caugant and Maiden, 2009). The 
carriage rate is also reported to be higher among adolescents compared to infants 
and adults (Goldschneider et al., 1969, Gold et al., 1978, Christensen et al., 2010). 
Since humans are the only known reservoir, carriers are presumably the major 
source of the pathogenic strains, with the disease usually occurring 1-14 days after 
colonization (Caugant and Maiden, 2009, Stephens, 2009). The relationship between 
the carriage rate and disease is unclear, as there are reports of both a correlation 
between increasing disease and increasing carriage (Olsen et al., 1991) as well as 
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reports of no difference in carriage in high and low disease incidence areas 
(Fernandez et al., 1999). 
Meningococci exhibit a significant amount of antigenic and genetic diversity, making 
classification based on both structural variation as well as multi locus sequence 
typing necessary.  N. meningitidis  is classified into 12 serogroups  ( A, B, C, 29E, H, 
I, K, L, W135, X, Y and Z) based on its polysaccharide capsule, of which serogroups 
A, B, C, Y and W135 are associated with 90% of disease (Tzanakaki and 
Mastrantonio, 2007). Alternative classification systems, based on other structural 
differences, divide the species into serotypes [PorB, class 2 or 3 outer membrane 
proteins (OMPs)], serosubtypes (PorA, class 1 OMP), immunotypes 
(lipopolysaccharide) and iron-regulated meningococcal OMP (FrpB/FetA) (Jolley et 
al., 2007, Vogel et al., 2010); these are used for epidemiology surveillance. These 
are complemented with enzyme type (ET) and sequence type (ST) based on 
housekeeping gene analysis (Maiden et al., 1998). The current recommended 
meningococcal nomenclature is; serogroup: PorA type: FetA type: sequence type 
(clonal complex), for example: B: P1.19,15: F5-1: ST-33 (cc32) (Jolley et al., 2007). 
1.3  Meningococcal disease, treatment and prevention 
In this era of various advanced vaccine and treatment strategies, meningococcal 
disease is still associated with high mortality and morbidity. The meningococci 
invasion and subsequent crossing of the nasopharyngeal epithelium to the 
bloodstream and occasionally csf lead to sepsis and meningitis (Caugant, 2008). 
Meningococcal disease is associated with a wide spectrum of illness; in addition to 
meningitis, septicaemia and severe septic shock, it can result in conjunctivitis, otitis 
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media, sinusitis, septic arthritis, pneumonia, pericarditis and urethritis (Brandtzaeg 
and Van Deuren, 2012, Rosenstein et al., 2001).   Although mortality rates are ~10% 
in general (Stephens, 2009, Trivedi et al., 2011), it can be as high as 40% in cases 
involving septic shock (Emonts et al., 2003).  Of those that survive, 10-25% sustain 
permanent sequelae including deafness, neurological disability and amputation 
(Gruenert et al., 1988, Yogev and Tan, 2011). Disease onset is rapid, with often less 
than 24 hours between the manifestation of specific meningitis symptoms and 
mortality (Thompson et al., 2006).  
Meningococcal infections are usually treated with β-lactam antibiotics, especially 
penicillin and cephalosporin (Hill et al., 2010), whilst chloramphenicol is the standard 
therapy in developing countries (Tzanakaki and Mastrantonio, 2007). The 
chemoprophylaxis of choice is rifampicin as well as ciprofloxacin. Recently, reduced 
susceptibility as well as resistance to these antimicrobial agents has been seen 
especially with penicillin as well as third generation cephalosporin (Deghmane et al., 
2017, Hedberg et al., 2009, Ibarz-Pavón et al., 2011, Jorgensen et al., 2005, 
Tzanakaki and Mastrantonio, 2007). Clinically these strains are reported to be 
responsive to high doses of benzylpenicillin or cephalosporins (Cartwright and 
Aldeen, 1997). Resistance against rifampicin, ciprofloxacin and chloramphenicol, 
although very rare, have also  been identified (Jorgensen et al., 2005, Vogel et al., 
2010). Although multi drug resistance is not an issue at the moment, these 
resistance reports support the concern that the highly transformable meningococci 
may acquire antibiotic resistance genes from other flora in the nasopharynx niche. 
The difficulty of early diagnosis due to diseases’ generalised clinical manifestation 
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that is often similar to other common but less serious illnesses, and the rapid 
progress of the disease, makes prevention much more effective than cure.  
1.3.1  Meningococcal vaccine 
Meningococcal disease is preventable by vaccination, but to date there is no vaccine 
that provides long term protection and that covers all the disease causing 
serogroups, especially serogroup B because of the capsule’s poor immunogenicity. 
The first anti-capsular vaccines were licensed more than 40 years ago against 
serogroup A and C meningococcal strains in response to epidemics among US 
military recruits (Gotschich et al., 1969, Artenstein et al., 1970, Devine et al., 1970 
Gold et al., 1975). Since then, simple polysaccharide vaccines are being replaced 
with conjugated vaccines as they are weakly immunogenic in infants and young 
children and do not activate a T-cell response (Girard et al., 2006). Carrier proteins 
used in the conjugated vaccine for better immunogenic response include diphtheria 
toxoid, a non-toxic diphtheria toxoid, CRM197 and tetanus toxoid (Vipond et al., 
2012).  
The monovalent MenC conjugate vaccine introduced in the United Kingdom in 
November 1999 led to a reduction of more than 80% of meningitis caused by 
serogroup C within 18 months (Miller et al., 2001) as well as a 66% decrease in 
asymptomatic carriers (Maiden et al., 2002).  An affordable meningitis A conjugate 
vaccine has been developed recently for usage in the African Meningitis Belt 
(MenAfriVac),  in addition to the quadrivalent  conjugate vaccine against A, C, Y and 
W135 developed in 2005, to broaden population protection (Nadel, 2012, Pace et al., 
2009).  The vaccination programme with MenAfriVac in the meningitis belt epidemic 
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areas has shown a dramatic reduction of cases due to serogroup A (Maïnassara et 
al., 2015), but an increase in serogroup X outbreaks have been seen since 2006, 
stressing the need for a serogroup X cross-serogroup vaccine (Xie et al., 2013).  
Since the capsular polysaccharide of serogroup B is not a suitable vaccine 
candidate, other outer membrane vesicles (OMV)  that raise antibodies mainly to 
PorA/B,  H-binding protein, Neisserial surface protein A (NspA) and meningitidis 
adhesion A (NadA), are being studied (Girard et al., 2006, Nadel, 2012). OMV-based 
vaccines had been successful, especially during epidemics but these vaccines are 
strain-specific due to  Neisseria’s high antigenic variability and thus failed to induce 
protection in heterologous strains (Pizza et al., 2000). In 2000, the whole genome of 
the N. meningitidis serogroup B strain MC58 was sequenced, (Tettelin et al., 2000) 
making reverse vaccinology possible. Nearly 600 potential vaccine candidates were 
selected, of which 350 recombinant proteins were expressed in Escherichia coli 
andused to immunize mice. Eighty-five (85) proteins were confirmed to be surface 
exposed and 25 proteins were found to be able to induce bactericidal antibodies 
(Pizza et al., 2000, Roderick and Finn, 2014, Seib et al., 2012).  
This reverse vaccinology approach had led to a vaccine targeting serogroup B 
(4CMenB), which has been licensed for use in the European Union in 2014, and was 
introduced into the national infant immunisation programme in UK in 2015 (Ladhani 
et al., 2015). This vaccine targets surface proteins,  factor H binding protein (fHbp), 
neisserial adhesion A (NadA) and  neisserial heparin binding antigen (NHBA) 
combined with OMV containing porA serosubtype P1.4 (Andrews and Pollard, 2014, 
Seib et al., 2012). Nevertheless, this vaccine still does not cover all the invasive 
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serogroup B strains, as the antigens all show inter-strain variation. The use of 4 
different antigens is designed to avoid such limitations and increasing potential 
vaccine coverage (Andrews and Pollard, 2014, Roderick and Finn, 2014). Parikh et 
al. (2016) have shown that the he two-dose 4CMenB  priming schedule has halved 
the meningococcal B cases in infants, thus a highly effective preventive tool.  
1.4  Epidemiology 
N. meningitidis causes both epidemic and endemic disease, with a disease burden 
1-1000 cases per 100,000 population (Caugant, 2008). The incidence varies 
according to geographic region, ranging from <0.5 to 0.9 cases per 100,000 
population in North America and Europe to 10 to 1,000 cases per 100,000 population 
in the African meningitis belt (Pelton, 2016). Meningococcal disease has the highest 
incidence in infants and children <4 years and subsequently increases again in 
adolescent and young adults (Stephens, 2009, Stephens et al., 2007) (Figure 1.1).  
As mentioned above, serogroups A, B, C, W135 and Y account for most 
meningococcal disease, although lately there had been a rise in serogroup X 
incidence especially in sub-Saharan Africa (Caugant and Maiden, 2009), perhaps as 
a result of group A vaccination. Carriage studies show approximately 50% of the 
isolated strains are non-encapsulated compared to the disease strains (Caugant et 
al., 2007, Nicolas et al., 2007), thus rendering them un-groupable in the serological 
assays and non-pathogenic, as the capsule is a crucial virulence factor. 
Nevertheless, recent sequencing-based methods have been adopted to improve 
serogroup detection especially with the introduction of the new MenB vaccine 
(Gottfredsson, 2016, Jones et al., 2016). Studies using multilocus enzyme 
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electrophoresis (MLEE) and MLST  showed that the meningococci from carriers are 
more diverse compared to isolates recovered from  patients (Vogel et al., 2010). 
Common hyperinvasive lineages were found to be ST-11, ST-23, ST-32, ST-35, ST-
162, ST-269 and ST-41/44 (Maiden and Caugant, 2006), while ST32, ST41 and 
ST11 were also found in carriers (Yazdankhah and Caugant, 2004). 
Epidemiology studies show that the serogroups have a regional distribution pattern 
(Figure 1.2). Serogroup A N. meningitidis is linked to the highest incidence of 
meningococcal disease, hence causing  large epidemics, especially in sub-Saharan 
Africa  (Stephens et al., 2007). These strains belong to  ST-5 and ST-7 complexes, 
are highly clonal as well as emerge and spread rapidly (Nicolas et al., 2005). 
Serogroup B is known to be a major cause of sporadic disease, with prolonged 
outbreaks especially in Europe, Cuba, Chile and in New Zealand  causing significant 
morbidity and mortality (Stephens et al., 2007, Tzanakaki and Mastrantonio, 2007). 
Genotypes ET-5 (ST-32) and ST41/44 complexes isolated from these outbreaks are 
also known to cause endemic disease (Tzeng and Stephens, 2000).  
Serogroup C meningococci (especially ET-37/ST-11 complexes) have  caused both 
major epidemic outbreaks (sub-saharan Africa, Brazil), as well as case clusters and 
local outbreaks (US, Canada and Western Europe) (Claus et al., 2005, de Lemos et 
al., 2007). Worldwide outbreaks in 2000-2002 associated with the Hajj pilgrimage 
was caused by serogroup W (Zombré et al., 2007). A rise is also seen recently in 
Europe, UK, US and Canada (Campbell et al., 2017, Lucidarme et al., 2016). 
Serogroup Y have been reported to cause diseases since 1990s in USA and Canada 
(Stephens et al., 2007, Tsang et al., 2007). 
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Figure 1-1 Invasive meningococcal disease by calendar year (2004-2013) and age group in 
England & Wales  
Data extracted from “Invasive meningococcal disease by calendar year, age group and capsular 
group. England & Wales, 1998 to 2013* (*provisional)”. Part of Health Protection Report: latest 
infection report. (Public Health England, 2014)  
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Figure 1-2 Global distribution of major serogroups associated to meningococcal disease.   
The meningitis belt (dotted line) of sub-Saharan Africa and other areas of substantial meningococcal 
disease in Africa are shown. Serogroup B outbreaks by serotype are shaded in purple. Reproduced 
from (Stephens et al., 2007) 
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1.5  The meningococcal genome 
The whole genome sequences of N. meningitidis strains MC58, Z2491 and FAM18 
(Sg C, ET-37/ST-11) first published in 2000 and 2007 gave rise to new insights into 
the pathogen (Bentley et al., 2007, Parkhill et al., 2000, Tettelin et al., 2000). With 
the advancements in sequencing technology, the whole genome sequence of more 
strains including disease and carrier isolates have been characterized (Kretz et al., 
2016, Piet et al., 2011). The meningococci genome is approximately 2.1-2.2 
megabases with a GC content of approximately 52%, and contains roughly 2000 
genes. Seventy percent of the genome encodes metabolic function (Rouphael and 
Stephens, 2012) and  only 9% of the coding sequence is strain-specific (Schoen et 
al., 2007).  
Large numbers of repetitive sequences were present in the genome, especially the 
10bp Neisseria uptake sequence (5’-GCCGTCTGAA-3’), which explains its high 
recombination activities and natural competence. Other families of repetitive DNA 
are also found including the neisserial intergenic mosaic elements, correia and 
simple sequence repeats (Bentley et al., 2007, Davidsen and Tonjum, 2006, Schoen 
et al., 2009). The phenotypic variations mediated by these repetitive elements is 
crucial in meningococcal survival in the host. 
Comparative genomic studies using microarrays show that there is high homologous 
recombination, with  evidence of numerous horizontal gene transfers between 
meningococci and other commensal Neisseria sp., especially N. lactamica, as well 
as the pathogenic N. gonorrhoeae (Stabler et al., 2005, Snyder and Saunders, 
2006). No loci were found that were specific for invasive strains.  Studies on genomic 
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differences between carriage and invasive disease strains show that they belong to 
genetically distinct groups even though there is high variability in terms of virulence 
within the clonal complexes (Hao et al., 2011, Schoen et al., 2014).  
1.6  Virulence factors 
1.6.1  Surface components involved in virulence  
Capsular polysaccharide, a short-chained lipooligosaccharide, pili and other 
membrane proteins in the meningococcal outer membrane are major contributors to 
the virulence of N. meningitidis.  The polysaccharide capsule is an essential 
virulence factor in meningococcal disease as it prevents complement mediated lysis, 
opsonization and phagocytosis, thus enhancing the meningococcal survival during 
invasion of the bloodstream (Tzeng et al., 2001). Since capsule polysaccharides are 
not involved in colonization, up to 50% of the carried strains are non-encapsulated 
(Caugant et al., 2007, Nicolas et al., 2007) either due to lack of capsule production or 
due to downregulation of capsule production (Tzeng et al., 2001, Yazdankhah and 
Caugant, 2004).  
The primary meningococcal capsular polysaccharides which are associated with 
invasive disease, are composed of sialic acid derivatives (5-N-acetyl-neuraminic 
acid), except for  serogroups A and X, which are composed of N-acetyl-
mannosamine-1-phosphate and  N-acetyl-D-glucosamine-1-phospate respectively 
(Frosch and Vogel, 2006, Rosenstein et al., 2001). The capsule of  serogroup B 
meningococci is identical to the human neural cell adhesion molecule, a molecular 
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mimicry of human structure, thus explaining the  poor immune response in the host 
(Hill et al., 2010).  
Meningococcal lipooligosaccharide (LOS) causes inflammation during sepsis and is 
also known to be highly toxic to endothelial cells (Virji, 2009). LOS consists of two 
discrete regions, lipid A and the core oligosaccharide (inner and outer core regions). 
The 12 distinct immunotypes (L1-L12) are classified based on the structural 
difference of the outer core and the highly variable oligosaccharide chains. L1 and 
L8 are characterised by short chains and are found in carrier strains, compared to 
invasive strains that express the long chains (Rouphael and Stephens, 2012). L3, L7 
and L9, found in the invasive strains, can be sialylated, thus increasing the negative 
surface charge, eliciting an anti-adhesive effect mediated by the Opa and Opc outer 
membrane proteins (OMP). Nevertheless, it does not strongly inhibit type IV pili 
mediated adhesion (Bourdoulous and Nassif, 2006, Virji, 2009).   
Meningococcal adherence is facilitated by multiple structures known as the major 
and minor adhesins. Pili and opacity proteins (Opa and Opc), which are the major 
adhesins, are abundantly expressed and determine host and tissue specificity 
(Carbonnelle et al., 2009). The type IV pili (tfp) expressed in meningococci are 
involved in twitching motility, promoting bacterial aggregation as well as facilitating 
DNA uptake (Carbonnelle et al., 2009, Virji, 2009). The pili interact with non-ciliated 
cells and not only play an important role in determining the specificity for human 
epithelial and endothelial but also mediate adhesion to the meninges (Virji, 2009). 
The suspected receptors of this molecule are the I-domain of intergrin α chain or 
CD46 (Stephens, 2009).  
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The tfp are found in both Gram-negative and Gram-positive bacteria (Mattick, 2002, 
Varga et al., 2006), and the major pilin, PilE in Neisseria sp., is assembled in a 
polymeric helical fibre with the conserved N-terminal domains buried in the centre of 
the fibre (Craig et al., 2004, Gault et al., 2015). The pilus assembly involves a pre-
pilin peptidase which cleaves the N-terminal of the pre-pilin (PilD), ATPase that 
supplies energy (PilF), proteins involved in the synthesis and emergence of the pilus 
(PilM, PilN, PilO and Pil Q) in addition to PilT which controls the retraction of the 
pilus (Pelicic, 2008, Takahashi et al., 2012).  The minor proteins incorporated with 
the pili, PilX, PilV and ComP are also involved in natural competence, resistance to 
sheer stress as well as adhesion to human cells (Hélaine et al., 2005, Cehovin et al., 
2011). 
N. meningitidis expresses two opacity proteins, Opa, which is found in other 
Neisseria species and Opc found only in meningococci. Opa proteins, which consist 
of 8 stranded β barrel with 4 surface exposed loops, interacts with carcinoembronic 
antigen-related cell adhesion molecule (CEACAM) molecules, whilst Opc proteins, 
10-stranded β barrel with 5 surface exposed loops, are known to  interact with  
extracellular matrix proteins, vitronectin and /or fibronectin (Carbonnelle et al., 2009, 
Hill et al., 2010). In addition, both Opa and Opc are known to interact with heparin 
sulphate proteoglycans (HSPGs) and sialic acids. Thus Opa and Opc play important 
roles in the adhesion and invasion of epithelial and endothelial cells.  
Several minor adhesins have been identified, but the biology of the molecules, 
especially in vivo and some of their receptors have yet to be defined. Examples of 
minor adhesins include Neisseria hia homologue A (NhhA), adhesion and 
16 
 
penetration protein (APP), neisserial adhesinA (NadA) and meningococcal serine 
protease A (MspA) (Hill et al., 2010, Scarselli et al., 2006, Virji, 2009).  
1.6.2  Other molecules 
The most abundant proteins produced by the meningococci are the porin proteins, 
PorA and PorB. The porin proteins form channels in which small hydrophilic nutrients 
diffuse via cation or anion selection. In addition, they are involved in cell interactions 
(invasion) by interference of cell membrane through porin insertion. They are also 
targets for bactericidal antibodies (Derrick et al., 2006, Rouphael and Stephens, 
2012) but are not appropriate vaccine candidates as they are highly variable and 
strain specific.  
Iron is an important growth requirement for meningococci during its colonization of 
the nasopharynx as well as invasion of the bloodstream and disease. The iron in the 
body is stored intracellularly, in ferritin and haemoglobin, as well as extracellularly, 
bound to transferrin in serum and lymph, and in lactoferrin in milk and secretions 
(Perkins-Balding et al., 2004, Weinberg, 2009). Thus, iron binding proteins such as 
transferrins (TbpA and TbpB), lactoferrins (HbpA and HbpB), haemoglobin-
haptoglobulin complex (HpuA and HpuB) and haemoglobin receptors (HmbR) as 
well as receptors for specific siderophores produced in the nasopharynx (Ekins and 
Schryvers, 2006, Rouphael and Stephens, 2012, Schryvers and Stojiljkovic, 1999) 
are used by the bacterium to acquire iron from the host. 
Other than these molecules and the surface components, the meningococci has 
other virulence-related mechanisms especially phase and antigenic variation of the 
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surface molecules related to genetic switches as well as molecular mimicry 
(Stephens et al., 2007).  
1.7  Meningococcal adhesion and invasion of epithelial cells 
As mentioned before, colonization of the upper respiratory epithelial cells by N. 
meningitidis is the first stage of carriage as well as invasive meningococcal disease. 
The mechanism of epithelial cell attachment have been intensively studied, 
contrasting with what is known about the internalization, translocation and survival of 
the bacterium in epithelial cells. The mechanisms of N. meningitidis adhesion and 
invasion of nasophryngeal epithelial cells are summarized below based on the works 
published by Bourdoulous and Nassif (2006), Carbonnelle et al. (2009), Stephens 
(2009), Hill et al. (2010) and Trivedi et al. (2011). An illustration of the interaction 
between meningococci and epithelial cells is shown in Figure 1.3. 
The adhesive properties of meningococci are facilitated primarily by the type IV pili, 
especially in the capsulated strains, where the pili extend beyond the capsule and 
bind with non-ciliated nasopharygeal epithelial cells. Nevertheless, during the 
presence of high level of CEACAMs, a family of cell-expressed receptors, an 
interaction with Opa is seen and cellular invasion can occur. In non-encapsulated 
strains, the OMPs, Opa and Opc interact with their respective receptors; Opa with 
CEACAMs and heparin sulphate proteoglycans  (HSPGs), and Opc with HSPGs and 
intergrins. After the initial attachment, the bacterium forms microcolonies and this 
close adherence to the cells leads to the formation of cortical plaques, facilitating the 
extension of epithelial microvilli to engulf and internalize the bacteria. Alternatively, 
the intimate association between the meningococci and the cells mediated by the 
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opacity proteins triggers meningococcal internalization. Intracellular meningococci 
survive and proliferate within the cells, and translocate through the epithelial layers 
within 18-40h. The internalized encapsulated bacterium will also migrate back to the 
surface for transmission. Perhaps surprisingly, these transversal processes, cause 
no obvious disruption of the tight junction of epithelial cells nor their barrier 
properties.  
 
 
Figure 1-3 Schematic representation of N. meningitidis interaction with epithelial cell  
The extending pili beyond the capsule mediates the primary interaction with the cells (A). The 
meningococci induce the formation of the protrusions in the host plasma membrane which 
aggregates the bacteria into micro-colonies and facilitate pili-mediated contact with the host cells 
(B). The meningococci then, detach from the aggregates to invade the host epithelium or becomes 
aerosolized and spread to a new host (C). Reproduced from Quagliarello (2011) 
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1.8  Meningococcal traversal across the epithelial cell 
N. meningitidis colonizes and persists in the epithelial layer of the nasopharynx 
without any adverse consequence to the host. Only a small percentage of the 
bacterium internalize the cells compared to adhesion as shown in various infection 
assays using cultured cell lines (Bartley et al., 2013, Plant et al., 2006, Takahashi et 
al., 2011) and those cells that do traverse the barrier do so without disrupting the 
tight junction barrier (Merz and So, 2000, Pujol et al., 1997). Unlike meningococcal 
adherence and invasion of epithelial cells, the traversal of meningococci across the 
epithelial barrier is poorly understood. Internalized meningococci are normally 
observed in vacuoles (Pujol et al., 1997) known as Neisseria containing vacuole 
(NCV)  (Nikulin et al., 2006) and are shown to have traversed to the sub epithelial 
compartment after 18-24 hour of infection (McGee et al., 1983, Sim et al., 2000, 
Stephens et al., 1983). Studies of NCVs in endothelial cells suggest they acquire 
early endosomal marker protein, transferrin receptor and the late 
endosomal/lysosomal marker protein Lamp-1, by interacting with the endocytic 
pathway (Nikulin et al., 2006).   
Studies using polarized epithelial cells grown on semipermeable membrane inserts 
have shown a transcellular meningococcal traversal without disruption of tight 
junctions (Barrile et al., 2015, Johnson et al., 2001, Merz et al., 1996, Pujol et al., 
1997, Sutherland et al., 2010) except for Birkness et al. (1995) who demonstrated 
paracellular traversal. Birkness and colleagues used a non-polarising epithelial cell 
line for their bilayer infection model where they observed paracellular, transcellular 
and lateral passage of NCV; it is possible that their differing results can be attributed 
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to their choice of cell line. Recent work by Sutherland et al. (2010) has shown the 
importance of the type IV pili and capsule in traversal of the epithelial barrier as well 
as its dependence on the host cell microtubule network. Barrile and colleagues 
(Barrile et al., 2015) further showed that meningococci subverts the host cell 
polarization again without disrupting the tight junctions, but rather crosses the 
epithelial barrier in association with apical recycling endosomes. The meningococci-
containing phagosomes were positive for several Rab proteins typical of recycling 
vesicles, such as Rab22a. Even though these two studies hypothesized how the 
meningococci might traverse the cells, they did not investigate the genetic basis of 
the phenomena, which will be the focus of this study. 
1.9  Nutrition requirements during nasopharyngeal colonization 
In general, bacterial pathogens are heterotrophs, whereby their metabolism is 
dependent on at least one carbon source for energy and catabolic intermediates are 
anabolized into macromolecules (Eisenreich et al., 2010). N. meningitidis utilizes 
glucose, lactate, pyruvate and some amino acids as carbon sources when grown on 
minimal media (Schoen et al., 2014). Meningococci catabolizes glucose through the 
Entner-Douderoff (ED) and pentose phosphate pathways, not  through the standard 
glycolytic  Embden-Meyerhof-Parnas (EMP) pathway as the meningococci lacks the 
phosphofructokinase gene (Baart et al., 2007). Lactate is converted to pyruvate by 
lactate dehydrogenase (LDH) enzymes (Erwin and Gotschlich, 1996), entering the 
tricarboxylic acid cycle (TCA) via acetyl-CoA. N. meningitidis contains all the TCA 
genes except for the malate dehydrogenase gene, and the oxidation of malate is 
carried out  by a quinone-oxidoreductase, a membrane-bound malate 
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dehydrogenase (Leighton et al., 2001). The meningococci genome contains all the 
genes involved in amino acid biosynthesis except for certain genes involved in serine 
biosynthesis (Baart et al., 2007). Despite this N. meningitidis can synthesize  all the 
amino acids as demonstrated by Leighton et al. (2001) who measured labelled 
carbons in amino acids.   
N. meningitidis encounters ever changing physical and nutritional environments 
during its progress from colonization of the nasopharynx to penetration of the blood 
brain barrier. Thus its success as a pathogen, like other pathogens, involves the 
ability of the pathogen to successfully acquire nutrition for survival from the host cell 
and proliferate (Brown et al., 2008), a phenomena known as  “nutritional virulence”. 
Nutritional virulence is defined as a specific virulence mechanism that uses the 
host’s major biosynthetic pathways or nutrient-rich sources to improve its’ supply of 
limiting nutrients (Abu Kwaik and Bumann, 2013). Knowledge of the nutrition 
virulence of N. meningitidis could not only lead to alternative treatment strategies 
based on depriving the pathogen of essential nutrients or highlighting new targets for 
antimicrobial agents, but may also facilitate development of auxotrophic mutants for 
vaccine development.  
N. meningitidis depends on the host for its nutritional requirements during 
colonization. Examples of nutrients required during interaction with the 
nasopharyngeal epithelium, include iron and lactate as well as other trace elements 
(Trivedi et al., 2011). Few studies have been conducted on the nutrient requirements 
required during the interactions with epithelial cells, other than lactate and iron, 
(Schoen et al., 2014, Trivedi et al., 2011).  For example, Exley et al. (2005) 
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demonstrated that a mutant defective in lactate uptake showed significantly reduced 
growth in nasopharyngeal tissue compared to the wild type. There is limited free iron 
in the nasopharynx, but meningococci can acquire iron through lactoferrin binding 
proteins as well as iron-bound siderophores made by other colonizing bacteria 
(Ekins and Schryvers, 2006).  
Other studies have used indirect techniques such as comparative genomics, 
transcriptomics and signature tagged mutagenesis (STM) to study the nutrient 
requirements during meningococci colonization. Schoen et al. (2014) 
comprehensively reviewed the metabolism of the meningococci, from the 
perspective of nutritional virulence and highlighted the possible importance of amino 
acids and sulphur acquisition in meningococci colonization of the host. Evidence for 
this came from DNA microarray data. Dietrich et al. (2003) used DNA microarrays to 
analyse the transcriptome of N. meningitidis MC58 during different stages of 
infection including interaction with epithelial cells (HeLa cells) after 6h incubation. 
Seventy-two genes in 67 upregulated open reading frame (ORF) were differentially 
regulated. Twenty one of these 67 ORF encoded membrane proteins, transporter 
and secreted proteins. Of these, 8 were involved in transport (amino acid, sulphate 
and iron) and 16 were involved with metabolism. More recently, transcriptional 
differences in MC58 after 4h and 21 days colonization with 16HBE14 o-, human 
respiratory cells, was examined (Hey et al., 2013). A marked difference was seen 
between the two time points, with 382 and 552 of the 2062 genes respectively 
differentially expressed (Hey et al., 2013). Of these, 200 genes expressed at more 
than one time point encoded proteins related to metabolic functions, especially those 
involved in amino acid metabolism and inorganic ion transport (Schoen et al., 2014). 
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Jamet et al. (2013) used signature-tagged transposon mutagenesis to screen for 
genes involved in colonization of human epithelial cells. They screened 
approximately 1600 insertion mutants and identified 5 mutants that showed 
decreased ability to colonize the cells. The genes involved were fadD, nnrS, 
NMV_2034, estD and narP, encoding: a long fatty acid-CoA ligase,  a heme and 
copper containing membrane protein, a putative membrane associated thoredoxin, a 
putative esterase D, which is involved in redox signalling (Schoen et al., 2014), and 
the NarP regulator involved in the denitrification process, respectively. This study 
demonstrates the importance of nutrients including fatty acid, nitrogen and trace 
elements in meningococcal colonization.   
1.10  Genome wide transposon-based mutagenesis studies for determining 
essential genes/gene fitness in N. meningitidis 
1.10.1  Transposon mutagenesis experimental design 
The availability of whole genome sequences, developments in bioinformatics and 
high throughput sequencing has led to the revival of transposon-based mutagenesis 
studies, to determine gene fitness/essentiality (Barquist et al., 2013a, van Opijnen 
and Camilli, 2013). Transposon mutagenesis involves the parallel production of a 
large number of individual transposon insertion mutants. An insertion in an essential 
or fitness-associated ORF will render the attenuated mutant nonviable or decrease 
its abundance in the pool. Comparison of input and output libraries will thereby allow 
identification of genes needed for fitness or survival of the organism in the test 
condition. The transposons most popularly used in bacterial random genome wide 
mutagenesis are Tn5 (originated from bacteria) and Mariner transposon derivatives 
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(Barquist et al., 2013a, Choi and Kim, 2009). The transposon mutants are negatively 
selected, after which, the genomic locus of the inserted transposons are identified 
using DNA hybridization, microarrays [e.g. transposon site hybridization (TraSH),  
microarray tracking of transposon mutants (MATT) and designer arrays for defined 
mutant analysis (DeADMAn)] (Mazurkiewicz et al., 2006) as well as transposon 
insertion sequencing [e.g. transposon directed insertion site sequencing (TraDIS), 
insertion sequencing (INSeq), high throughput insertion tracking by deep sequencing 
(HITS) and transposon sequencing (Tn-Seq)] (van Opijnen and Camilli, 2013).   
In this project, we used transposon insertion sequencing (Tn-Seq) to analyse the 
data from the mutant library, based on the workflow illustrated in Figure 1.4. Many 
factors affect the data generated from Tn-Seq including the experimental design and 
downstream analysis. Experimental design includes consideration of the choice of 
transposon, the density of the library, the loss of mutants due to stochastic selection 
as well as the introduction of bias during amplification of transposon-chromosome 
junctions (Chao et al., 2016).  
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Figure 1-4 Transposon insertion sequencing workflow  
The workflow involved in the transposon insertion sequencing procedure involves the following 
steps. The transposon insertion mutant library is first created and pooled. The library is then grown 
in test conditions; selective (condition B) and non-selective (condition A). The viable mutants under 
each condition are recovered and the transposon junction in both pools are attached to sequencing 
adapters and amplified. The amplified product is then sequenced and mapped against the reference 
genome to identify the unique insertion sites. Reproduced from Chao et al. (2016). 
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1.10.2  Gene essentiality/gene fitness studies in N. meningococci 
The term “essential gene” or “essentiality” is differently defined in the reviews on 
genomic studies and includes terms such as “operationally” (Judson and Mekalanos, 
2000), “required” (Barquist et al., 2013a), “essential for survival” and “essential for 
fitness” (Gerdes et al., 2006). Nevertheless, there is general agreement that the 
essential genes/gene fitness is specific to a particular growth condition, thus it is 
crucial to always define how the “essentiality” was assessed. Even though the 
combination of transposon mutagenesis and high throughput sequencing is a 
powerful tool, not all the essential genes can be easily identified. In part, this is 
dependent on the density of the insertion in a specific gene, as well as the possibility 
of multiple redundant, or partially overlapping pathways of the biological process of 
interest (Barquist et al., 2013a, Judson and Mekalanos, 2000). 
In N. meningitidis, transposon-based mutagenesis has been used to determine 
genes involved in competence (Sun et al., 2005), maltose catabolism (Pelicic et al., 
2000), complement-mediated lysis (Geoffroy et al., 2003), systemic infections in 
infant rats (Sun et al., 2000), resistance to heme iron and other hydrophobic agents 
(Rasmussen et al., 2005) and in vitro and in sera growth (Mendum et al., 2011).  
When we started this research in 2014, two studies on meningococcal colonization 
was reported; Jamet et al. (2013) and Exley et al. (2009), but the libraries they used 
were relatively small, which would result in incomplete coverage. Exley et al. (2009) 
screened 576 mutants to identify genes involved in colonization of human 
nasopharyngeal tissue using an organ culture model (at 6 and 18 hours exposure), 
whilst Jamet et. al. screened 600 mutants for adhesion (at 18 hours exposure) to 
27 
 
T48 human colonic carcinoma derived epithelial cells and pharynx carcinoma 
derived FaDu epithelial cells. The findings from the two groups were quite variable. 
Exley et. al. identified 8 mutants that were impaired for colonization of human 
nasopharyngeal tissue, of which five were related to surface molecules: a gene 
predicted to encode a TonB receptor and two novel factors (related to a bacteriocin 
processing protein in Haemophilus influenzae and outer membrane protein OmpU). 
Jamet et al. (2013) identified some metabolic genes as described in 1.7.,  of which 
narP and estD  appeared to be involved in adaptation to hypoxic conditions and 
stress resistance. One of the limitation of the two studies, was the use of low 
saturated mutant libraries for screening. Thus, my research using an extensive 
mutant library (~14,500 mutants) created by Mendum et al. (2011) would provide a 
more comprehensive genome wide screen to identify important genes not only in 
adhesion, but also invasion and traversal across the epithelial cells. 
Whilst this research, Capel et al. (2016) described a similar approach in identifying 
genes involved in colonization of epithelial and endothelial cells. Using a mariner 
based transposon mutagenesis, they assessed the gene fitness during growth and 
colonisation using a microfluidic flow device with a 99.99% genome saturation 
library.  A total of 288 genes and 33 intergenic regions containing small noncoding 
RNA candidates were found to be important in cell colonization. Genes involved in 
type IV pili biogenesis as well carbohydrate and amino acid metabolism were among 
the genes shown to be important. 
This study uses the transposon library created by Mendum et al. (2011) and the work 
involved in its construction and the results obtained will be described. These authors 
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constructed a relatively large meningococcal transposon library, of approximately 
14,500 mutants based on Tn5 insertions in N. meningitidis strain L91543. The fitness 
effects of the genes were assessed using transposon site hybridization (TraSH) 
when grown in complete media, minimal media (to identify metabolic requirements) 
and complement inactivated serum (to determine growth requirements in serum). 
The transposon data was used to interrogate a genome-scale metabolic model that 
the group had constructed, Nmb_iTM560. Twenty six percent of the genome, i.e. 585 
genes was identified as essential when grown in Columbia blood agar with 6% 
defibrinated horse blood, the complete media.  These genes were mostly associated 
with transcription, protein synthesis, protein export and modification, DNA replication, 
fatty acid biosynthesis and cell wall biosynthesis (Mendum et al., 2011). In addition, 
a few metabolic pathways were also predicted to be essential for growth in serum, 
including genes associated with synthesis of aromatic amino acid, purines, folic acid 
and panthothenate as well as genes required for iron acquisition. In addition, the 
essentiality screen also identified amino acid transporters and lactate permease.    
1.11  Aim of the study 
Acquisition of Neisseria meningitidis in the nasopharynx, is the first stage of 
colonization as well as disease. When the bacterium crosses the epithelial barrier to 
enter the blood stream, disease occurs. The interaction of the bacterium with the 
epithelial cell layer is thereby crucial to the disease process but is poorly understood, 
especially the intracellular survival after invading the cell as well as the traversal of 
meningococci across the epithelial barrier. Thus, the overall aim of this research was 
to investigate the genetic basis of meningococci pathogenesis during colonization 
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and traversal of the epithelial barrier using transposon mutagenesis. This allows us 
to test the hypothesis that specific meningococci genes are involved in adhesion, 
invasion and traversal across the epithelial barrier.   
Main aims 
1. To optimize adhesion and invasion assays for use in transposon mutagenesis 
studies including choice of an appropriate epithelial cell line, preferably of 
respiratory origin, and conditions that facilitate high bacterial uptake while 
minimizing stochastic selection. 
2. To establish an epithelial cell traversal assay using Transwell® wells to 
provide an intact and functional cell barrier and optimize conditions for use in 
the transposon mutagenesis studies. 
3. To apply the assays to screen a Tn5-based mutant library to identify mutants 
with reduced fitness for adherence, internalization and traversal of epithelial 
cells. 
4. To perform Tn-Seq and bioinformatics analysis to identify genes involved in 
adherence, internalization and traversal of epithelial cells. 
5. To validate the function of predicted genes by individual phenotypic assays in 
order to verify the usefulness of the Tn-Seq based approach. 
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CHAPTER 2:  
MATERIALS AND METHODS 
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2    MATERIALS AND METHODS 
2.1  Bacterial strains and culture conditions 
The meningococcal strain used in this study, N. meningitidis L91543 (C:2a:P1.2, ST-
11; ET-37), also referred to as wild-type, was grown on Columbia agar base (Oxoid, 
UK) supplemented with 6% defibrinated horse blood agar plates (CBA) at 37 ˚C with 
5% CO2.  The strains were stored in Mueller Hinton broth (MHB) with 15% glycerol at 
-80 °C until further analysis. The bacterial strain was kindly provided by Manchester 
Public Health Laboratory, UK. 
The Tn5 transposon mutant library derived from the L91543 strain (Mendum et al., 
2011) was grown on CBA supplemented with 2 μg ml-1  erythromycin. The insertional 
knock out mutants created in this study as well as the phoP mutant was grown on 
CBA supplemented with 100 μgml-1 kanamycin. All plates were incubated under the 
conditions described above. The phoP mutant was kindly provided by Dr Jane 
Newcombe, Faculty of Health and Medical Sciences, University of Surrey. 
2.2  Determination of bacterial count using Miles and Misra technique  
The Miles and Misra technique was used to determine the number of viable bacteria 
in a suspension. 180 µl phosphate buffered saline (PBS) (Sigma, UK) was added 
into the wells in a sterile 96 well plate and 20 µl of inoculum was added into the first 
well. Tenfold serial dilution was done using the subsequent wells and the tips were 
discarded in between transfers to avoid carry over.  CBA plates were clearly labelled 
and 20 µl in triplicates were dropped onto each sector and incubated accordingly.  
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The plates were enumerated and the colony forming unit (cfu) was calculated using 
the formula below.  
cfu/ml = Average No. of colonies x Plating factor x Dilution factor 
2.3  Growth in MHB and tissue culture medium  
A series of growth assays were performed to assess the growth and survival of the 
wild type (N. meningitidis L91543) in MHB as well as the 3 different tissue culture 
medium used in the cell infection assays. This was necesary to establish if the tissue 
culture medium could support the growth of the strain at the inoculum size and 
duration used for the infection assays. The tissue culture media used were: 
a. Dulbecco’s Modified Eagle Medium (DMEM) (with L-Glutamine 4500 mg/L D-
Glucose) (Gibco, Fisher Scientific, UK) supplemented with 10% heat 
inactivated foetal bovine serum (FBS) (Sigma, UK) and 1% non-essential 
amino acid (NEAA) (Sigma, UK). This is referred as DMEM complete medium 
hereafter. 
b. Minimum Essential medium Eagle (EMEM) (with Earl salt and sodium 
bicarbonate) (Sigma, UK) supplemented with 2mM glutamine (Sigma, UK), 
1% NEAA(GE Health care, PAA Laboratories, Austria), 1mM sodium pyruvate 
(Sigma, UK), 0.1% lactalbumin hydrolysate (Sigma, UK) and 10% FBS 
(Sigma, UK). This is referred as EMEM complete medium hereafter. 
c. F-12K Nutrient Mixture Kaighn’s Modification (with L-Glutamine) (Gibco, 
Fisher Scientific, UK) supplemented with 10% FBS (Sigma, UK). This is 
referred as F-12K complete medium hereafter. 
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A bacterial suspension was made in PBS using a culture grown for approx. 18 h in 
CBA. The optical density (OD) reading of the suspension was taken at 600nm and 
the appropriate volume needed to give an OD of 0.05 was added to 20 ml of test 
medium in a non-vented T25 tissue culture flask. The respective medias were used 
as a blank for each measurement. These cultures were incubated at 37 ˚C in a 
shaking incubator at 200 rpm and sampled at hour 0, 2, 4, 6, 8, 10 and 24. The 
OD600nm and bacterial counts were determined at these time points. These assays 
were performed using three biological repeats.  
2.4  Epithelial cell lines and tissue culture conditions  
Three different types of epithelial cell line were used in this study. The details of the 
cell lines are summarized in Table 2.1. 
Table 2-1 Cell lines used in this study 
Cell Line Name Description Growth medium Source 
A549 Human lung 
carcinoma epithelial 
cells 
F-12K complete 
medium (Refer 2.3) 
Kindly provided by Dr Hajah 
Sajda Bibi Mohammad Afsar, 
University of Surrey, UK 
Detroit 562 Human pharynx 
epithelial cells 
(Pharyngeal 
carcinoma) 
EMEM complete 
medium (Refer 2.3) 
European Collection of Cell 
Culture (ECACC), Public 
Health England, UK 
16HBE14 o- Simian virus 40-
transformed bronchial 
epithelial cells 
DMEM complete 
medium (Refer 2.3) 
Kindly provided by Dr Li Ming 
Shi, Imperial College London, 
UK 
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2.4.1  Resuscitation from frozen stocks 
Prior to defrosting, the cap of the frozen ampoule containing each epithelial cell line 
was slightly turned while holding in tissue soaked in 70% alcohol, to release any 
trapped residual liquid nitrogen. The cap was then retightened and immediately 
transferred to a 37 ˚C water bath until all the ice crystals disappeared. The ampoule 
was wiped again with tissue soaked in 70% alcohol before opening. The content of 
the ampoule was carefully pipetted into a T25 tissue culture flask containing the 
appropriate pre-warmed growth medium (refer to Table 2.1) with 100 µg/ml 
streptomycin and 100 U/ml penicillin (Sigma, UK). The medium used for 16HBE14 o- 
cells were supplemented with 30% FBS instead of 10% during the resuscitation 
process. The flask was incubated at 37 ˚C, 5% CO2 humidified incubator. The media 
which still contained traces of the cryoprotectant, dimethyl sulfoxide (DMSO) was 
changed the next day with new complete medium with antibiotics. Cells were re-
incubated as described above and split into new flasks when grown to 80-90% 
confluence. 
2.4.2  Subculture of cell lines 
Once the cells had grown to 80-90% confluence, they were passaged and the 
passage number was noted. The flasks were checked under an inverted microscope 
to assess the cells for confluence and contamination prior to subculture. To passage 
the cells, the medium was removed, and the cells were washed twice with 
Dulbecco’s PBS without Ca2+ and Mg2+ (Sigma, UK). Cells were detached from the 
flask using 5ml trypsin-EDTA. 1X trypsin-EDTA (0.25% trypsin, 1 mM EDTA) (Gibco, 
Fisher Scientific, UK), with a 3-5 min incubation used for A549 and Detroit 562 cell 
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lines, and 10X trypsin-EDTA (0.5% trypsin, 0.2% EDTA) (Sigma, UK) with 10-15 min 
incubation used for 16HBE14 o- cells. The cells were resuspended in an equal 
volume of the growth medium with antibiotic to inactivate the trypsin and transferred 
into a falcon tube. The tube was centrifuged at 1500 rpm for 5 min (20 ˚C). The pellet 
was resuspended in the respective complete growth medium with antibiotic, and the 
appropriate volume was transferred to new flask containing pre-warmed growth 
medium with antibiotic and the flask was incubated as described above. The flasks 
were checked periodically and the medium changed every 2-4 days.  
2.4.3  Freezing of cell lines 
The cells were frozen down in liquid nitrogen for long term storage at a low passage 
number, less than 6 passages. The cells were harvested when they were 80 - 90% 
confluent as described in 2.4.2 and viable cells were quantified using trypan blue 
staining. Approximately 2-4 x106 cells/ml were frozen in 90% FBS and 10% DMSO. 
The cryovials were kept overnight at -80 ˚C in Mr. Frosty™ Freezing Container 
(Thermo Scientific, UK) and transferred into liquid nitrogen the following day. The 
viability of the stored cells was checked after 2 weeks by thawing out one ampoule.  
2.5  Optimization of adhesion and invasion assay 
2.5.1  Optimization of seeding density of 6 well plates for the adhesion and 
invasion assays 
The seeding density for all three cell lines used for the adhesion and invasion 
assays, were optimized such that they produced an 80 - 90% confluent monolayer in 
6 well plates by 48 h. Seeding densities ranging from 1x105 to 2x106 cells/well were 
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tested. Wells were seeded in triplicates in the respective growth medium without 
antibiotic and incubated at 37˚C, 5% CO2 for 48 h. The plates were checked at 48 h 
as well as 72 h to assess the growth. The cells in wells with 80 - 90% growth were 
quantified using trypan blue staining. 
2.5.2  Standard curve (OD600nm vs. cfu) for N. meningitidis L91543 
A standard curve (OD600nm vs. cfu) using 4 h culture from CBA was generated in 
order to determine the inoculum concentration of the cell infection assays. CBA 
plates were inoculated from overnight cultures and incubated for 4 h. Culture from 
the plates was suspended in PBS was made and adjusted to a series of OD at 
600nm (0.1, 0.5, 0.75, 1.0 and 1.5). The bacterial count for each OD was verified 
using the Miles and Misra technique. Three biological repeats were set up, and the 
standard curve was plotted using Microsoft Excel. 
2.5.3  Susceptibilty of N. meningitidis L91543 to gentamicin and saponin  
A literature review of the methods used for cell infections using the three different 
cell lines found that various conditions were used for protection assays and cell lysis. 
To standardize the adhesion and invasion assay used in this study, bacterial 
susceptibility to gentamicin at different concentrations and under different lysis 
conditions was tested.  
Two gentamicin concentrations (100 µg/ml and 150 µg/ml) using 4 h culture from 
CBA (1x106 cfu/ml and 1x109 cfu/ml inoculum size) at two incubation time (1 h and 
2 h) were used to optimize the gentamicin protection assay. Control wells contained 
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tissue culture media without gentamicin. The plates were incubated for 2 h and 
bacterial counts taken at 0, 1 and 2 h in three biological repeats.  
Susceptibility to saponin was performed to examine the effect on N. meningitidis 
L91543 when exposed to 2% saponin (Sigma, UK) in PBS for 10 min as required in 
the adhesion and invasion assays. The inoculum was prepared as described above 
and the volume needed for the 3 inocula were added to 2 ml of 2% saponin in PBS 
as well as to PBS alone as a control. Bacteria numbers were determined after 10 
min incubation. Three biological repeats were carried out.  
2.5.4  Adhesion and invasion (gentamicin protection) assay 
To optimize the transposon screen but also avoid stochastic selection of mutants in 
the library, the number of individual mutants present at all stages of the assay must 
be experimentally optimized. Therefore, adherence and invasion assays were 
carried out with all three cell lines using N. meningitidis L91543 to determine which 
cell line and incubation time obtained the highest bacterial uptake. The adhesion and 
invasion assay was carried out using a MOI of 1:200, at the 0, 2, 4, 6 and 24 h of 
incubation. 
Based on the results from seeding density optimization, 2.5.1, 6 well plates were 
seeded with 2x105, 3x105 and 8x105 cells/well for A549, 16HBE14 o- and Detroit 562 
cell lines respectively. After 48 h incubation, the wells were washed twice with 
Dulbecco’s PBS before infection with a 4 h culture of N. meningitidis L91543 at a 
MOI of 200. Immediately three wells were lysed to enumerate the viable cells in the 
wells and the average cell count was used to determine the bacterial inoculum 
(cfu/ml) needed to achieve the desired MOI.  
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Adhesion assay: After the infection, the bacteria in the media were enumerated 
before washing the epithelial cells three times with Dulbecco’s PBS using gentle 
pipetting. PBS containing 2% saponin was then added into each well and incubated 
for 10 min. Thereafter, the number of bacteria were determined by the Miles and 
Misra (section 2.2). 
Invasion assay: The assay was carried out as for the adhesion assay but with 100 
µg/ml gentamicin added to each well after the wash and incubated for 1 h. Bacterial 
counts were determined after the incubation to examine the effectiveness of 
gentamicin killing. The wells were washed four times with Dulbecco’s PBS to remove 
any residual gentamicin, incubated for 10 min with 2% saponin and the number of 
bacteria was determined by the Miles and Misra technique (Section 2.2). 
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2.6  Optimization of traversal assay 
2.6.1  Coating of Transwell® insert with collagen 
The effect of cell growth on pre-coating the Transwells with bovine collagen was 
assessed. The Transwell® insert were coated with bovine collagen (Sigma-Aldrich, 
UK) by incubating overnight with 50 µg/cm2 of bovine collagen diluted in 0.1 N HCL 
(Sigma-Aldrich, UK) at 4 ˚C. Unbound collagen was aspirated out and the plates 
were irradiated with UV for 30 min. The Transwell® inserts were then washed three 
times with HyClone™ Cell Culture-Grade Water (Thermo Fisher Scientific, UK) to 
remove any acid residue as well to hydrate the collagen matrix.  
2.6.2  Growth of 16HBE14o- cells in Transwell® insert  
16HBE14o- cells harvested from flasks at 80 - 90% confluence were used to seed 
the 24 mm diameter, polyester, 3 µm pore sized Transwell® inserts (Corning, Thermo 
Fisher Scientific, UK). Both collagen coated and uncoated inserts were used. The 
collagen coated inserts were prepared according to 2.6.1. Prior to seeding, the non-
coated Transwell® inserts were hydrated and equilibrated to the DMEM complete 
medium by incubating the inserts filled with the medium (1.5 ml apical chamber and 
2.6 ml basal chamber) at 37 ˚C for at least 30 min.   
Each insert was seeded with 5x105 cells, and maintained with 1.5 ml and 2.6 ml of 
tissue culture medium in the apical and basal chamber respectively. The cells were 
allowed to grow and differentiate at 37 ˚C, 5% CO2 and the medium was changed 
every 2 days. Alternatively, for cells grown in the air-liquid interphase, the media 
from the upper chamber was removed from day 2 onwards.  
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Figure 2-1 General scheme of the in-vitro model using 16HBE14o- cells grown on 
Transwell® inserts.  
The epithelial cells were seeded on the upper chamber of the insert. The growth of the monolayer 
and the formation of the barrier were monitored by measuring the trans-epithelial electrical 
resistance (TEER) complemented with the passive diffusion of the FITC-labelled 70kDa dextran across 
the cells.  
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2.6.3  Assessment of epithelial barrier integrity 
2.6.3.1  Trans-epithelial electrical resistance (TEER) measurement 
One of the tools used to assess the integrity of the monolayer was to measure the 
TEER of the formed barrier.  TEER was measured using the EVOM2, epithelial 
voltohmmeter and STX2 electrode (World Precision Instruments). All measurements 
were done under sterile conditions. The electrode was rinsed and submerged in 70% 
ethanol for at least 10 min and equilibrated to the tissue culture medium for 2-3 min 
before use. At least 2 resistance readings were taken for each insert. A no cell 
control (blank) was included in all assays to calculate the true resistance as 
described in Strengert and Knaus (2011), using the following equation: 
Resistance (R) = R with cells – R blank (Ω) 
2.6.3.2  Permeability assay 
Examining paracellular diffusion is another way of assessing the integrity of the 
monolayer and any disruption to the tight junctions between cells.  Fluorescein 
isothiocyanate (FITC) – labelled 70 kDa dextran at 0.5 mg/ml was added to the 
apical region of the insert (Strengert and Knaus, 2011), and the wells were incubated 
at 37 ˚C, 5% CO2. At each time point, 50 µl of media from the basolateral chamber 
was transferred to 96 well plates, and the fluorescence was read using Fluoroskan 
Ascent FL 2.6 Microplate Fluorometer and Luminometer (Thermo Fisher Scientific) 
with excitation and emission wavelength of 485 nm and 538 nm respectively. Tissue 
culture medium without phenol red was used in all the permeability assays, so as to 
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not interfere with the measurements due to its similar absorbance spectrum with 
FITC (Strengert and Knaus, 2011).  
2.6.4  Immunofluorescence microscopy 
In order to further demonstrate that the 16HBE14o- cells were polarized before 
bacterial infection, the localization of the tight junction proteins, occludin and ZO-1 
were examined. The inserts were washed three times with PBS before fixation with 
4% paraformaldehyde (PFA) (Thermo Fisher Scientific) for 30 min at room 
temperature (RT). The fixed cells were washed with PBS thrice and permeabilized 
with 0.3% Triton X-100 (Sigma-Aldrich, UK, UK) in PBS for 10 min, and blocked with 
1% bovine serum albumin (Thermo Fisher Scientific, UK) in PBS for 1 h. The inserts 
were incubated 1 h at RT in a humid chamber with either 5 µg/ml Occludin Mouse 
Monoclonal Antibody-Alexa Fluor®594 (Invitogen, Thermo Fisher Scientific, UK) or 
10 µg/ml ZO-1 Mouse Monoclonal Antibody-Alexa Fluor®594 (Thermo Fisher 
Scientific, UK). Alexa Fluor® 594 Mouse IgG1, κ Isotype Ctrl Antibody (Cambridge 
Bioscience, UK) was used as an isotype control. The unbound antibodies were 
removed by washing three times with PBS for 5 min. The inserts were then co-
stained with Alexa Fluor® 647 Phalloidin (Thermo Fisher Scientific, UK) and 
Molecular Probes™ DAPI (Fisher Scientific, UK). The inserts were cut out carefully 
after staining and mounted onto coverslip apical side up with mounting medium, 
SlowFade® Gold Antifade Mountant (Thermo Fisher Scientific, UK). The stained 
cells were stored at 4 ˚C in the dark until microscopic analysis using Nikon Ti-Eclipse 
with A1M Confocal.  
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2.6.5  Traversal Assay 
As discussed in the previous chapter, it is crucial in transposon library screening to 
minimize stochastic selection, thus the traversal assay was optimized to enable 
analysis of the highest number of mutants possible. Polarized 16HBE14o- cells on 
day 6 with a TEER more than >500 Ω were used for the traversal assays. Similar to 
the adhesion and invasion assay, a 4h culture of N. meningitidis L91543 at a MOI of 
200 was used for the infection and applied to the apical chamber of the insert. FITC 
labelled 70kDa dextran at 0.5mg/ml was also added to the upper chamber at time 
zero. Fresh medium was added to the basal chamber and the plates were incubated 
at 37˚C, 5% CO2 for up to 24 h. The inserts were transferred to new plates with fresh 
medium in the basal region every 2 h, and the bacteria from the both the basal 
chamber and the upper chamber were enumerated by Miles and Misra at all-time 
points, including time zero. The TEER and dextran permeability across the barrier 
were also monitored at each time point. Three independent experiments each with 
three Transwells were carried out for each assay.  
2.7  Optimized adherence and invasion assay used for Tn5 mutant library and 
single gene knock out (K/O) mutants 
The adhesion and invasion assay, which had been optimized to maximize the uptake 
of the mutants (Section 2.5), was used to screen the pooled mutant library as well 
the knock out (K/O) mutants. 16HBE14o- cells were seeded onto 6 or 24 well tissue 
culture at a concentration of  3x105  cells/well and 5x105  cells/well respectively. The 
cells were incubated at 37˚C, 5% CO2 for 48 h. On the day of the experiment, the 
cells were washed twice with Dulbecco’s PBS before infection with a 4 h culture of 
44 
 
the testing meningococcal strains at a MOI of 200. Two - three wells were lysed to 
enumerate the viable cells in the wells, and the average cell count was used to 
determine the bacterial inoculum (cfu/ml) needed for the MOI. The infected plates 
were incubated for 6 h at 37 ˚C with 5% CO2. Three independent assays either in 
duplicates or triplicates were carried out. 
Adhesion assay: After 6 h incubation, the bacteria in the media were enumerated 
before washing three times with Dulbecco’s PBS with gentle pipetting. PBS 
containing 2% saponin was added into each well and incubated for 10 min and the 
number of bacteria determined by Miles and Misra (Section 2.2). 
Invasion assay: The assay was carried out as for the adhesion assay but with 100 
µg/ml gentamicin added to each well after the wash and incubated for 1 h. Bacterial 
counts were determined after the incubation to examine the gentamicin killing. The 
wells were washed four times with Dulbecco’s PBS to remove any residual 
gentamicin, incubated for 10 min with 2% saponin and the number of bacteria was 
determined by the Miles and Misra technique (Section 2.2). 
2.8  Optimized traversal assay used for Tn5 mutant library and single gene 
knock out (K/O) mutants 
The traversal assay, which had been optimized to maximize the number of 
meningococci crossing the intact epithelial barrier (Section 2.6), was used to screen 
the pooled mutant library as well the K/O mutants. 16HBE14o- cells were seeded 
onto the 24 mm or 6 mm polyester, 3 µm pore sized Transwell® inserts using the 
parameters described in Table 2.2. The inserts were coated with collagen as 
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described in 2.6.1 prior to seeding. The cells were allowed to grow and differentiate 
at 37 ˚C, 5% CO2 and the medium was changed every 2 days.  
Polarized 16HBE14o- cells on day 6 with a TEER more than >500 Ω  (24 mm 
inserts) or day 3 with a TEER more than >1200 Ω (6 mm inserts) were used for the 
traversal assays. The inserts were transferred to new plates with a change of fresh 
media before infecting with the bacterium. Similar to the adhesion and invasion 
assay, a 4h culture of meningococci at a MOI of 200 was used for the infection of the 
apical region of the insert. The infected plates were incubated at 37 ˚C, 5%  CO2 for 
12 h. TEER readings were taken at time zero before incubation.  
After 12 h of incubation, the bacteria in the apical chamber as well as the basal 
chamber were enumerated using Miles and Misra. TEER readings were also taken 
to determine the intergrity of the epithelial barrier. Dextran permeability was also 
checked at this point by adding 0.5 mg/ml FITC-labelled 70 kDa dextran onto the 
apical chamber.  The inserts were transferred to new plates with fresh medium in the 
basal region and the fluorescence was measured after 2 h incubation. Three 
independent experiments each with three Transwells were carried out for each 
assay.  
 
Table 2-2 Seeding parameters used in Transwell® inserts 
Transwell® insert’s 
diameter 
Media volume added 
to the upper chamber 
Media volume added 
to the basal chamber 
Incubation time 
24mm 1.5 ml 2.6 ml 6 days 
6mm 0.6 ml 0.2 ml 3 days 
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2.9  Preparation of genomic DNA from transposon library for Tn-Seq 
This method section will highlight the methods involved in genomic DNA extraction, 
amplification and Tn-Seq data analysis of the library.  
2.9.1  Genomic DNA extraction 
Bacterial library ‘input’ cultures used to infect the cells and ‘output’ samples (the 
mutants recovered at the end the assays) were collected and stored in 15% glycerol 
at -80⁰C until further downstream analysis. Genomic DNA was extracted from the 
samples as follows: 100µl of the thawed glycerol stock was added to 900µl of LB 
broth and centrifuged at 5000 × g  for 10 min. The cell pellet was resuspended in 1 
ml of LB broth and the centrifugation process repeated to remove any remnants of 
glycerol. The pellet was then subject to genomic DNA extraction using Qiagen 
DNeasy® Blood and Tissue kit (Qiagen, UK), in accordance with the manufacturer’s 
recommendations. DNA was treated with RNAse (Sigma, UK) after the lysis step as 
recommended by the manufacturer in order to acquire RNA-free genomic DNA. 
Bound DNA was eluted from the spin columns by adding 150 µl of Buffer AE as 
provided in the kit. The quantity and quality of eluted DNA was assessed using the 
NanoDrop and storeed at -20 °C for further analysis. 
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2.9.2 Preparation of extracted genomic DNA from transposon library for Tn-
Seq  
Following extraction, the DNA was sheared by sonication to fragments of < 1 kb. 
Whereby, 5 µg of DNA from each sample made up to 150 µl with TE buffer, was 
sheared using the Covaris SonoLab 7 instrument with the following parameters:   
Incident Power - 105, Duty Factor – 5%, 200 cycles/burst for 80 sec. The size of the 
fragments were checked using 1% agarose gel electrophoresis  
The sheared DNA was blunt-ended using the NEBNext® End Repair Module (New 
England Biolabs) as follows: Sheared DNA ( 1 µg) was mixed with 10 µl of the 10X 
reaction buffer and 5 µl of the enzyme mix, to a total volume of 100 µl. The mix was 
incubated at 20 ˚C for 30 min and purified using the QIAquick PCR purification kit 
(Qiagen, UK). Next, a 3’-A was added to the blunt-ended DNA using the NEBNext® 
dA-Tailing Module (New Englands Biolabs, UK). The end-repaired DNA (~45 µl) was 
mixed with 5 µl of the 10x reaction buffer and 3 µl of Klenow Fragment and 
incubated at 37 ˚C for 30 mins. The A-tailed DNA was then purified using the 
QIAquick PCR purification kit. 
In order to allow the DNA to be sequenced in the Illumina platform, two adapters 
were used, Adap1 and Adap2, where the 3’-‘T’ overhang links to the A-tailed DNA 
samples. These adaptors not only allowed the DNA to be sequenced but also 
enabled quality control post-sequencing, namely PCR duplicates to be removed from 
the data.  
Adap1 (caagcAGAAGACGGCATACGAGATNNNNNNNNGTGACTGGAGTTCAGA 
CGTGTGCTCTTCCgatct) contains the 5’ Illumina binding region (shown in red), a 
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NNNNNNNN index and the Illumina read sequence (shown in blue). The binding 
region and index allow the removal of PCR amplification artefacts where products 
with an identical position and index to an already identified product are discarded 
during analysis. The lower case letters in the Illumina read sequence indicate the 
phosphorothioate (PTO) bonds, which will prevent endonuclease degradation. 
Adap2 (gatcgGAAgagca-PHO) is 3’ phosphorylated to prevent extension of the 
adapter by polymerases.  
The adaptors were prepared by mixing equal volumes of 100 µM of each adapter in 
2 mM MgCl2, giving a final concentration of 50 µM of each adapter. The adaptor mix 
was then heated at 95 ˚C for 5 min in a thermocycler, to denature any secondary 
structures  and then cooled down slowly (~2-3 h) to room temperature, to allow them 
to anneal. The adapters were ligated to the A-tailed DNA samples by adding 4 µl of 
T4 DNA ligase (Promega, UK), 6 µl of 10X ligase buffer and 4 µl adapter mix and 
incubating for 2 h at room temperature. The initial ligation was supplemented with a 
second overnight ligation with the addition of the following components: 4 µL T4 DNA 
ligase, 4 µL 10X ligase buffer and 32 µL nuclease free water. The ligation reactions 
were purified using a QIAquick PCR purification kit but with additional wash steps. 
The columns were washed 4 times with PE buffer, where 2 of the washes were left 
on the column for 5 min each. The samples were eluted in 50 µl nuclease free water 
as usual.  
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2.9.3  Amplification of loci adjacent to Tn5 transposon insertion 
The loci adjacent to the transposon insertion were selectively amplified by PCR 
using primers containing the index sequence required to multiplex-sequence the 
libraries. This enables multiple libraries to be sequenced in one lane on the Illumina 
platform and the sequence data can be re-sorted according to the library using the 
unique index/barcode used. Two types of primers were used in the amplification: 
IS6 (CAAGCAGAAGACGGCATACGA) is homologous with the 5’ Illumina binding 
region of the final product. 
NeiTR-A to NeiTR-L (Table 2.3) which contain the Illumina binding region, an index 
to identify the sample, a spacer and the transposon specific sequence.   
Twelve of the indices published by Kozarewa and Turner (2011), a study that 
involved multiplexing of 96 samples, were used in this assay. This was to ensure the 
indices were as different as possible and not have the same bases at any given 
position to avoid mis-identification of samples due to sequencing errors. The 
Hamming distance of the indices were confirmed to be between 4 and 8 (data not 
shown) with the assistance of Dr Huihai Wu, Core Bioinformatics Support, University 
of Surrey.  
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Table 2-3 List of primers used in amplification of transposon-chromosome junctions  
Primer Primer Sequence 
NeiTR-A AATGATACGGCGACCACCGAGATCTACACAAGAGATCACACTCTTTCCCTACACGACGCTCTTCCG
ATCTTCGATGATGGTTGAGATGTGT 
NeiTR-B AATGATACGGCGACCACCGAGATCTACACACAAGCTAACACTCTTTCCCTACACGACGCTCTTCCG
ATCTGTCGATGATGGTTGAGATGTGT 
NeiTR-C AATGATACGGCGACCACCGAGATCTACACACCTCCAAACACTCTTTCCCTACACGACGCTCTTCCG
ATCTAGTCCTCGATGATGGTTGAGATGTGT 
NeiTR-D AATGATACGGCGACCACCGAGATCTACACAGATCGCAACACTCTTTCCCTACACGACGCTCTTCCG
ATCTCAATGATCGATGATGGTTGAGATGTGT 
NeiTR-E AATGATACGGCGACCACCGAGATCTACACAGTACAAGACACTCTTTCCCTACACGACGCTCTTCCG
ATCTTCGATGATGGTTGAGATGTGT 
NeiTR-F AATGATACGGCGACCACCGAGATCTACACATAGCGACACACTCTTTCCCTACACGACGCTCTTCCG
ATCTGTCGATGATGGTTGAGATGTGT 
NeiTR-G AATGATACGGCGACCACCGAGATCTACACCAACCACAACACTCTTTCCCTACACGACGCTCTTCCG
ATCTAGTCCTCGATGATGGTTGAGATGTGT 
NeiTR-H AATGATACGGCGACCACCGAGATCTACACCATACCAAACACTCTTTCCCTACACGACGCTCTTCCG
ATCTCAATGATCGATGATGGTTGAGATGTGT 
NeiTR-I AATGATACGGCGACCACCGAGATCTACACCCATCCTCACACTCTTTCCCTACACGACGCTCTTCCG
ATCTTCGATGATGGTTGAGATGTGT 
NeiTR-J AATGATACGGCGACCACCGAGATCTACACCGAACTTAACACTCTTTCCCTACACGACGCTCTTCCG
ATCTGTCGATGATGGTTGAGATGTGT 
NeiTR-K AATGATACGGCGACCACCGAGATCTACACCGGATTGCACACTCTTTCCCTACACGACGCTCTTCCG
ATCTAGTCCTCGATGATGGTTGAGATGTGT 
NeiTR-L AATGATACGGCGACCACCGAGATCTACACCTGGCATAACACTCTTTCCCTACACGACGCTCTTCCG
ATCTCAATGATCGATGATGGTTGAGATGTGT 
Note: The primers contain the Illumina binding region (black), an index (red), a spacer (blue) and the 
transposon specific sequence (green) 
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Prior to a scaled up amplification of the prepared libraries, the number of cycles to be 
used was optimized using real-time PCR (q-PCR). This optimization is necessary to 
minimize accumulation of PCR artefacts, both sequence duplication and sequence 
biases that may result from the amplification of the templates, which are fragments of 
various sizes. A 10 µl reaction was set in Quant StudioTM 7 with the following 
reactions: 5 µL Phusion® High-Fidelity PCR master mix (NEB), 0.5 µL EvaGreen Dye 
(x20), 1 µl of IS6/NeiTR-X primer mix (2 pmol/µl each primer) and 1 µl of template. 
The initial denaturation was 98 ˚C for 2 min, followed by 45 cycles of 98 ˚C for 10 
sec, 58 ˚C for 10 sec, and 72 ˚C for 30 sec.  A ‘no template’ control as well as an IS6 
only control was also set up for each NeiTR-A to L/sample pair. 
Once the cycle numbers were determined, PCR amplifications were prepared with 
larger volumes of the library DNAs. Four 50 µl PCR reactions were set up for each 
sample: 25 µl Phusion® High-Fidelity PCR master mix, 5 µl IS6/NeiTR-X primer mix 
and 5 µl template. Controls as described above were also set up. The amplified 
products were pooled for each sample type and run on 1.5% agarose gel. The DNA 
fragments between 300-750 bp were extracted using QIAquick Gel Extraction Kit 
(Qiagen, UK) according to the manufacturer’s recommendation of an additional 5 
washes. Two of the washes were left on the column for 5 min each and the DNA was 
eluted into 50 µl nuclease free water. Sample fragment distribution, quality and 
concentration were checked using the 2100 BioAnalyzer and the DNA1000 chip 
(Agilent Genomics, UK). The libraries were pooled in equimolar concentrations into  
2 pools, Pool 1 and Pool 2, containing the input and output libraries of the 
adhesion/invasion assay and traversal assay respectively,  before being sent out for 
Illumina sequencing.  
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2.9.4  Tn-Seq data analysis 
The libraries were sequenced on the Illumina HiSeq 2500 platform by Genewiz Inc, 
US, where 12 libraries were multiplexed per HiSeq lane (dual indexed, single 100 bp 
read). The sequence and initial data analysis was carried out by Dr Huihai Wu. The 
data was de-multiplexed to separate the reads according to the different libraries, 
filtered and trimmed before alignments. Two mismatches were allowed for the index, 
and the reads were filtered by both the read quality and the presence of the 
transposon sequence (ATAAGAGACAG) before the first 22 bp of the reads. A quality 
score, Q >50 was used, giving a 1:100 000 chance a base was incorrectly called. 
The reads were then aligned onto the reference genome (N. meningitidis L91543) 
using Bowtie 2 alignment and the PCR duplicates, as well as reads with low mapping 
quality (MAQ ≤30), were excluded.  
The TRANSIT re-sampling tool (DeJesus et al., 2015) was used on the aligned and 
filtered reads to detect the conditional essentiality of genes between two conditions, 
based on the insertion counts for each sample. TRANSIT re-sampling is based on a 
permutation test and is able to determine read-counts that are significantly different 
across conditions. Since this method involves pooling all the reads from all biological 
repeats, the fold-change difference between the input and output pool of each 
biological repeat was also computed separately. T-test analysis comparing the fold-
change of the gene, and the whole population  corrected with Benjaminii &  
Hochberg False Discovery Rate (BH-FDR) (Benjamini and Hochberg, 1995), was 
performed.  Genes with a negative fold change >1.5 with p value less than 0.05 were 
selected for further analysis.  
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2.10  Construction and verification of knock out (K/O) mutants  
K/O mutants were created to verify the prediction of genes with reduced fitness 
detected in the Tn-Seq analysis. A total of 8 K/O mutants were created. 
2.10.1  Mutant construction 
Chromosomal DNA from Himar1 mariner transposon insertion mutants previously 
constructed as described in Table 2.4 was used to transform into N. meningitidis 
L91543 strain by homologous recombination. 0.5 μg transposed DNA was mixed 
with 10 μl of N. meningitidis grown on CBA for 18 h and resuspended in PBS to an 
OD600 of 0.5. The mix was spotted onto CBA and incubated at 37 ˚C, 5 % CO2 for 
4 h. The resulting cells were then washed from the plates and plated onto fresh CBA 
plates containing 100 μg ml-1 kanamycin. 
 
Table 2-4 List of mutant DNA transformed into N. meningitidis L91543 
N. meningitidis 
L91543 locus 
Gene N. meningitidis 
MC58 orthologs 
Chromosomal DNA Himar 1 transposition mutants used for 
transformation 
Description Reference /Source 
QP84_08240 pilF NMB0329 NMV0364 (Mutant Id:41/32) Dr Vladimir Pelicic, Faculty 
of Medicine, Imperial 
College London 
(Geoffroy et al., 2003, 
Rusniok et al., 2009) 
QP84_03755 - NMB1966 NMV2159 (Mutant Id:16/45) 
QP84_10205 carB NMB1855 NMV2044 (Mutant Id:94/39) 
QP84_06260 purE NMB1439 NMV0948 (Mutant Id:60/29) 
QP84_09625 - NMB1638 NMV0745 (Mutant Id:83/24) 
QP84_11070 mtrD NMB1715 NMV0654 (Mutant Id:55/14) 
QP84_06585 potB NMB0611 NMV1801 (Mutant Id:73/29) 
QP84_00370 fbp NMB1060 KA2014  Dr Yih-Ling Tzeng, 
Department of Medicine, 
Emory University School of 
Medicine 
(Tzeng et al., 2005) 
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2.10.2  Verification of K/O mutants 
Mutations in the wild type strain, L91543 was confirmed by PCR as well as by 
Sanger sequencing. Genomic DNA from the mutants was extracted from an 
overnight culture grown on CBA with kanamycin using the Qiagen DNeasy® Blood 
and Tissue kit (Qiagen, UK) according to the manufacturer’s recommendation. The 
eluted DNA was then quantified using NanoDrop and kept at -20 °C for further 
analysis.  
PCR Assay. The PCR was carried out using the fbp-1 and fbp-2 primers described 
by Tzeng et al. (2005) for the NMB1060 mutant. The putative mutants were 
confirmed by PCR using the primer IR1 (Pelicic et al., 2000) targeting the inverted 
repeats of the Himar1 element and primers designed to target the adjacent gene to 
the insertion sites using the Primer3 tool (Rozen and Skaletsky, 1999). The primer 
details as well as the expected product size are specified in Table 2.5 
A 50 μl PCR reaction mixture consisting of 1× Green GoTaq® reaction buffer 
(Promega, UK), 1.25 U of GoTaq® G2 DNA polymerase (Promega, UK), 0.8 mM of 
nucleotide mix (Promega, UK), 0.4 μM each of forward and reverse primers and 1 μl 
of the genomic DNA was prepared. A no template control (nuclease free water) and 
positive control using the provided chromosomal DNA (diluted 1:10) was also set up. 
The PCR reaction was performed in an Applied Biosystems 2720 thermal cycler 
according to the following program: 94 °C for 2 min; 30 cycles of 94 °C for 30 s, 
59 °C for 30 s, 72 °C for 60 s; 72 °C for 5 min and then held at 4 °C. The PCR 
products presence and size were then determined by agarose gel electrophoresis. 
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Sanger sequencing. The expected amplicons obtained following PCR of the K/O 
mutants were confirmed by sequencing. The PCR products were purified using 
QIAquick Gel Extraction kit (Qiagen, UK) and subjected to Sanger sequencing 
(GENEWIZ, UK) with the IR1 primer for all genes except for NMB1060, where fbp-1 
was used. The sequence was analysed using Basic Local Alignment Search Tool 
(BLAST) 
Table 2-5 List of primers used in amplifying Himar1 insertion K/O mutant  
K/O mutant 
name 
Primer Sequences (5’-3’) Expected 
amplicon size  
ΔNMB1060 fbp-1: GCAAACTATGGACACACTGAC fbp-2: TCTATTTTGCGTGCAGGCGGT  ~2500 bp 
ΔNMB0329 IR1: CCGGGGACTTATCAGCCAACC 
   
NMB0329: TTGTCGAGGATGACCAGTTG ~681 bp 
ΔNMB1966 NMB1966: GAGCCCATCCCCCTTTATC ~247 bp 
ΔNMB1855 NMB1855: AAAACGGCGTGAACATCATC ~677 bp 
ΔNMB1439 NMB1439: CATCATCATGGGCAGCAAC ~181 bp 
ΔNMB1638 NMB1638: AGTGCGGCGGTGTCTTAC ~645 bp 
ΔNMB1715 NMB1715: TAAGACTTTCCGCATGATGG ~650 bp 
ΔNMB0611 NMB0611: GGCTTTTGGTGCTGTTTCTG ~642 bp 
 
2.11  Statistical analysis 
Statistical analysis was performed using Graph Pad Prism6 (GraphPad Prism 
version 7.00 for Windows, GraphPad Software, La Jolla California USA, 
www.graphpad.com). Paired T-tests were used to determine the significance of 
differences between 2 groups whilst one-way ANOVA and two-way ANOVA with 
Bonferroni’s or Tukey’s post-hoc tests were used for analysis of more than 2 groups. 
In all cases, a value of P < 0.05 (*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 and **** p ≤ 
0.0001) was considered statistically significant.  
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3    DEVELOPMENT OF IN-VITRO MODEL FOR MENINGOCOCCAL 
COLONIZATION OF EPITHELIAL CELLS 
3.1  Introduction 
N. meningitidis is a strict human pathogen and the human nasopharynx is the only 
known reservoir of the organism. Hence, animal models cannot be used to study the 
interaction of this organism with the epithelial cells of the respiratory system. 
Researchers have therefore opted to use in vitro methods such as cell lines or organ 
culture to study these interactions. Organ culture has the advantage in that it 
contains an intact upper respiratory mucosa with normal populations of human 
epithelial cells and leukocytes, however it is labour intensive and prone to biological 
variation that reflects the source of the organ and the coincident disease status of 
the donors (Read and Goodwin, 2001). 
 Alternatively, cell lines have been widely used to study bacterial adhesion and 
invasion, including immortalized cell lines derived from the upper and lower 
respiratory systems (Bartley et al., 2013, Grifantini et al., 2002, Hey et al., 2013, 
Jamet et al., 2013, Wong et al., 2011a) as well as the conjunctiva (Hey et al., 2013, 
Hung et al., 2013), colon (Jamet et al., 2013) and cervix (Dietrich et al., 2003, Kurz et 
al., 2003). In these studies, a range of experimental parameters have been used, 
with MOIs ranging from as low as 10 (Kurz et al., 2003) to as high as 5000 
(Takahashi et al., 2008), and incubation times ranging from 4 (Li et al., 2009) hours 
to 96 hours (Hey et al., 2013). In addition, several variations in the methods used to 
perform cell disruption and gentamicin protection assays are evident from the 
studies.  The impacts of these parameters on assay outcome, demonstrate that 
58 
 
assay optimization is a necessary first step when deciding the cell type, MOI and 
incubation time for the adhesion and invasion assays. 
 Another important consideration when working with transposon mutagenesis 
libraries is to ensure that bacterial uptake is optimized to avoid stochastic selection 
during adherence or invasion processes. Bottlenecks are a major technical challenge 
in high-throughput assays such as transposon insertion sequencing, as it can limit 
the library complexity as well as overshadow the effects of fitness defects leading to 
false positive results (Abel et al., 2015, Pritchard et al., 2014). Therefore the aim of 
this chapter is to optimize the conditions of adhesion and invasion assays including 
deciding which respiratory epithelial cell line to use, in order to maximize the 
bacterial uptake of N. meningitidis L91543, the strain harbouring the Tn5 mutant 
library. Three cell lines of respiratory origin were considered for this project: the 
Detroit 562 cell line since N. meningitidis colonizes the upper respiratory tract, 
16HBE14o- cells as they are able to withstand prolonged incubation times of up to 
21 days (Hey et al., 2013) and A549 cells, which can be used with a high MOI 
(Takahashi et al., 2008). 
3.2  Results 
3.2.1  Optimization of seeding number of 6 well plates for the adhesion and 
invasion assays 
The three chosen cell lines (A549, Detroit 562,16HBE14o-) were grown on 6-well 
plates and the seeding densities that gave 80-90% confluence by 48 h incubation 
were considered optimal. Thus, wells were seeded with 1 x 105 to 2 x 106 cells, 
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visually checked up to 96 h post incubation and the cell number quantified when 80-
90 % growth at the desired endpoint had been reached. Cells were grown in media 
without antibiotics, in triplicate. The results obtained are summarized in Table 3.1. 
Based on the data, 2 x 105, 3 x 105 and 8 x 105 cells/well for A549, 16HBE14o- and 
Detroit 562 respectively, were chosen as the seeding density for all subsequent 
adhesion and invasion assays. 
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Table 3-1 Summary of seeding numbers tested to obtain growth of 80-90% confluence in 6 
well plates and the cell numbers in the wells when confluent 
Seeding number (cells/well) 
Growth (Confluence) 
Cell counts (cells/well)* 48 hours 72 hours 
Detroit 562 cells 
3x105 40-50% 80-100%  
 4x10
5 40-50% 80-100%  
 5x10
5 50-60% 80-100%  
 6x10
5 50-60% 90-100%  
 7x10
5 50-60% 90-100%  
8x105 70-90%  1.62x106 ± 6.73x105 
9x105 70-90%  2.15x106 ± 2.73x105 
1x106 90-100%   
 2x10
6 100%   
 16HBE14o- cells 
1x105 20-30% 60-70%  
 2x10
5 50-60% 100%  
 3x10
5 70-90%  4.67x105 ± 2.15x105 
3.5x105 70-90%  1.34x105 ± 1.33x105 
4x105 80-100%  3.88x105 ± 8.64x104 
5 x105 100%   
 A549 cells 
1x105 40-50% 100%  
 2x10
5 80-90% 100% 1.08x106 ± 5.73x104 
3x105 90-100%  6.99x105 ± 2.01x105 
3.5x105 90-100%  6.48x105 ± 1.25x105 
4x105 100%   
 5x10
5 100%   
 
Note:  Cells were grown on 6 well tissue culture plate and the confluence was assessed visually. * Mean ± SD 
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3.2.2 Standard curve for N. meningitidis L91543 
In order to use the optical density (OD) of N. meningitidis L91543 cultures as a way 
to ensure known concentrations of bacteria were added during adhesion and 
invasion assays, a standard curve of optical density vs cfu was obtained.  Growth of 
N. meningitidis L91543 was measured by absorbance (OD600nm) and viable bacteria 
were determined by performing serial dilution and plating on media. As can be seen 
in Figure 3.1, a linear relationship between OD and the number of viable cells was 
obtained (R-squared value = 0.9783). Thus in all future experiments, this standard 
curve was used to estimate the MOI. 
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Figure 3-1 Standard curve of OD600 vs cfu for N. meningitidis L91543 
A line of best fit (R-squared value= 0.9784) for the average cfu/ml against the corresponding OD 
readings to extrapolate the inoculum during the cell infection assays. Viable bacterial counts for 5 
corresponding OD 600nm (0.1, 0.5, 0.75, 1.0 and 1.5) was determined. Data is shown as mean ±SEM 
of the bacterial counts from 3 biological repeats. 
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3.2.3 Growth in Mueller Hinton broth (MHB) and tissue culture medium 
In order to determine whether tissue culture media, which will be used in the 
adhesion and invasion assays, could support the growth of N. meningitidis L91543, 
growth curve experiments were performed in tissue culture media. Triplicate cultures 
of all three media types (F-12K complete medium used for A549 cells, EMEM 
complete medium used for Detroit 562 cells and DMEM complete medium used for 
16HBE14o- cells) as well as MHB as a positive control were sampled. OD (600nm) 
readings and viable counts were taken every 2 h for 10 h and at 24 h of incubation. 
Growth differences between MHB and the different media were analysed using two-
way ANOVA test followed by Bonferroni’s multiple comparison post-hoc tests. The 
results showed that growth between the tested media and control (MHB media) was 
significantly greater at hours 2 and 4, but significantly poorer for F12K and EMEM at  
24 h (Figure 3.2).  The absorbance data showed similar results (data not shown). 
However, overall all media were capable of supporting N. meningitides growth and 
so further optimization of the respective cell lines was performed. 
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Figure 3-2 Growth curves of N. meningitidis L91543 (wild type) in MHB, F12K complete 
medium, EMEM complete medium and DMEM complete medium  
20ml of the tested tissue culture media and MHB were inoculated with an overnight culture of 
L91543 strain to an OD600nm and incubated in a shaking incubator. The bacterial counts were set up 
every 2 h for each media using Miles and Misra. Data are shown as the mean ± SEM of cfu/ml against 
incubation time. The assays were done in 3 biological repeats.   
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3.2.4  Susceptibilty of N. meningitidis L91543 to gentamicin  
In order to optimize the gentamicin protection assay, bacterial survival of 2 inoculum 
concentrations (1x106 cfu/ml and 1x109 cfu/ml) were exposed to different gentamicin 
concentrations (100 µg/ml and 150 µg/ml) for varying exposure times (1 and 2 h) 
was assessed in each of the 3 media. Corresponding bacterial counts were 
calculated and analysed using two-way ANOVA with Tukey’s correction. In general, 
at the lower inoculum density (1x106 cfu/ml), no bacteria were recovered at either 
gentamicin concentration (Figure 3.3 A-C). However, this was not the case when 
using the higher density inoculum, where despite a significant reduction in cell 
numbers compared to the controls (p values ranged from <0.0001 to 0.0227), some 
bacteria (~0.05%) survived the treatment. While Tukey’s multiple comparison test 
showed significant differences between gentamicin concentration and incubation 
time for DMEM and EMEM media, this was not the case in the F12K complete 
medium.  The reasons for these differences are not known.  
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Figure 3-3 Gentamicin susceptibility assay of N. meningitidis (wild type) in DMEM 
complete medium (A), EMEM complete medium (B) and F12K complete medium (C) 
Tissue culture medium with gentamicin concentrations of 100 µg/ml and 150 µg/ml were inoculated 
with 4 h culture of the L91543 strain at 1x106 cfu/ml and 1x109 cfu/ml inoculum sizes. Controls, 
gentamicin free media was also set up concurrently. Bacterial counts at 1 and 2 h incubation was set 
up using Miles and Misra. Data is shown as mean ± SEM of 3 independent experiments. The 
significant difference between the different testing conditions were determined using two-way 
ANOVA with Tukey’s correction, where *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 and **** p ≤ 0.0001.  
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3.2.5 Susceptibility of N. meningitidis L91543 to saponin  
Saponin is used to disrupt the epithelial cells in the adhesion and invasion assays. 
To ensure that this did not impact the viability of the meningococci, the effect of 2% 
saponin on N. meningitidis was tested.  Bacterial survival following exposure of three 
bacterial densities (1x106 cfu/ml, 1x108 cfu/ml and 1x109 cfu/ml) to PBS 
supplemented with and without 2% saponin, was compared. As can be seen in 
Figure 3.4, there were no significant differences between the recovery of bacteria in 
control (PBS) versus 2% saponin at the two lower cell densities (1x106 cfu/ml 
(p=0.7836) and 1x108 cfu/ml (p=0.0852). However, saponin treatment caused a 
small but significant reduction in cell viability when the highest cell density was 
tested (1x109 cfu/ml inoculum (p=0.0105)). Thus in all future studies the bacterial 
samples are diluted immediately by serial dilution for plating to minimize any possible 
loss due to the effect of saponin.  
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Figure 3-4 Growth of N. meningitidis L91543 when exposed to 2% saponin in PBS for 10 
minutes compared to control (PBS) 
A 4 h culture of the L91543 strain at 1x106 cfu/ml, 1x108 cfu/ml and 1x109 cfu/ml concentration were 
added to 2 ml saponin and PBS, as control. Viable meningococci was enumerated after 10 min of 
incubation. Three independent experiments were set up and the data is presented as mean ± SEM.  
The significant differences between the strains were determined using two-tailed paired T-test, 
where * denotes P ≤ 0.05.   
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3.2.6  Adhesion and invasion assay 
Adhesion and invasion assays were carried out using A549, 16HBE14o- and Detroit 
562 cells to determine the most suitable cell line and infection time to be used on the 
future studies with the transposon library. The assays were carried out in triplicates 
(3 wells per cell type) with one ‘no cell’ control, at a multiplicity of infection of 1:200 
for each biological repeat. The cells were exposed to the bacterium for 2, 4, 6 and 24 
hours and the number of bacteria determined at each time point including 0 hour 
incubation. In order to check the effectiveness of gentamicin killing, bacterial counts 
were also determined after the 1 h incubation with 100 µg/ml gentamicin. No growth 
was obtained for all time points, demonstrating that extracellular bacteria had been 
killed using this gentamicin concentration. 
The number of adhering bacteria in each cell type was determined by subtracting the 
bacterial counts after gentamicin protection assay from the adhesion assay counts. 
The number of adhering bacteria was plotted against time for all 3 cell types (Figure 
3.5) and the differences between the time points, including unspecific attachment in 
control wells were analysed using two-way ANOVA test with Tukey’s multiple 
correction. The highest number of adherent meningococci was seen at hour 6 in 
Detroit 562 cells (p=0.0001) with a mean of 4.25 x 105 cfu/well, and at hour 24 in the 
16HBE14o- cells (p<0.0001; mean=3.77x107 cfu/well) and A549 (p=0.0130; 
mean=1.76x106 cfu/well). These values corresponded with 25% adhesion to 
16HBE14o- cells at 24 hours to less than 2% in the other two cell lines, indicating 
that meningococci adhere best to 16HBE14 σ cells.  
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Non-specific bacterial attachment to the plastic surface of the wells was seen at all-
time points in the ‘no cell control’ well for each media. However, these numbers 
represented a small fraction of the input bacteria (range 0.03% - 0.137%). Studies 
show N. meningitidis forms biofilms on abiotic surfaces (Lappann and Vogel, 2010, 
O'Dwyer et al., 2009), so this artefact may be unavoidable. Since we observed 
meningococcal adherence at time zero, the adhesion counts were normalised to time 
zero. However, similar values were obtained (data not shown), thus in future 
experiments we used adherence counts without normalization for determining 
meningococcal adherence.  
The invasion assays produced similar results with the highest number of internalized 
bacteria evident at 6 h post infection in Detroit 562 cells (p<0.0001), and 24 h in 
16HBE14o- (p=0.0086) and A549 (p=0.0003) cells (Figure 3.6). The mean cfu/well at 
these time points was 4.11x102, 1.67x104 and 3.89x102 respectively. When 
expressed as a percentage, 0.0053% of the meningococci were internalized in the 
16HBE14o- cells compared to only 0.0004% in A549 cells at 24 h.  One-way ANOVA 
test and Tukey’s post hoc test was used to determine the significant difference 
between the time points in each cell type (Figure 3.6). Meningococcal invasion of all 
cell lines was significantly greater compared to the time zero data, and for 
16HBE14o- cells, significantly increased between 4 and 6 h post infection. 
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Figure 3-5 Adherence assay with Detroit 562 (A), 16HBE14o- (B) and A549 (C) cells  
Detroit 562 (A), 16HBE14o-  (B) and A549 (C) cell layers grown to 80-90% confluence in  6 well tissue 
culture plates were infected with a 4 h culture of N .menigitidis L91543 strain with a MOI of 200. No 
cell controls were also set up. The number of adhering bacteria were enumerated using Miles and 
Misra at hours 0, 2, 4, 6 and 24.  Data is shown as mean ± SEM of the bacterial counts from 3 
biological repeats. The significant differences between the counts were determined using two-way 
ANOVA with Tukey’s correction where *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 and **** p ≤ 0.0001. The 
asterisks in black show the statistical difference compared to time 0.  
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Figure 3-6 Internalization assay with Detroit 562 (A), 16HBE14o- (B) and A549 (C) cells  
Detroit 562 (A), 16HBE14o-  (B) and A549 (C) cell layers grown to 80-90% confluence in  6 well tissue 
culture plates were infected with a 4 h culture of N .menigitidis L91543 strain with a MOI of 200. The 
number of internalized bacteria were enumerated using Miles and Misra after the gentamicin 
protection assay at hours 0, 2, 4, 6 and 24. Data is shown as mean ± SEM of the bacterial counts 
from 3 biological repeats. The significant differences between the counts were determined using 
one-way ANOVA with Tukey’s correction where *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 and **** p ≤ 
0.0001. The asterisks in black show the statistical difference compared to time 0.  
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3.2.7 Multiplicity of infection (MOI) determination using 16HBE14o- cells 
Based on the experiments carried out with the 3 cell lines described above, the 
16HBE14o- cell line which demonstrated the highest bacterial adhesion and invasion 
was selected for further optimization.  Studies to check if a higher MOI could be used 
for the library screening were performed. Infections were set up as described in 
section 3.2.6 using a MOI of 200, 500 and 1000 with an incubation time of 24 h, as 
16HBE14o- cells had shown the highest bacterial uptake at this time point.  Bacterial 
counts were determined at both 0 h and 24 h. Meningococci were seen to adhere 
even at zero hour as before, with a mean of 2.33x104, 3.17x104 and 2.04x105 
respectively. Even though, there was a trend towards lower levels of adhesion and 
higher internalised bacteria at the higher MOIs after 24 hours of exposure (Figure 
3.7), differences were not statistically significant (one-way ANOVA).  
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Figure 3-7 Adhesion and internalization assay with 16HBE14o- cells for MOI determination  
16HBE14o- cells grown to ~ 80% confluence were infected with 4 h culture of N. meningitidis L91543 
strain at MOIs of 200, 500 and 1000.  The number of adhering and internalized (gentamicin 
protection assay) bacteria were enumerated using Miles and Misra after 24 h incubation.  The data 
shown is the mean cfu/well of 3 biological repeats, with the error bars representing the standard 
error of mean. No significant difference was seen between the MOIs for both the adherence 
(P=0.1120) and internalization (P=0.5733) assays using the one-way ANOVA test 
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3.2.8  Verification using phoP mutant  
The optimization thus far, has been done using N. meningitidis L91543, the strain 
harbouring the Tn5 mutant library. To provide a control in which we expected 
reduced adherence/invasion, we used a phoP mutant, which is inactivated for a gene 
regulator previously shown to be involved in virulence of N. meningitidis (Johnson et 
al., 2001). This mutant has previously been shown to be attenuated in adhesion and 
invasion of epithelial cells (Afsar (2012). Herein, the phoP mutant showed reduced 
adherence and invasion compared to the wild type strain, i.e. 62.4% and 9.5% 
respectively (Figure 3.8). The difference in adherence was not statistically significant 
between the mutant and wild type (t-test p=0.1690), however, a significant reduction 
in the number of internalised bacteria was found (p=0.0014). Assessment of bacterial 
growth in tissue culture media revealed that the phoP mutant was attenuated for 
growth in vitro compared to the wild type (p<0.001) (Appendix A.1). A 10- to 20-fold 
difference in bacterial counts was seen between the wild type strain and mutant 
between the 2nd to 6th hour post inoculation; therefore, the decrease could also be 
due to the inability of the mutant to grow in the media.  
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Figure 3-8 Adhesion and invasion of 16HBE14o- cells by wild type N. meningitidis and the 
phoP mutant  
16HBE14o- cells grown to ~ 80% confluence were infected with 4 h culture of N. meningitidis L91543 
strain at MOIs of 200.  The number of adhering and internalized (gentamicin protection assay) 
bacteria were enumerated using Miles and Misra after 6 h incubation.  The data shown is the mean 
cfu/well of 3 biological repeats, with the error bars representing the standard error of mean. The 
significant differences between the strains were determined using two-tailed T-test, where ** 
denotes P ≤ 0.01.  A. The number of adherent and internalized bacteria; B. Relative percentage of 
adherent and internalized bacteria compared to wild type, N. meningitidis L91543.   
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3.3  DISCUSSION 
Humans are the only known reservoir for meningococci and an important stage in 
meningococci pathogenesis is the colonization and traversal of the nasopharyngeal 
epithelial cells. During selection of a transposon library, it is important to maintain 
maximal numbers of mutants to avoid stochastic loss of cells and to ensure 
confidence in the fitness values that are obtained. Given that a variety of cells as well 
as testing parameters have been used by other researchers when studying 
meningococcal adhesion and invasion, it was important to optimize the parameters 
used in our screen.  
Our adhesion and invasion assay were optimized for three epithelial cell lines of 
respiratory origin: 16HBE14 o- cells, A549 cells and Detroit 562 cells. The 
parameters that were sequentially optimized and checked included:- 
 Seeding number of each cell lines 
 Concentration and exposure time of gentamicin in gentamicin protection 
assay 
 Susceptibility of N. meningitidis to saponin 
 Cell type and incubation time which enables the highest bacterial uptake, and 
 MOI  
Approximately 105 cells/ml was found to be the optimal seeding number to achieve 
80-90% confluence after 48 h incubation for each of the cell types and this was used 
in all future studies. N. meningitidis L91543 was shown to be susceptible to 100µg/ml 
gentamicin at 1 hour incubation with an inoculum of 1x106. At the higher inoculum 
(1x109), meningococci continued to grow in all three tested media even at the 
concentration of 150 µg/ml at 2 hours but showed a significant reduction (99.94% - 
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99.99%) in growth compared to the controls. N. meningitidis is normally highly 
susceptible to gentamicin, with no resistance being reported, although gentamicin is 
not a recommended course of treatment. The gentamicin resistance seen in the 
assay could therefore be due to tolerance rather than resistance to gentamicin. 
Tolerance to antibiotic is often reported to be caused by dormant, non-dividing 
bacteria, or bacteria with a slower growth rate, thus minimizing the target for the 
antimicrobial activity, for example interrupting translation by aminoglycosides (Gefen 
and Balaban, 2009, Lewis, 2007). Even though ~0.06% survival was seen with the 
higher inoculum, it’s highly unlikely that 1x109  bacteria would be present after the 
three PBS washing steps that occur during the gentamicin protection assay, thus the 
lowest concentration (100µg/ml) and shortest incubation time (1 h) was chosen for 
use in future assays. These conditions would also minimize the possibility of 
gentamicin entering the host cell and killing any internal bacteria.  
Saponin was used to disrupt the host cells when counting the internalized bacteria. 
Saponin forms pores in membranes and also is reported to have antifungal and 
antiviral properties (Francis et al., 2002). Some bacteria, such as Streptococcus 
bovis  and Butyrivibrio fibrisolvens (Wallace, 2004) appear to be susceptible to the 
chemical, thus its effect on N. meningitidis was determined. While saponin treatment 
caused a slight reduction (up to ~3%) in the number of bacteria compared to the 
control, this was much less than that found with Triton X-100, a detergent commonly 
used to disrupt cells, which caused 100% meningococcal death when tested (data 
not shown). In order to minimize the slight bactericidal effect, samples were diluted 
and plated immediately after 10 min exposure to 2% saponin.  
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The adhesion and invasion assays that were carried out demonstrated that, of the 
three cell lines tested, 16HBE14o- cells are best suited for the library screen as they 
exhibited the highest number of adherent and internalized meningococci at all time 
points when compared to A549 and Detroit562 cells. Adhered and internalized 
meningococci were up to 24- and 44-fold higher in 16HBE14o- cells compared to the 
other cell lines at 6 and 24 h post infection, respectively. While Detroit 562 cells may 
represent a more relevant cell line (as meningococcal colonizes the upper 
respiratory tract and this cell line is derived from the pharynx), they exhibited very 
low levels of meningococcal interaction.  Since the purpose of establishing the 
infection assays was to enable screening of a large number of mutants and to 
minimize stochastic selection in the library, 16HBE14o- were considered the best cell 
line to use for this purpose as they exhibited higher numbers of adherent bacteria. 
16HBE14o- cells are described as non-serous, non-cilliated, polarised cell with 
functional tight junction (Ehrhardt et al., 2008), and meningococci are reported to 
attach mainly to non-cilliated  columnar cells (Stephens et al., 1983). Furthermore, 
16HBE14o-  cells would also be suitable in the meningococcal traversal study using 
Transwell® as they are reported to form stronger intercellular contacts with a 10-fold 
higher resistance compared to A549 cells (Heijink et al., 2010).   
Once the cell line was chosen, we attempted to determine the exposure time that 
facilitated the highest meningococcal adherence and internalization, again to avoid 
stochastic selection. Other researchers have used a range of adherence and 
invasion time periods (Hey et al., 2013, Jamet et al., 2013, Kumar et al., 2012, Li et 
al., 2009). Hey et al. (2013) had demonstrated that there is difference in genes 
expressed in short (2, 3, 4 and 6 hours) and long term (18 h, 24 h, 96 h and 21 days) 
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co-cultivation assays, suggesting that the genes identified with a loss in fitness in our 
screen may differ depending on the length of the incubation time. Based on our 
optimization data, we decided on 24 h as a suitable period because the highest 
meningococci uptake was observed at this time point. 
Using the 16HBE14o- cells with meningococci exposure time of 24 h we proceeded 
to optimize the MOI. MOIs greater than 200 did not give rise to significantly more 
adherent or invasive bacteria, and moreover, visual observation of cell layer at these 
high MOIs revealed degeneration; thus we opted to maintain the MOI at 200. Upon 
further review of the results and taking into account the possible impact of higher cell 
detachment from the tissue culture plate wells at 24 h compared to 6 h (based on 
visual observation), the incubation time was also switched to 6 h as similar numbers 
of  adherent (P=0.2903; 2-way ANOVA with Tukey’s multiple correction) and 
internalized (P=0.9917; one way ANOVA  with Tukey’s multiple correction) bacteria 
was seen between these time points.  
All the optimization experiments performed thus far used the wild type strain, L91543 
as it will harbour the Tn5 mutant library. We used a PhoP mutant to show that under 
the conditions of our assays, mutants containing a known adherence defect could be 
detected. PhoP has been previously shown to be attenuated in colonizing the human 
umbilical vein endothelial cells (HUVECs) (Jamet et al., 2009) as well as attenuated 
in traversing Chang conjunctiva human epithelial cells (Johnson et al., 2001).  While 
neither of these papers looked directly at adherence and invasion of epithelial cells, 
the PhoP-PhoQ regulatory system has been shown to be important in mediating 
interactions with the epithelium in other Gram negative bacteria, such as Salmonella 
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(Behlau and Miller, 1993) and Pseudomonas (Gellatly et al., 2012). Herein, we 
showed that the N. meningitidis PhoP mutant exhibited reduced adhesion and 
invasion compared to the wildtype, although only reductions in invasion reached 
statistically significant levels. These findings indicate that our assay conditions are 
suitable for detecting previously undiscovered meningococci factors involved in 
adherence and invasion. 
In summary, this chapter describes the steps taken to optimize the adhesion and 
invasion assays for use in transposon mutagenesis protocols so that the maximum 
number of mutants can be screened. This optimized method will now be applied to 
screen the transposon library (Chapter 4) as well as to verify the phenotypes of 
single gene deletion mutants (Chapter 6). The experimental conditions are 
summarized in Figure 3.9 and the methods used to generate them described in 
detail in Chapter 2 (Section 2.7). 
 
Figure 3-9 Optimized adhesion and internalization assay with 16HBE14o- cells  
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4    DEVELOPMENT OF AN IN-VITRO MODEL FOR MENINGOCOCCAL 
TRAVERSAL OF EPITHELIAL CELLS 
4.1  Introduction 
Meningococci adherence to, and internalization of, epithelial cells are the first stages 
of colonization and disease, as emphasized in the previous chapters. Nevertheless, 
meningococcal disease only occurs once the bacterium has successfully crossed the 
epithelial layers and entered the bloodstream. The first barrier faced by the 
meningococci is the nasopharynx, which is composed of ciliated pseudostratified 
columnar epithelial cells (Reznik, 1990). To date, very few studies have been 
published in regards to meningococcal traversal of the epithelial barrier, and of these 
only Sutherland et al. (2010) and Barrile et al. (2015) used cells of respiratory origin, 
i.e. Calu-3 cells. The other four published works used T84 cells, human colonic 
carcinoma-derived epithelial cells (Merz et al., 1996, Pujol et al., 1997), Chang cells, 
human conjunctiva epithelial cells (Johnson et al., 2001) and HecIB cells, 
endometrial carcinoma epithelial cell line (Birkness et al., 1995). Birkness et al. 
(1995) developed a bilayer infection model using both epithelial and endothelial cell 
lines which enabled them to study virulence factors of the bacterium involved in 
traversing across the bilayer.  None of these published works used transposon 
mutagenesis libraries to enable genome-wide identification of the factors involved in 
traversal of the epithelial barrier. However, all used semipermeable cell inserts from 
various manufacturers to investigate meningococcal migration across the epithelial 
barrier.  
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In order to maximize the information obtained from a transposon-based mutagenesis 
study, it is essential to optimize the number of mutants used in the experimental 
system while limiting loss due to stochastic processes. Hence, the in-vitro cell layer 
model must withstand a high MOI inoculum to enable high numbers of 
meningococci, ideally representing the entire library, to traverse the cell layer. The 
previous chapter provides substantial evidence that the 16HBE14o-  cell line is the 
best choice for screening the Tn5-based mutant library as it is not only able to 
withstand infection with high MOI, but also enables the highest meningococci 
adherence and internalization, which one could extrapolate, will lead to higher 
migration of meningococcal across the epithelial barrier, thus minimising stochastic 
selection during the library screening.  
The SV40-transformed bronchial epithelial cell line, 16HBE14o-, which has cuboidal-
shaped cells with retained tight junctions and microvilli (Cozens et al., 1994, Ehrhardt 
et al., 2002) has not been used previously for meningococcal traversal assays. 
Nevertheless, 16HBE14o-  cells have been used to study other bacterial and viral  
infections of the respiratory system including Haemophilus influenza (Ketterer et al., 
1999), Burkholderia cenocepacia (Kim et al., 2005), Pseudomonas aeruginosa 
(Bucior et al., 2014) and Rhinovirus (Sajjan et al., 2008).  This cell line is also 
commonly used in drug transport and metabolism studies due to its strong 
intercellular contacts which form a permeability barrier (Ehrhardt et al., 2008, Heijink 
et al., 2010), making it ideal for our traversal assay with the pooled mutants.  
The main objectives in developing culture conditions for measuring meningococcal 
traversal across respiratory epithelial cells are to promote the formation of a suitable 
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barrier encompassing differentiated, polarized epithelial cells. In order to better 
mimic the physiological conditions of the respiratory system, the cells are grown on 
semipermeable cell inserts; whereby the integrity of the formed barrier are 
determined by trans-epithelial electrical resistance (TEER) measurements 
complemented with  paracellular diffusion of radioactively or fluorescently-labelled 
hydrophilic markers of various molecular weights, such as BSA, sucrose, dextran etc 
(Benson et al., 2013, Georas and Rezaee, 2014, Pujol et al., 1997).  TEER provides 
a measure of barrier integrity while causing minimum disruption to the monolayer 
(Srinivasan et al., 2015). 
Two methods are commonly utilized when growing respiratory epithelial cell lines 
such as Calu-3, A549 and 16HBE14o-, namely liquid covered culture (LCC) and air 
interphase culture (AIC). LCC involves growing cells which are submerged in media 
on both the apical and basal sides of the vessel. AIC is used when cells are grown in 
the presence of media only in the basal chamber, similarly to how cells are exposed 
to air in situ in the respiratory tract.  Cells exhibit different degrees of cell 
differentiation in addition to lower TEER and permeability marker diffusion  (Forbes 
and Ehrhardt, 2005) when grown in the AIC conditions. Other factors that also affect 
the growth and differentiation of epithelial cell cultures include the seeding density, 
the passage number of cell lines, time in culture and the surface the cells are grown 
on. 
The aim of this chapter is to optimize and establish a traversal assay with 
16HBE14o- cells grown on permeable membrane inserts (Transwells®), which would 
 provide a barrier of fully differentiated and polarized epithelial cells 
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 withstand infection with a high MOI  
 enable the highest meningococcal migration across the epithelial barrier to 
minimize the stochastic selection of the transposon library 
4.2 Results 
4.2.1  Optimization of 16HBE14o- cell growth in Transwell® inserts to provide 
an epithelial barrier for the traversal assay 
Before assessing the integrity of the barrier, the difference in the cell growth to reach 
a stable TEER between bovine collagen coated vs uncoated PET inserts was 
examined over 20 days. The highest TEER was reached on day 12 (930 Ω) and day 
14 (917 Ω) in the coated and non-coated inserts respectively. Even though the TEER 
of the 16HBE14o- cells on the collagen coated inserts were slightly higher compared 
to the uncoated ones (Figure 4.1), there was no significant difference observed in the 
resistance between the inserts on each tested day using 2-way ANOVA corrected 
with Bonferonni’s multiple comparison test.  
Preliminary studies were performed using cultures grown in AIC and LCC conditions. 
Under AIC conditions, cell growth was inconsistent and TEER measurements were 
not as high as when the cell layers were grown in LCC (data not shown). Thus, all 
subsequent experiments were of cells grown in under LCC rather than AIC 
conditions.  
Since the growth of the cells in the collagen coated inserts did reach a slightly higher 
TEER, all consecutive experiments were set up on 50 µg/cm2 of bovine collagen 
coated inserts. The integrity of the barrier formed by the 16HBE14o- cell monolayer 
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was then assessed by measuring both the TEER as well as the paracellular diffusion 
of FITC-labelled 70 kDa dextran.  The dextran was added to the apical region of the 
insert and the fluorescence reading was taken at 2 and 6 h of incubation. As shown 
in Figure 4.2, there was a drastic increase in the TEER from day 6 onwards as well 
as a decrease in the 70 kDa permeability after 2 h incubation from 26.2% on day 4 to 
1.1% on day 6. There was no significant difference in the fluorescence in the basal 
chamber from day 6 onwards (p ≥ 0.9994; one-way ANOVA with Tukey’s post hoc 
test), even though there was an evident increase in the TEER. Similar results were 
observed with the 6 h incubation of the permeability test, whereby the fluorescence 
ranged from 0.6% to 1.7% from day 6 onwards (data not shown).  
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Figure 4-1 16HBE14o- cells growth optimization on 24 mm diameter, 3 µm pore sized PET 
Transwell® inserts.  
5 X 105 16HBE14o- cells were seeded onto both 50 µg/cm2 of bovine collagen coated and non-coated 
24 mm diameter, 3 µm pore sized, PET inserts. Cell growth and the formation of a confluent layer of 
barrier was monitored by measuring the TEER every 2 days. The data of 3 independent experiments 
are shown as the mean of the TEER against incubation time, with the error bars representing 
standard error of mean.  No significant difference was seen in the TEER of the different inserts using 
two-way ANOVA test with Bonferonni’s correction (p > 0.9999) even though the TEERs were higher 
in the collagen coated inserts. 
88 
 
2 4 6 8
1
0
1
2
1
4
1
6
1
8
0
200
400
600
800
1000
1200
1400
0
20
40
60
80
100
T E E R  +  7 0 k D a  D e x tr a n  P e r m e a b il i ty  M e a s u r e m e n ts
O v e r  T im e
D a y s
T
E
E
R
 (
O
h
m
)
F
lu
o
r
e
s
c
e
n
c
e
 in
 th
e
 lo
w
e
r
 c
h
a
m
b
e
r
(%
 c
o
m
p
a
r
e
d
 to
 n
o
 c
e
ll c
o
n
tr
o
l)
R e s is ta n c e  (O h m )
7 0 k D a  D e x tra n  P e rm e a b ility
 
Figure 4-2 Assessment of epithelial barrier integrity  
The epithelial barrier formed by the 16HBE14o- cells were assessed by measuring the TEER and the 
FITC-labelled 70 kDA dextran permeability across the cell layer after 2 h incubation. The percentage 
of fluorescence in the basal chamber was calculated by comparing against the fluorescence in the no 
cell (blank) inserts. The experiments were carried out in 3 biological repeats, and the data is shown 
as mean, with the error bars representing standard error of mean.  No significant difference was 
seen in the fluorescence from day 6 onwards using one-way ANOVA test with Tukey’s multiple 
comparison even though the highest TEER was only reached on day 12. 
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4.2.2  Immunofluorescence microscopy 
The 16HBE14o- monolayer grown on the Transwell® inserts were further 
characterized to confirm the cells had both differentiated and polarized. This was 
achieved by examining the distribution of the tight junction related proteins, occludin 
and ZO-1, in the cells. Inserts from days 6, 8 and 12 were stained and visualized by 
confocal microscopy. The results were similar for all the 3 days tested, and the 
images acquired from the day 6 inserts are shown in Figure 4.3. Both occludin and 
ZO-1 were expressed and seen to be localized at the cell-to-cell contact region 
(Figures 4.3B and 4.3C). The relative position of the proteins was confirmed as 
limited to the apical region following Z-stack analysis (Figures 4.4C to 4.4F). Z-stack 
analysis also indicated multiple layers of cells in some regions of the 16HBE14o-   
cell layer. More cell stacking was evident by day 8 and 12 (TEERs of 825 ± 66 Ω and 
1266 ± 20 Ω  respectively) compared to day 6 (data not shown). 
Controls are important in immunofluorescence assays for correct interpretation. 
Thus, various controls were also set up, including isotype control (negative control) 
and single fluorophore controls for occludin, ZO-1 and phalloidin. No non-specific 
signals were detected with the IgG isotype control (Figure 4.4A) and cross-talking 
between the signals was also not seen (Figure 4.4B-4.4D). All the single fluorophore 
controls were counter-stained with DAPI to aid the visualization process.  
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Figure 4-3 Representative of immunofluorescence microscopy of polarized 16HBE14o- 
cells on day 6 post seeding  
16HBE14o- cells were fixed and immunostained with tight junction markers (occludin and ZO-1), 
actin (phalloidin) and nuclei (DAPI) on day 6 post seeding. Occludin (A) and ZO-1 (B) were expressed 
and the typical chicken wire-like pattern was seen, indicating cell-cell contact. The Z-stack of the 
stained cells showed the tight junction proteins localized to the apical region (C and E). Actin and 
nuclei were present in both apical and basolateral regions (C, D, E, F). The Z-stack also revealed that 
multiple layers of cells could be seen in some areas. Images were viewed under 60 X magnification 
are shown. C and D: Z stack images were collected at 0.66 μm intervals ranging from 2025 μm to 
2061 μm. E and F: Z stack images were collected at 0.55 μm intervals ranging from 2017 μm to 2044 
μm. 
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Figure 4-4 Representative of immunofluorescence staining controls  
Immunofluorescence staining of 16HBE14o- cells for isotype and single fluorophores controls. A. 
Alexa Fluor® 594 Mouse IgG1, κ Isotype Ctrl (10 µg/ml for 1 h); B. Occludin Mouse Monoclonal 
Antibody-Alexa Fluor®594 (5 µg/ml for 1 h) ; C. ZO-1 Mouse Monoclonal Antibody-Alexa Fluor®594 
(10 µg/ml for 1 h); D. Alexa Fluor® 647 Phalloidin (3 units/ml for 20 min). Images were viewed under 
60 X magnification are shown. 
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4.2.3  Optimization of the traversal assay using Neisseria meningitidis L91543 
Since the experiments conducted above demonstrated that the 16HBE14o-  cell on 
day 6 provided an intact barrier of fully differentiated polarized cells, all consecutive 
traversal assays were carried out using cells grown to day 6 with a TEER >500 Ω.  
Three independent traversal assays were carried out in triplicate with one no cell 
control for each biological repeat. The 16HBE14o-  cells were exposed to apically-
applied N. meningitidis L91543 strain at a MOI of 200 for up to 24 h. Interestingly, 
there was no significant difference in the number of meningococci that had crossed 
the epithelial cell layer between the incubation time points except for at 24 h (one-
way ANOVA; Tukey’s multiple comparison test).  The Pearson correlation, r, 
between the TEER and the meningococcal counts at each time point ranged from -
0.086 to 0.958 with p values between 0.058 to 0.958.  In addition, 22% - 44% of 
wells did not have any bacteria in the basal chamber up to the 12th hour of incubation 
(Figure 4.5A). TEER and 70kDa dextran diffusion was monitored throughout the 
experiment. At  24 h post inoculation, TEER in both the infected and non-infected 
wells was reduced to 69.6 ± 6.8% and 61.6 ± 10.7% respectively, compared to time 
zero. Both the TEER and dextran permeability data showed no significant difference 
between the infected and non-infected wells at each of the time points, indicating 
that the barrier remained intact throughout the experiment (Figure 4.5B and 4.5C) 
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Figure 4-5 Traversal assay with N. 
meningitidis L91543  
A. 16HBE14o- cell layers were infected 
with the L91543 strain on day 6 of 
seeding with a MOI of 200. The inserts 
were transferred to new plates with fresh 
media in the basal chambers at the 
specified time points and the 
meningococci that crossed the barrier 
were enumerated after 2h incubation. 
The assay was done in 3 biological 
repeats and each dot represents a tested 
well, whilst the bar represents the mean. 
No significant difference was seen in the 
bacterial counts between hours 2 to 12 
when tested with one-way ANOVA with 
Tukey’s posthoc test.  
B. The TEER was measured at time zero, 
post inoculation and every 2 hours 
onwards. No significance differences 
were seen between infected and non-
infected wells in each time point**.  
C. Paracellular permeability of the cell 
barrier was tested with FITC-labelled 
70kDa dextran which was added to the 
apical chamber at time zero. 
Fluorescence reading were taken 
concurrently from the basal chamber 
when bacterial counts were set up. No 
significance differences in the 
fluorescence were seen between infected 
and non-infected wells in each time 
point**. 
**Two-way ANOVA with Bonferroni’s 
multiple comparison was used. The error 
bars represents standard error of mean 
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4.2.4  Verification of the traversal assay using phoP mutant  
A phoP mutant, which has previously been shown to be impaired in crossing the 
epithelial cell barrier (Johnson et al., 2001), was used to verify the conditions of the 
traversal assay. Based on the experiments above, two time points, the 8th and 12th 
hour was used to assess the passage of the phoP mutants. To maximise sensitivity, 
media in the lower chamber was also assessed for bacterial counts by spreading the 
remainder volumes on plates.  The TEER was measured throughout the experiment 
to monitor the cell barrier integrity. Unlike the previous experiments, where the 
dextran was added at time zero to monitor the integrity of the barriers over time, an 
end point approach was adopted in order not to expose the presence of dextran as a 
selection factor for the mutants.   Thus, the 70kDa dextran was added to the upper 
chamber at the end of the experiment, i.e.  the 14th hour, and the fluorescence was 
measured from the lower chamber after 2 h incubation. Three independent 
experiments were set up with 2-3 wells per strain.  
Consistent with previous findings (Johnson et al., 2001), the phoP mutant showed a 
reduced ability to cross the 16HBE14o-  cell barrier, with less than 1.5% compared to 
the wild type L91543 strain (Figure 4.6). There was no significance difference in the 
number of bacteria between 8 and 12 hours. The TEER and dextran permeability 
assay (Table 4.1) showed that the cell barrier was intact during the assays. No 
significant difference was seen between the infected and non-infected wells when 
tested with two way ANOVA for the TEER (p=0.7895) and one way ANOVA for 
dextran permeability (p=0.2460). The results thereby demonstrated that the assay is 
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capable of differentiating between invasive and non-invasive strains of the 
meningococcus. 
 
 
 
Figure 4-6 Traversal assay with Neisseria meningitidis L91543 and phoP mutant  
Polarized 16HBE14o- cell layers were infected with the L91543 strain and the phoP mutant with a 
MOI of 200. The number of meningococci that crossed the barrier was determined by Miles and 
Misra after 2 h incubation in fresh basolateral media at each time point. Data is shown as the mean 
of the bacterial counts (A) and the mean relative percentage of the traversed mutants compared to 
L91543 (B). The error bar represents standard error of mean. The significant differences between 
the strains were determined using two-tailed paired T-test, where * denotes p ≤ 0.05 and **** 
denotes ≤ 0.001 
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Table 4-1 Assessment of 16HBE14o- cell layer integrity using TEER and FITC-labelled 70kDa 
dextran permeability during infection with phoP  mutants  
Strains TEER at 0h (Ω) TEER at 8h (Ω) TEER at 12h (Ω) 
70 kDa Dextran 
Fluorescence 
unita 
L91543 532 ± 35 524 ± 67 508 ± 35 0.64 ± 0.02 
phoP mutant 528 ± 46 489 ± 29 485 ± 67 0.61 ± 0.03 
Non-infected wells 509 ± 46 448 ± 9 487 ± 73 0.56 ± 0.03 
No cell control   44.04 ± 8 
All values are the mean ± standard deviation 
a Fluorescence (arbitrary unit) from the basal chamber at the 14th hour with 2h incubation 
 
4.3  Discussion 
N. meningitis normally colonizes the human nasopharynx and only causes 
bacteraemia and meningitis when the bacterium crosses the epithelium to reach the 
bloodstream, and the blood-brain barrier. Our aim was to, for the first time, use 
transposon mutagenesis to study gene fitness during traversal of the organism 
across the epithelium. To do this, we developed an in vitro epithelial model system 
that as closely as possible replicated the in vivo situation. This was achieved by 
growing polarized respiratory epithelial cells to form an intact barrier with functional 
tight junctions on a semipermeable insert, which allows sampling of cells capable of 
basolateral escape. Our preliminary work using 16HBE14o-  cells under LCC or AIC 
conditions showed similar results to those previously reported (Forbes and Ehrhardt, 
2005), namely that cells grown in AIC took longer to reach the same TEER levels as 
cells grown in LCC. This was up to 4 days longer in our study (data not shown). 
Ehrhardt et al. (2002) also reported that the presence of apical fluid is pertinent to 
formation of a functional 16HBE14o-  cell layer with higher TEER and well-defined 
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tight, adherens, and gap junctions. Thus, all further work was done with 16HBE14o-  
cells grown in liquid-liquid condition.  
As previously mentioned, cell growth is also affected by the substrate they are grown 
on.  The inserts are commonly coated with Vitrogen or bovine collagen prior to 
seeding, but various groups have reported that the cell barrier is adequately formed 
even in the absence of any filter coating (Ehrhardt et al., 2003, Forbes and Ehrhardt, 
2005). When bovine collagen was used to coat the Transwell® inserts in our study, 
no significant difference was seen in terms of the level of epithelial resistance 
obtained in the presence or absence of the coating. Nevertheless, all future work 
was carried out using collagen coated inserts as the epithelial resistance was 
marginally higher in this situation and more importantly, it is thought to prevent the 
possibility that  cells may grow down into the pores located on the surface of the 
insert (Forbes et al. (2003)).  
Next, we focused on establishing an intact barrier of differentiated, polarised 
16HBE14o- cells. We defined an intact cell layer as one having an elevated TEER, 
low permeability to small molecules and the expected localization of apical tight 
junction proteins, occluding and ZO-1 markers. We monitored the growth of the 
16HBE14o- cells through time, for up to 18 days, measuring epithelial resistance and 
the permeability of the formed layer to FITC labelled 70k Da dextran.  No difference 
in paracellular diffusion was observed after day 6 concurrent with an increase in 
TEER to 475±16 Ω. This demonstrated that an intact barrier had been formed as 
early as day 6 even though a steady increase in TEER was seen up to the 12th day 
post culture. By immunostaining for tight junction proteins, ZO-1 and occludin, we 
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further confirmed that the difference in TEER and permeability was due to cell 
differentiation and polarization. Increase in TEER is indicative of higher 
differentiation and polarization of cells. Nevertheless, even an incompletely polarized 
cell layer can form a functional barrier with intact tight junctions and adherens 
junctions (Bucior et al., 2014). 
Tight junctions are the most apical intercellular junction in epithelial cells as well as 
endothelial cells, and are central for the development and function of the barrier 
(Balda and Matter, 1998).  ZO-1, claudin, and occludin are tight junction markers 
usually used to determine whether cells were differentiated and polarised (Bazzoni 
and Dejana, 2004, McClean and Callaghan, 2009). According to our results, the day 
6 cell layers, with a TEER of ~500Ω were adequate for the traversal assay as they 
formed an intact barrier made of differentiated polarized 16HBE14o- cells as shown 
by the apical localization of ZO-1 and occludin and the characteristic ‘chicken wire’ 
pattern of staining connecting neighbouring cells. More importantly, only minimal cell 
stacking was observed at day 6 compared to the other tested time points. Therefore, 
all future experiments were conducted using cells grown on 24 mm Transwell® 
inserts for 6 days to a TEER >500 Ω.  
Differentiated, polarized 16HBE14o- cells were then challenged with N. meningitidis  
L91543, the strain which was used to build the Tn5 based library, at a MOI of 200. At 
this MOI, meningococci migrated across the epithelial layer without breaching the 
barrier as shown by the TEER and 70kDa dextran permeability data (when 
compared to the control (non-infected wells). This is consistent with findings by Merz 
et al. (1996) and Sutherland et al. (2010), both of whom reported that the 
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meningococci cross the epithelial layer by transcellular passage without disrupting 
the cell to cell contact. High levels of TEER were also maintained for other bacterial 
and viral transcytosis events that did not disrupt the cell barrier such as for N. 
gonorrhoeae (Wang et al., 1998) and adenovirus (Tang et al., 2007). In contrast, 
when bacteria or viruses traverse the epithelial cells by the paracellular route, this 
leads to tight junction protein disruption and/or cell disruption, and a drop in TEER  
(Chen et al., 2006, Fiorentino et al., 2014). Our findings also attest that this model is 
sufficiently sturdy to withstand infections with high MOI, i.e. MOI of 200, which is 
critical when working with mutant libraries to minimize selection bias.  
As shown in Figure 4.5A, the bacteria crossed the barrier as early as 2 h incubation 
and no significant difference was seen between the time points even after 12 h of 
incubation, making it difficult to determine the best incubation time for the infection. 
Even though the number of meningococci crossing the epithelial barrier was a ~4 log 
increase at 24 h, this time point was not used as this may be more reflective of 
intracellular survival compared to traversal. Furthermore we may be looking at a 
different population of mutants compared to the adhesion and invasion assays at 6 h 
(as optimized in Chapter 3).  Hey et al. (2013) demonstrated the transcriptome of 
adherent meningococci obtained at 24h was more similar to those at 96h, compared 
to an earlier time point (4 h) during co-cultivation of N. meningitidis MC58 strain with 
confluent monolayers of 16HBE14o-  cells. Thus, 8 h incubation, as used by Pujol et 
al. (1997) and Sutherland et al. (2010), as well as the 12 h incubation which provided 
higher cumulative bacterial counts, were both used to verify the model with the 
L91543 strains and the phoP mutant.  
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Nearly half (44%) the wells contained no traversed bacteria, despite efforts to 
increase the sensitivity of detection, indicating that the absence of meningococci was 
real, and not due to sampling error. The possibility that this was due to the formation 
of a multi-layered cell barrier was ruled out by testing the correlation between the 
TEER and CFU counts, since  Lu et al. (1996) demonstrated by electron microscopy 
that higher TEER values were indicative of multiple layered cell barriers of Caco-2 
cells. However, no correlation was observed between TEER and CFU in our 
experiments. Moreover, Pujol et al. (1997) who worked with T84 mono layered 
barrier showed 70% and 15% of inserts had zero bacterial transmigration at 8 and 23 
h of incubation respectively. Thus it does not seem likely that multi-layered barrier 
forming in the tested inserts is responsible for zero bacterial traversal and the 
phenomenon remains unexplained.  
The optimized traversal model using 16HBE14o- cells was successfully verified with 
the L91543 strain and the phoP mutants. Using this model, translocation of the phoP 
mutant was reduced (<1.5%) when compared to the wild type strain, even at a high 
infectious dose. These results are consistent with published work (Johnson et al., 
2001), in which <2.5% of the phoP cells crossed an epithelial cell barrier composed 
of Chang human conjunctiva epithelial cells compared to 42% of  the wild type 
meningococci. The magnitude change in translocation between L91543 and the 
phoP mutant demonstrates that this system can successfully differentiate between 
strains differing in transversal capability, and is thereby suitable for the transposon 
library screen. Since no significant difference was seen in the bacterial counts 
between the two tested time points, we opted for the 12 h incubation as this was 
marginally better (~22% difference in the relative percentage of traversed phoP 
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mutants compared to 8 h) and  was also more suitable to the restricted working 
hours of the meningococcal laboratory.  
Thus, based on the outcomes of the optimisation experiments, the following 
methodology will be used during the transposon mutagenesis experiments: 
1. 16HBE14o-  cells are seeded at a density 5x105 cells onto 24 mm diameter, 
polyester, 3 µm pore sized Transwell® inserts coated with bovine collagen. 
2. After 6 days the polarized 16HBE14o-  cells are confirmed to have a TEER 
more than 500 Ω and can be used for the traversal assays. 
3. The cells are challenged in the upper chamber with a  4 h culture grown in 
CBA at a MOI of 200  
4. The wells are incubated for 12 h, after which they are transferred to new 
plates with fresh medium in the basal chamber. 
5. The bacterial counts are set up from both upper and lower chambers after 2 h 
incubation. 
6. The TEER is monitored at all the tested time points and the permeability to 70 
kDA dextran is checked at the end of the experiment.  
Even with all this optimization, the data to be obtained from the Tn5 derived mutant 
library has to be interpreted with care as this would be a snapshot of the traversal at 
only hours 12-14. This population might differ from the bacteria crossing the 
epithelial barrier at other time points. 
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5    GENOME WIDE IDENTIFICATION OF GENES INVOLVED IN ADHESION, 
INTERNALIZATION, AND TRAVERSAL OF NEISSERIA MENINGITIDIS IN 
EPITHELIAL CELLS USING TN-SEQ 
5.1  Introduction 
Neisseria meningitidis causes bacterial meningitis and sepsis in both adult and infant 
populations worldwide. The meningococci is also a facultative commensal whereby it 
colonizes the nasopharynx in up to 35% of healthy individuals (Caugant et al., 2007). 
Disease occurs when the bacterium crosses the epithelial barrier invading the 
bloodstream. Although many virulence factors have been identified in nasopharynx 
colonization, primarily type IV pili (tfp) and outer membrane proteins (Opa and Opc) 
(Hill et al., 2010, Pizza and Rappuoli, 2015), how the organism ‘switches’ from being 
a commensal to a pathogen that is capable of invading the bloodstream as well as 
the genes involved in this process, are still not known. Moreover, traversal of 
meningococci across the nasopharynx epithelial barrier is poorly understood 
compared to the processes involved in meningococcal adhesion and internalization 
of the epithelial cells. 
Significant advances and easy access to high throughput DNA sequencing 
technologies have enabled variations in the fitness of individual members within a 
large pool of mutants to be identified at different stages of host infection. Transposon 
insertion site sequencing, aka Tn-Seq, is a powerful analytical method that allows 
quantitation of the number of individual mutants, enabling  “negative selection” by 
identifying the relative decrease in abundance of mutants of a specific phenotype 
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compared to the rest of the population (Capel et al., 2016, Fu et al., 2013, Gallagher 
et al., 2011, Mendum et al., 2015, Wong et al., 2011b). 
Here we use a previously published Tn5 transposon insertion library (Mendum et al., 
2011) to challenge the infection models described in Chapters 3 and 4 and so 
simultaneously assess the gene fitness of thousands of meningococcal mutants 
during colonization (adhesion and internalization) and traversal of the epithelial cells. 
5.2 Results 
5.2.1  Screening the transposon library pool using the established adhesion, 
internalization and traversal assays using 16HBE14o- cells  
The N. meningitidis Tn5 mutant library described by Mendum et al. (2011) containing 
~14,500 mutants was used. The library was subject to the adhesion, internalization, 
and traversal assays described in Chapters 3 and 4. Briefly, an overnight culture of 
the mutant library grown on CBA with erythromycin was used to set up the 4 h 
cultures as described in Chapter 2 (this represented the ‘input’ pool). Three 
independent assays were carried out in triplicate in the 6-well plates and wild type N. 
menigitidis L91543 was used as a control in each assay. The number of cells 
recovered in the adherence and internalization assays as well as the traversal assay 
are reported in Tables 5.1. and 5.2, respectively. The adhered, invaded and 
translocated meningococci from the replicates from each biological repeat were 
pooled, designated as ‘outputs’ and stored at -80°C in 15% glycerol. In order to 
examine whether growth of the library in cell-free tissue culture medium affected the 
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mutant population, a sample was also collected and stored frozen until subsequent 
analysis. 
 
Table 5-1 Adherence and Internalization assay using Tn5 mutant library derived from N. 
meningitidis L91543  
Bacterial counts of the output library pool (cfu/ml) 
    Repeat 1 Repeat 2 Repeat 3 
Adherence 
Library (cumulative cfu counts of 3 wells) 1.58 x108 3.47 x108 5.43 x108 
L91543 strain (control) 4.99 x107 1.57x108 1.7 x108 
Internalization 
Library (cumulative cfu counts of 3 wells) 1.80 x105 3.7 x105 4.43 x105 
L91543 strain (control) 1.50 x105 1.13 x105 1.07x105 
 
 
Table 5-2 Traversal assay using Tn5 mutant library derived from N. meningitidis L91543  
 
Repeat 1 Repeat 2 Repeat 3 
Output library pool  (Cumulative cfu counts of 6 wells) 
(cfu/ml) 
1.26 x 104 1.85 x 104 7.52 x 102 
L91543 strain (control) (cfu/ml) 
 
2.40 x 102 4.40 x 102 7.24 x 102 
TEER at 0 h  (All wells) (Ω) 587 ± 40 606 ± 21 597 ± 50 
TEER at 12 h (Infected wells) (Ω) 521 ± 42 563 ± 26 544 ± 47 
TEER at 12 h (Non-infected wells) (Ω) 488 513 493 
70 kDa Dextran 
fluorescence unita  (Infected wells) 
0.60 ± 0.03 0.62± 0.05 0.57 ± 0.04 
70 kDa Dextran 
fluorescence unita  (Non-Infected wells) 
0.60 0.70 0.50 
70 kDa Dextran 
fluorescence unita  (No cell control) 
28.25 27.85 27.69 
All values are the mean ± standard deviation 
a Fluorescence (arbitrary unit) from the basal chamber at the 14th hour with 2h incubation 
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Since the number of cells recovered in the output pool of the traversal assays was 
low, following the advice of Dr Sajjan Uma (personal communication, University of 
Michigan), we decided to switch to using 6 mm inserts (24-well) rather than the 24 
mm inserts (6-well) described in Chapter 2. Dr Uma, who has considerable 
experience working with 16HBE14o-  cells, also found that it was more difficult to 
grow cell layers on inserts with a larger diameter compared to those that are smaller. 
Thus, the traversal assays were repeated using cells grown on 6 mm inserts to a 
TEER of >1200 Ω; this allowed 9 replicates for each biological repeat. Barrier 
formation and cell polarization was checked following growth on the 6 mm inserts to 
confirm the integrity of the epithelial barrier. The results of the verification showed 
formation of barrier on day 3 with a TEER ~1200 Ω, as illustrated in Appendix A.2. 
The output of the assay with 6 mm Transwell® inserts is summarized in Table 5.3. 
Even though ~20% reduction of TEER was seen between the infected and 
uninfected wells, no significant difference was seen in the permeability of the barrier 
to 70 kDa dextran (T-test, p=0.2371) indicating the barrier was still intact at the end 
of the experiment.  
Bacterial traversal was seen in all wells of the 6mm inserts, unlike for the 24mm 
inserts where only ~50% of wells showed meningococci crossing the barrier. 
However, the number of output bacteria detected followed a bimodal population 
(Figure 5.1). Thus, the traversed meningococci were arbitrarily pooled as high (>106 
cfu/well) and low (<106 cfu/well), in order not to miss any mutants that may be 
present exclusively in the slower traversing meningococci. The 4 h culture from CBA, 
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12 h growth in tissue culture medium and the traversed bacteria were stored at -80 
°C in 15% glycerol for subsequent genomic DNA extraction. The results are 
summarized in Table 5.3. 
 
 
Table 5-3  Traversal assay of Tn5 mutant library derived from N. meningitidis L91543 using 
6 mm Transwell® insert  
 
Repeat 1 Repeat 2 Repeat 3 
Library (Cumulative CFU counts of 9 wells)  2.85 x 107 cfu/ml 7.98 x 107 cfu/ml 1.13 x 107 cfu/ml 
L91543 strain (control) 
 1.03 x 106 cfu/ml 1.75 x 106 cfu/ml 9.30 x 105 cfu/ml 
TEER at 0h (All wells) (Ω) 1420 ± 122 1424 ± 200 1363 ± 118 
TEER at 12h  (Infected wells) (Ω) 1266 ± 48 1092 ± 226 1007 ± 130 
TEER at 12h (Non-infected wells) (Ω) 1455 1570 1531 
70kDa Dextran 
Fluorescence unita  (Infected wells) 0.4 3± 0.06 0.43 ± 0.02 0.45 ± 0.04 
70kDa Dextran 
Fluorescence unita  (Non-Infected wells) 0.41 0.39 0.43 
70kDa Dextran 
Fluorescence unita  (No cell control) 19.28 17.98 17.27 
All values are the mean ± standard deviation 
a Fluorescence (arbitrary unit) from the basal chamber at the 14th hour with 2h incubation 
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Figure 5-1 Traversal of Tn5 mutant library derived from N. meningitidis L91543 across 
16HBE14o- cell barrier grown on 6 mm Transwell® insert  
16HBE14o- cell layers were infected with the pooled library on day 3 of seeding (TEER >1200 Ω) with 
a MOI of 200. The inserts were transferred to new plates with fresh media in the basal chambers at 
the 12th hour and the meningococci that crossed the barrier were enumerated after 2 h incubation. 
The assay was done in 3 biological repeats and each dot represents a tested well, whilst the bar 
represents the mean.  
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5.2.2  Transposon library preparation for Tn-Seq 
A total of 24 samples obtained from the assays above, illustrated in Figure 5.2 and 
summarized in Table 5.4, were processed for Tn-Seq analysis. Genomic DNA was 
extracted from the frozen samples as described in section 2.9 and sheared by 
sonication. The size of the resulting fragments was confirmed using agarose gel 
electrophoresis, with a smear of fragments <1 kb being observed (Figure 5.3). Un-
sheared genomic DNA was included as a control to exclude the possibility of the 
smear being attributed to degradation of the extracted genomic DNA. The samples 
were processed and amplified by q-PCR (in triplicate) to determine the optimal cycle 
number for each sample in order to prevent the accumulation of PCR artefacts 
(Figure 5.4). A no-template control as well as IS6 primer alone was also set up as a 
control for each sample. Each DNA preparation was labelled with primers carrying a 
different index sequence. Fluorescence from the EvaGreen© dye bound DNA was 
detected from cycle 16 onwards, and reached mid-log between 26-28 cycles. No 
amplification was detected with the no DNA controls whilst the IS6 only primer 
fluoresced after the 30th cycle in some of the samples. The chosen amplification 
cycles are summarized in Table 5.5.  
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Figure 5-2 Illustration of the assays used to screen the Tn5 mutant library derived from N. 
meningitidis L91543  
Schematic representation of the input and output pools from the Tn5 library screen for identification 
of genes involved in adhesion, internalization and traversal across 16HBE14o- cells.  
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Table 5-4 Summary of sample designations 
Adherence and Internalization Assays 
4 h culture from CBA 
(Input_BA) 
 BA1 
 BA2 
 BA3 
Adherence assay 
(Output_Adherence) 
 Ad1 
 Ad2 
 Ad3 
Gentamicin protection 
assay (Output_Invasion) 
 In1 
 In2 
 In3 
Growth in tissue culture 
medium for  6 h 
 TCM1 
 TCM2 
 TCM3 
 
Traversal Assay 
4 h culture from CBA 
(Input_BA) 
 T_BA1 
 T_BA2 
 T_BA3 
Traversal Assay with 6 mm Transwell® inserts 
(Output_Traversal) 
 T_Low1; T_Low2; T_Low3 
 T_HIgh1; T_High2; T_HIgh3 
 
Growth in tissue culture 
medium for 12 h 
 T_TCM1 
 T_TCM2 
 T_TCM3 
 
 
Table 5-5 Amplification cycles used in Tn-Seq sample preparation for Illumina sequencing   
Number of cycles determined 
from q-PCR assays 
Sample 
26  BA1, Ad1, In1, Ad3, In3, TCM 3 
 T_High1, T_BA2, T_Low2, T_Low2, T_High2, T_TCM2, 
T_BA3, T_Low3, T_TCM3 
27  BA2 
 T_Low1 
28  BA3, TCM1, Ad2, In2, TCM2 
 T_BA1, T_TCM1, T_High3 
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Figure 5-3 Representative of gel electrophoresis image of sheared DNA following 
sonication 
Both sheared and un-sheared genomic DNA was run on 1% agarose. Smeared bands can be seen 
between 1 kb and 250 bp indicating the shearing was successful. The genomic DNA shows no 
degradation. 1kb ladder was used as the marker.  
 
 
 
 
 
 
 
BA2 Ad2 In2 6h2 BA2 Ad2 In2 6h2 
Sheared genomic DNA 
 
Genomic DNA 
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Figure 5-4 Representative of amplification plot of q-PCR in optimization of PCR 
amplification for Tn-Seq library preparation   
Adapters ligated In2 sample was amplified in triplicates with barcoded index and IS6 
(homologous to the 5’ Illumina binding region) as primers for library preparation for 
sequencing. Amplified DNA was quantified by fluorescence of the bound EvaGreen© dye to 
double stranded DNA. The cycle number corresponding to mid-log phase of the amplification 
was chosen, cycle 28 in this case (circled in red). Even though the IS6 did amplify, but was 
negligible at the selected cycle number. No amplification was observed with the no template 
controls. Similar results were observed in all tested samples, where by the chosen cycle 
numbers were between 26 and 28.  
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Before the DNA was prepared in large volumes to be sent for next generation 
sequencing, one of the samples, i.e. 6h-1, was used to verify the amplification of the 
transposon-chromosome junction by TOPO cloning and sequencing. The ligated 
sample 6h-1 DNA was amplified 28 cycles with the corresponding index as 
described in section 2.9.3. The PCR product was then TOPO cloned and 
transformed into competent E. coli DH5α cells. Single mutants were then grown in 
LB broth for plasmid extraction and Sanger sequencing. The sequence was 
analysed to confirm the presence of Tn5 junction and the adjacent loci was aligned 
to the N. meningitidis  genome using the NCBI BLAST tool. Nine out of ten screened 
mutants possessed the Tn5 sequence, of which eight were successfully aligned to N. 
meningitidis genome (Table 5.6). Even though only a small number of mutants were 
sequenced, insertion bias was not seen as no mutant was sequenced twice nor 
insertions in the same genes/functions were detected. These findings gave some 
confidence in the library preparation approach, and subsequently this procedure was 
applied to all input and output DNA samples.  
Following the verification described above, all the adapter-ligated samples were 
amplified in large volumes (200µl) with the corresponding cycle numbers and 
separated by agarose gel electrophoresis (Figure 5.5A). No amplification was seen 
with the no-template and IS6 only primer controls (data not shown). The preparative 
PCR products of ~250 bp to -750 bp were extracted from the gel and the purified 
fragments were further analysed using the Agilent Bioanalyzer to confirm the sizes of 
the DNA fragments (Figure 5.5B). DNA fragments between ~300 bp and ~700 bp 
were seen in all samples. The DNA concentration was estimated by calculating the 
area below the curve on the x-axis. Two pools of DNA were prepared for 
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sequencing: the adherence and internalization samples were pooled separately from 
the traversal samples. The pooled amplified DNA samples were then sent for double 
indexed, single read sequencing on an Illumina HiSeq platform. 
 
Table 5-6 Confirmation of Tn5 insertion mutants using Sanger sequencing and BLAST 
analysis  
Mutant Target (N. meningitidis MC58) % of Identity 
Locus Gene 
M1 NMB0257 (259503..261527) nuoL 91% 
M3 NMB1928 (2025870..2026697, R*) lgtB 98% 
M4 NMB1594 (1655387..1656517, R*) potD-3 95% 
M5 NMB2005 (2116621..2117841) argJ 99% 
M6 NMB0277 (279721..281262, R*) mviN 98% 
M8 NMB2073 (2195622..2195825) - 94% 
M9 NMB0263 (266442..267365, R*) - 99% 
M10 NMB1449 (1493916..1497005, R*) - 100% 
R* Complementary strand 
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Figure 5-5 Representative of gel electrophoresis of preparative PCR reactions (A) for 
Illumina sequencing and Agilent BioAnalyzer analysis of the extracted PCR product (B)  
A. Preparative PCR products of Ad1 and Ad2 samples run on 1.5% agarose with 1 kb markers. Bands 
between 250 bp – 750 bp were excised and purified. B. The purified products were analysed and the 
expected fragment size distribution was seen, a “bump” at ~300 bp to ~700 bp. The concentration of 
the DNA was estimated by calculating the area under the curve at the x-axis.  DNA markers are seen 
at both end of the x-axis, 15 bp and 1500 bp respectively. y-axis represents the fluorescence 
intensity. 
 
 
A 
B 
117 
 
5.2.3  Tn-Seq data analysis, mapping and quality control 
The raw data from Illumina HiSeq sequencing was sorted and preliminarily analysed 
by Dr Huihai Wu, Core Bioinformatics Support, University of Surrey. The de-
multiplexed, filtered and aligned reads of both Pool 1 and Pool 2 are summarized in 
Table 5.7 and Table 5.8 respectively. Pool 1 represents the libraries from the 
adherence and internalization assays whilst Pool 2 represents the libraries from the 
traversal assays. The read quality of both pools were excellent, where 100% of the 
reads had a Q score >50, i.e. indicating less than 1 in 100,000 chance a nucleotide 
being miscalled. The second filter, selecting reads with the transposon sequence 
(ATAAGAGACAG) led to approximately 10 to 12% loss in both pools. The largest 
loss, 49±5% in Pool1 and 61±9% in Pool 2, occurred during the removal of PCR 
duplicates and alignment to the reference genome (N. meningitidis L91543). 
Nevertheless, the negligible difference between the loss of reads between the 
libraries in each pool suggests the loss was due to protocol and filtering parameters 
instead of variation of sample preparation.  
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Table 5-7 Summary of filtered and aligned sequenced reads from input and output library 
pools (Pool1  )of the adhesion and internalization assay  
Sample 
Number of 
reads 
Read quality filter Transposon filter 
Aligned, Deduplicate, 
Map quality filter  
Bowtie2 
overall 
alignment 
rate** *No. % *No. % *No. % 
BA1 3344091 3343065 100% 3013374 90.1% 1216486 36.4% 70.81% 
BA2 4301004 4299816 100% 3759313 87.4% 1611474 37.5% 70.75% 
BA3 3055699 3054844 100% 2778269 90.9% 1184810 38.8% 71.94% 
6h1 2429296 2428600 100% 2009357 82.7% 748095 30.8% 63.14% 
6h2 1925741 1925177 100% 1731054 89.9% 794452 41.3% 72.40% 
6h3 1933413 1932979 100% 1711558 88.5% 832654 43.1% 74.96% 
Ad1 1206946 1206589 100% 1059177 87.8% 507552 42.1% 72.18% 
Ad2 2707207 2706572 100% 2382460 88.0% 1041369 38.5% 69.22% 
Ad3 6527605 6525439 100% 5875527 90.0% 2371031 36.3% 69.90% 
In1 1427812 1427486 100% 1274791 89.3% 673134 47.1% 76.20% 
In2 6819938 6817723 100% 6109052 89.6% 2136648 31.3% 64.32% 
In3 3904057 3902963 100% 3327880 85.2% 1453107 37.2% 71.15% 
* Number of reads after filter 
** Alignment against N. meningitidis L91543 genome 
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Table 5-8 Summary of filtered and aligned sequenced reads from input and output library 
pools (Pool 2 ) of the traversal assay  
Sample 
Number of 
reads 
Read quality filter Transposon filter 
Aligned, Deduplicate, 
Map quality filter  
Bowtie2 
overall 
alignment 
rate** *No. % *No. % *No. % 
T_BA1   826544 826543 100% 764060 92.4% 378208 45.8% 73.08% 
T_BA2  1357401 1357400 100% 1228537 90.5% 467516 34.4% 64.27% 
T_BA3  1121475 1121475 100% 1044337 93.1% 442268 39.4% 66.97% 
T_Low1  1862885 1862885 100% 1726005 92.7% 603474 32.4% 67.19% 
T_Low2  1293038 1293037 100% 1136716 87.9% 392291 30.3% 62.36% 
T_Low3  930152 930152 100% 854121 91.8% 234685 25.2% 65.90% 
T_High1 2573408 2573408 100% 2326771 90.4% 836899 32.5% 64.80% 
T_High2 1784590 1784590 100% 1652559 92.6% 506584 28.4% 63.28% 
T_High3 2307354 2307353 100% 2150660 93.2% 399449 17.3% 60.80% 
T_TCM1  4688842 4688839 100% 4287015 91.4% 1017515 21.7% 55.23% 
T_TCM2  1566959 1566958 100% 1465676 93.5% 307759 19.6% 64.67% 
T_TCM3  595036 595036 100% 524754 88.2% 230072 38.7% 67.23% 
* Number of reads after filter 
** Alignment against N. meningitidis L91543 genome 
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Since the TRANSIT re-sampling method involved combining the reads of all 
biological repeats, the normalised number of insertions per site between the 
biological repeats was compared (Figure 5.6) and are summarized in Table 5.9. 
Correlation values indicated there was excellent correspondence between the 
biological repeats in the input (R2=0.8297) and output (R2 between 0.76 to 0.80) 
pools of the adherence assays as well as the input pool (R2=0.8740) of the traversal 
assays. These similarities indicate that the aliquots from the frozen library used  for 
the infections (Mendum et al., 2011), sample processing and analysis were highly 
reproducible. It also suggests that the population of mutants adhering and invading 
the 16HBE14o- cells are similar between the repeats. However, the low adjusted R2 
of the output pools (R2=0.02) from the traversal assay suggest that the biological 
repeats were highly variable and likely to be due to the inherently variable output of 
the testing system instead of sample handling. The high and low count reads of each 
replicate were merged for all future analysis to reduce variability of the data. 
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Table 5-9 Comparison of insertions per site between the biological repeats to assess the 
reproducibility of the library pools between repeats 
Libraries Adjusted R Square** 
Pool 1 (Adherence and internalization assay) 
Input (4h culture from CBA) 
BA1, BA2, BA3 0.8297 
Output (adhered and internalized meningococci) 
Ad1, Ad2, Ad3 
0.8010 
Output (internalized meningococci) 
In1, In2, In3 
0.7620 
Growth in tissue culture medium for 6h 
TCM1, TCM2, TCM 3 
0.8471 
Pool 2 (Traversal assay) 
Input (4h culture from CBA) 
T_BA1, T_BA2, T_BA3 0.8740 
Output (≤1 x 106 traversed meningococci) 
T_Low1, T_Low2, T_Low3 0.0297 
Output (>1 x 106 traversed meningococci) 
T_High1, T_High2, T_High3 0.0135 
Growth in tissue culture medium for 12h 
T_TCM1, T_TCM2, T_TCM 3 
0.5955 
** Adjusted R square based on multiple regression analysis of the tested mutant pool 
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Figure 5-6 Representative of sequence reproducibility of biological repeats  
Example of graph comparing the number of insertions per site for 2 biological repeats of the input 
pool libraries, BA1 and BA2. The adjusted R square indicates excellent correlation between the 
repeats.  
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Even though Tn5 transposition is thought to be random, we observed higher 
insertions in certain regions of the genome, in both the input and output pools 
(Figure 5.7A-B). The regions with high insertion frequency were similar in all the 
tested libraries and should not interfere with downstream analysis since we are 
assessing conditional essentiality (i.e. it is the relative abundance of the insertions in 
the pools that are analysed (Figure 5.7C)). Based on the results from Chapters 3 and 
4, where it was shown that the meningococci had adhered, invaded and traversed 
the 16HBE14o- cells from as early as the 2nd hour post infection, it was decided that 
the library obtained from the 4 h culture on BA used for the infections was a better 
representation of the input library than the DNA recovered following growth of the 
library in tissue culture medium for 6 and 12 hours. Thus, from this point onwards the 
library obtained following growth in tissue culture medium was not used when 
identifying the genes essential in adherence, invasion and traversal of meningococci 
in epithelial cells.  
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Figure 5-7 Distribution of transposon inserts in the tested libraries  
A and B shows the combined reads of the 3 biological repeats of the adherence and internalization 
assay (A) and traversal assay (B). The number of insertion per site of the input and output pools are 
represented by blue and green bars respectively mapped onto the N. meningitidis L91543 circular 
chromosome. Nucleotide positions are indicated in base pairs. B. Outer green ring represents the 
adherence output whilst the inner ring represents the invasion output. C. The difference between 
the abundance of transposon insertions between the input and output pools for pilF gene is shown 
(QP84_08240). The output pool is almost void of insertions.  
A 
B 
C 
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5.2.4  Identification of meningococcal genes involved in adherence and 
internalization of epithelial cells 
The TRANSIT resampling tool, which uses a permutation test to determine 
statistically-robust differences between counts under two different conditions, was 
used to identify genes involved in adherence to, and invasion, and traversal across 
epithelial cells of respiratory origin. Since the TRANSIT resampling method was 
designed primarily for TA insertions and the permutation test combines all biological 
repeats, thus losing the power of discrimination between variation that is within a 
selection experiment (variation between different mutants in the same pool and 
variation between selection i.e. each biological variation), the analysis was further 
complemented by comparing the average fold change of all 3 biological repeats with 
all genes using the T-test. In order to control for false discovery rate (FDR) for 
multiple traits in the T-test, p values were further corrected with Benjamini & 
Hochberg False Discovery Rate (BH-FDR) (Benjamini and Yekutieli, 2005) with a 
cut-off of  0.05.  An additional 39 and 64 genes were found to show reduced fitness 
in the adherence and internalization outputs when compared to the input pool 
respectively using the FDR calculations. Approximately 80% gene overlap was seen 
between the TRANSIT resampling and BH-FDR methods (Figure 5.8). The list of the 
selected genes that showed reduced fitness in both analysis methods (p value of ≤ 
0.05, with a negative fold change >1.5) are tabulated in Table 5.10 and 5.11. Thus, 
for the adherence and invasion assays, the genes selected for further investigation 
were drawn from this combined list.  
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However, the same criteria for selection as outlined above could not be applied to 
the results from the traversal assay. Two hundred and four (204) genes showed 
reduced fitness by T-test (p≤0.05) but none remained statistically significant after 
correction for the BH-FDR was applied. Repeating the analysis with the low and high 
output reads treated separately gave similar results (BH-FDR, p>0.05). Thus, for the 
traversal assay only the genes identified as significant in the TRANSIT resampling 
method were subject to further analysis (N=19) (Table 5.12).  
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Figure 5-8 Venn diagrams showing number of genes with negative fold change using 
TRANSIT resampling and BH- FDR  
Venn diagram comparing the genes found to of reduced fitness, negative fold change with p value ≤ 
0.05 using 2 data analysis methods, TRANSIT resampling and BH-FDR. No genes were selected from 
the traversal assay using BH-FDR calculations, as the p values were > 0.05.  
 
 
Adherence Internalization 
Traversal 
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Table 5-10 List of meningococcal genes showing reduced fitness in adhesion to epithelial cells 
N. meningitidis L91543 MC58 orthologs BH-FDR* 
TRANSIT 
Resampling COG Categories 
Locus Gene Product Length (bp) NMB Gene 
Average 
Log2 FC  p-value Log2 FC p-value Process Description 
QP84_00155 - alkylhydroperoxidase 546 NMB1036 leuC -2.39 3.44E-03     Metabolism 
Amino acid transport and 
metabolism 
QP84_00370 - fructose 1,6-bisphosphatase 972 NMB1060 fbp -5.72 3.03E-22 -6.54 2.11E-02 Metabolism 
Carbohydrate transport 
and metabolism 
QP84_00410 - membrane protein 678 NMB1066 - -2.01 3.90E-02     
Poorly 
characterized Function unknown 
QP84_00645 - hypothetical protein 195 NMB1175 - -2.79 1.65E-04     
Poorly 
characterized Function unknown 
QP84_00765 - GTP-binding protein 1809 NMB1199 typA -3.12 7.08E-06 -3.53 1.50E-03 
Cellular 
processes and 
signaling 
Signal transduction 
mechanisms 
QP84_01230 - membrane protein 477 NMB1026 - -2.34 4.64E-03     
Poorly 
characterized Function unknown 
QP84_01600 - 
aspartate carbamoyltransferase 
catalytic 918 NMB0106 pyrB -3.17 4.57E-06 -3.45 3.73E-02 Metabolism 
Nucleotide transport and 
metabolism 
QP84_01935 minC septum formation inhibitor 711 NMB0170 minC -2.38 3.79E-03     
Cellular 
processes and 
signaling 
Cell cycle control, cell 
division, chromosome 
partitioning 
QP84_02450 - hypothetical protein 357 NMB0695 - -2.24 9.03E-03     NA NA 
QP84_02685 - serine kinase 960 NMB1023 ttcA     -2.32 3.54E-02 
Cellular 
processes and 
signaling 
Cell cycle control, cell 
division, chromosome 
partitioning 
QP84_02690 - nucleotide-binding protein 852 NMB0738 - -2.64 5.94E-04 -2.73 2.03E-02 
Poorly 
characterized 
General function 
prediction only 
QP84_02795 - 
phosphoribosylaminoimidazole-
succinocarboxamide 861 NMB0757 purC -2.43 2.76E-03     Metabolism 
Nucleotide transport and 
metabolism 
QP84_02845 - elongation factor 4 1791 NMB0766 lepA -2.80 1.63E-04     
Cellular 
processes and 
signaling 
Cell 
wall/membrane/envelope 
biogenesis 
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N. meningitidis L91543 MC58 orthologs BH-FDR* 
TRANSIT 
Resampling COG Categories 
Locus Gene Product Length (bp) NMB Gene 
Average 
Log2 FC  p-value Log2 FC p-value Process Description 
QP84_02940 - 
exodeoxyribonuclease V subunit 
beta 3612 NMB0785 recB     -1.88 1.07E-02 
Information 
storage and 
processing 
Replication, 
recombination and repair 
QP84_02980 - VanZ family protein 360 NMB0794 - -2.34 4.82E-03     NA NA 
QP84_03620 - 
chromosome partitioning protein 
ParB 858 NMB1944 parB     -1.85 3.01E-02 
Information 
storage and 
processing Transcription 
QP84_03740 - transporter 588 NMB1963 - -3.30 1.21E-06     Metabolism 
Secondary metabolites 
biosynthesis, transport 
and catabolism 
QP84_03750 - ABC transporter permease 774 NMB1965 - -3.62 3.66E-08     Metabolism 
Secondary metabolites 
biosynthesis, transport 
and catabolism 
QP84_03755 - 
toluene ABC transporter ATP-
binding protein 798 NMB1966 - -3.48 1.85E-07 -3.4 1.61E-02 Metabolism 
Secondary metabolites 
biosynthesis, transport 
and catabolism 
QP84_03790 - hypothetical protein 1515 NMB1971 - -2.27 7.28E-03     NA NA 
QP84_04055 - protein-PII uridylyltransferase 1908 NMB1822 pglD -1.99 4.12E-02 -2.02 3.40E-03 
Cellular 
processes and 
signaling 
Cell 
wall/membrane/envelope 
biogenesis 
QP84_04095 - 
polysaccharide biosynthesis family 
protein 1422 NMB1818 -     -1.68 7.00E-03 
Poorly 
characterized 
General function 
prediction only 
QP84_04130 - pilin assembly protein 543 NMB1811 pilP -6.16 9.23E-26 -6.98 3.76E-02 
Cellular 
processes and 
signaling Cell motility 
QP84_04135 - pilus assembly protein PilO 645 NMB1810 pilO -6.72 5.77E-31 -6.65 3.24E-02 
Cellular 
processes and 
signaling Cell motility 
QP84_04145 - pilus assembly protein PilM 1113 NMB1808 pilM -6.04 5.74E-25 -6.14 2.13E-02 
Cellular 
processes and 
signalling 
 
 Cell motility 
130 
 
N. meningitidis L91543 MC58 orthologs BH-FDR* 
TRANSIT 
Resampling COG Categories 
Locus Gene Product Length (bp) NMB Gene 
Average 
Log2 FC  p-value Log2 FC p-value Process Description 
QP84_04175 - cytochrome C biogenesis protein 1185 NMB1803 - -2.55 1.23E-03     
Cellular 
processes and 
signaling 
Posttranslational 
modification, protein 
turnover, chaperones 
QP84_04430 - 
cytochrome C biogenesis protein 
CcmE 1644 NA NA -2.47 2.22E-03     NA NA 
QP84_04520 - exodeoxyribonuclease III 768 NMB0399 xthA -2.43 2.77E-03     
Information 
storage and 
processing 
Replication, 
recombination and repair 
QP84_04690 - aminotransferase 1212 NMB1473 - -1.99 4.05E-02 -1.96 1.48E-02 Metabolism 
Amino acid transport and 
metabolism 
QP84_04860 - 
amino acid ABC transporter 
permease 744 NMB1509 - -2.60 7.89E-04     Metabolism 
Amino acid transport and 
metabolism 
QP84_05060 - glutathione synthetase 954 NMB1559 gshB -3.97 5.04E-10     
Information 
storage and 
processing 
Translation, ribosomal 
structure and biogenesis 
QP84_05095 - 
phosphoribosylglycinamide 
formyltransferase 624 NMB1566 purN -2.63 6.18E-04     Metabolism 
Nucleotide transport and 
metabolism 
QP84_05100 - peptidylprolyl isomerase 804 NMB1567 fkpA -1.98 4.40E-02     
Cellular 
processes and 
signaling 
Posttranslational 
modification, protein 
turnover, chaperones 
QP84_05750 - major facilitator transporter 1215 NA NA -3.90 1.14E-09 -3.92 3.98E-02 NA NA 
QP84_06140 - 
crossover junction 
endodeoxyribonuclease RuvC 534 NMB1419 ruvC -2.35 4.62E-03     
Information 
storage and 
processing 
Replication, 
recombination and repair 
QP84_06260 - 
N5-carboxyaminoimidazole 
ribonucleotide mutase 483 NMB1439 purE -3.45 2.39E-07     Metabolism 
Nucleotide transport and 
metabolism 
QP84_06460 - 
ABC transporter substrate-binding 
protein 912 NMB0586 - -2.19 1.22E-02 -2.38 4.83E-02 Metabolism 
Inorganic ion transport 
and metabolism 
QP84_06555 - deacetylase 1107 NMB0605 - -2.27 7.35E-03     
Information 
storage and 
processing 
Chromatin structure and 
dynamics 
QP84_06800 - hypothetical protein 249 NA NA -1.99 4.19E-02     NA NA 
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N. meningitidis L91543 MC58 orthologs BH-FDR* 
TRANSIT 
Resampling COG Categories 
Locus Gene Product Length (bp) NMB Gene 
Average 
Log2 FC  p-value Log2 FC p-value Process Description 
QP84_06995 - 
phosphoribosylamine--glycine 
ligase 1269 NMB2151 purD -2.41 3.16E-03     Metabolism 
Nucleotide transport and 
metabolism 
QP84_07105 - membrane protein 972 NMB0012 - -2.15 1.56E-02 -3.01 3.17E-02 Metabolism 
Inorganic ion transport 
and metabolism 
QP84_07225 - heme transporter CcmA 627 NMB1669 - -2.13 1.75E-02     Metabolism 
Inorganic ion transport 
and metabolism 
QP84_07795 guaA GMP synthase 1563 NMB1920 guaA -2.02 3.73E-02     Metabolism 
Nucleotide transport and 
metabolism 
QP84_08030 - acetyltransferase 438 NMB1872 - -2.01 3.81E-02     
Poorly 
characterized 
General function 
prediction only 
QP84_08055 - hypothetical protein 273 NMB0361 - -2.27 7.14E-03     
Information 
storage and 
processing 
Replication, 
recombination and repair 
QP84_08095 - 
sugar ABC transporter substrate-
binding protein 528 NMB0355 lptA -3.63 3.40E-08     
Poorly 
characterized Function unknown 
QP84_08160 - intracellular septation protein A 528 NMB0342 - -2.39 3.52E-03     
Cellular 
processes and 
signaling 
Cell cycle control, cell 
division, chromosome 
partitioning 
QP84_08220 - type II secretion system protein F 1230 NMB0333 pilG -6.73 2.53E-32 -6.79 <0.00001 
Cellular 
processes and 
signaling Cell motility 
QP84_08240 - pilus assembly protein PilF 1674 NMB0329 pilF -6.12 1.38E-25 -6.25 1.00E-03 
Cellular 
processes and 
signaling Cell motility 
QP84_08565 - peptidase S41 1482 NMB1332 prc -2.44 2.78E-03     
Cellular 
processes and 
signaling 
Cell 
wall/membrane/envelope 
biogenesis 
QP84_08580 - creA protein 558 NMB1335 creA -3.90 1.19E-09     
Poorly 
characterized Function unknown 
QP84_08585 - hypothetical protein 546 NMB1336 - -3.22 2.71E-06     
Information 
storage and 
processing Transcription 
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N. meningitidis L91543 MC58 orthologs BH-FDR* 
TRANSIT 
Resampling COG Categories 
Locus Gene Product Length (bp) NMB Gene 
Average 
Log2 FC  p-value Log2 FC p-value Process Description 
QP84_08610 aceE pyruvate dehydrogenase 2661 NMB1341 pdhA -2.06 2.81E-02 -1.84 1.67E-02 Metabolism 
Energy production and 
conversion 
QP84_08635 - inositol monophosphatase 783 NMB1347 suhB -4.41 1.45E-12 -4.47 1.11E-02 Metabolism 
Carbohydrate transport 
and metabolism 
QP84_08755 hisZ 
ATP phosphoribosyltransferase 
regulatory 1149 NMB0814 hisZ -2.28 7.05E-03     Metabolism 
Amino acid transport and 
metabolism 
QP84_08760 - adenylosuccinate synthetase 1296 NMB0815 purA -4.26 1.16E-11     Metabolism 
Nucleotide transport and 
metabolism 
QP84_08795 - 
ADP-L-glycero-D-manno-heptose-6-
epimerase 1002 NMB0828 hldD -2.72 2.91E-04 -2.74 2.79E-02 
Cellular 
processes and 
signaling 
Cell 
wall/membrane/envelope 
biogenesis 
QP84_09275 - 
phosphoribosylformylglycinamidine 
synthase 3960 NMB1996 purL -2.52 1.51E-03 -2.36 5.00E-04 Metabolism 
Nucleotide transport and 
metabolism 
QP84_09245 - hypothetical protein 753 NMB1088 - -4.46 8.11E-13 -5.48 2.50E-03 
Poorly 
characterized Function unknown 
QP84_09550 - iron-regulated protein FrpA 2284 NMB1415 frpC -1.96 4.73E-02     
Cellular 
processes and 
signaling Cell motility 
QP84_09625 - sulfatase 1632 NMB1638 - -4.41 1.29E-12 -4.49 1.20E-03 
Poorly 
characterized 
General function 
prediction only 
QP84_09675 - hypothetical protein 726 NMB1648 -     -4.14 4.05E-02 
Poorly 
characterized Function unknown 
QP84_09680 - dihydrolipoamide acyltransferase 486 NA NA -2.75 2.43E-04 -2.65 2.26E-02 NA NA 
QP84_09930 - 
methenyltetrahydrofolate 
cyclohydrolase 852 NA NA -2.15 1.58E-02 -1.94 3.32E-02 NA NA 
QP84_10135 - recombinase XerC 915 NMB1868 xerC -1.96 4.65E-02     
Information 
storage and 
processing 
Replication, 
recombination and repair 
QP84_10205 carB 
carbamoyl phosphate synthase 
large subunit 3213 NMB1855 carB -3.26 1.84E-06 -3.24 2.00E-04 Metabolism 
Amino acid transport and 
metabolism 
QP84_10250 - carbamoyl-phosphate synthase 1131 NMB1849 carA     -0.93 1.68E-02 Metabolism 
Amino acid transport and 
metabolism 
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N. meningitidis L91543 MC58 orthologs BH-FDR* 
TRANSIT 
Resampling COG Categories 
Locus Gene Product Length (bp) NMB Gene 
Average 
Log2 FC  p-value Log2 FC p-value Process Description 
QP84_10740 - glutaminase 225 NA NA -3.14 5.61E-06     NA NA 
QP84_11070 - acriflavine resistance protein B 3201 NMB1715 mtrD -2.15 1.58E-02     
Cellular 
processes and 
signaling Defense mechanisms 
Note: List of genes selected using both TRANSIT resampling and BH-FDR with a cut-off of fold change (FC) < -1.5, p ≤ 0.05 
* Calculated from the T-test comparing the average fold change difference of each biological repeat of the tested gene against the average fold change difference of the 
whole population 
NA – Information not available 
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Table 5-11 List of meningococcal genes showing reduced fitness in invasion of epithelial cells 
N. meningitidis L91543 MC58 orthologs BH-FDR* 
TRANSIT 
Resampling COG Categories 
Locus Gene Product Length (bp) NMB Gene 
Average 
Log2 FC  p-value Log2 FC p-value Process Description 
QP84_00060 - hypothetical protein 432 NMB0986 - -2.54 2.25E-02     NA NA 
QP84_00095 - 
UDP-N-acetylmuramoylalanyl-D-
glutamate--2, 180 NMB1087 - -3.28 6.58E-04     NA NA 
QP84_00155 - alkylhydroperoxidase 546 NMB1036 leuC -2.57 1.99E-02     Metabolism 
Amino acid transport and 
metabolism 
QP84_00230 - 
BcepMu gp16 family phage-
associated protein 177 NA NA -2.76 8.33E-03     NA NA 
QP84_00320 - hypothetical protein 543 NMB1020 - -3.55 1.37E-04     NA NA 
QP84_00325 - anthranilate synthase component I 1473 NMB1021 trpE -2.87 4.76E-03     Metabolism 
Amino acid transport and 
metabolism 
QP84_00370 - fructose 1,6-bisphosphatase 972 NMB1060 fbp -5.35 6.01E-11 -5.91 2.74E-02 Metabolism 
Carbohydrate transport 
and metabolism 
QP84_00375 - competence protein ComJ 843 NMB1061 rlmJ -2.91 3.95E-03     
Poorly 
characterized 
General function 
prediction only 
QP84_00565 - hypothetical protein 207 NMB0590 trmD -3.22 8.16E-04     
Information 
storage and 
processing 
Translation, ribosomal 
structure and biogenesis 
QP84_00625 - ankyrin 759 NMB1171 - -2.48 2.97E-02     
Poorly 
characterized 
General function 
prediction only 
QP84_00645 - hypothetical protein 195 NMB1175 - -2.92 3.78E-03     
Poorly 
characterized Function unknown 
QP84_00675 - hypothetical protein 351 NMB1181 - -2.43 3.64E-02     NA NA 
QP84_00715 - dihydroxy-acid dehydratase 1857 NMB1188 ilvD1 -2.57 2.00E-02 -2.38 1.28E-02 Metabolism 
Amino acid transport and 
metabolism 
QP84_00765 - GTP-binding protein 1809 NMB1199 typA -3.32 5.26E-04 -4.15 5.00E-04 
Cellular 
processes and 
signaling 
Signal transduction 
mechanisms 
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N. meningitidis L91543 MC58 orthologs BH-FDR* 
TRANSIT 
Resampling COG Categories 
Locus Gene Product Length (bp) NMB Gene 
Average 
Log2 FC  p-value Log2 FC p-value Process Description 
QP84_00850 - membrane protein 1068 NMB1219 - -2.90 4.24E-03     
Poorly 
characterized 
General function 
prediction only 
 
 
QP84_00950 - 
exodeoxyribonuclease V subunit 
alpha 1743 NMB1233 recD -3.84 2.19E-05     
Information 
storage and 
processing 
Replication, 
recombination and repair 
QP84_01230 - membrane protein 477 NMB1026 - -3.09 1.55E-03     
Poorly 
characterized Function unknown 
QP84_01455 - 
dTDP-4-dehydrorhamnose 3,5-
epimerase 537 NMB0081 - -2.59 1.82E-02 -2.87 1.51E-02 
Cellular 
processes and 
signaling 
Cell 
wall/membrane/envelope 
biogenesis 
QP84_01600 - 
aspartate carbamoyltransferase 
catalytic 918 NMB0106 pyrB -3.00 2.72E-03 -3.5 3.09E-02 Metabolism 
Nucleotide transport and 
metabolism 
QP84_01645 - ATPase 2115 NMB0114 - -3.26 6.95E-04 -3.09 9.90E-03 
Cellular 
processes and 
signaling 
Signal transduction 
mechanisms 
QP84_01935 minC septum formation inhibitor 711 NMB0170 minC -2.40 4.10E-02     
Cellular 
processes and 
signaling 
Cell cycle control, cell 
division, chromosome 
partitioning 
QP84_01970 - amino acid dehydrogenase 1254 NMB0176 dadA -2.42 3.86E-02     Metabolism 
Amino acid transport and 
metabolism 
QP84_02260 - diadenosine tetraphosphatase 828 NMB0661 - -2.48 2.94E-02     
Cellular 
processes and 
signaling 
Signal transduction 
mechanisms 
QP84_02295 - 
N-acetyl-anhydromuranmyl-L-
alanine amidase 570 NMB0668 ampD -3.39 3.44E-04 -4.83 2.90E-03 
Cellular 
processes and 
signaling Defense mechanisms 
QP84_02435 - cell division protein FtsN 996 NMB0692 tpc     -3.59 1.16E-02 
Information 
storage and 
processing 
Translation, ribosomal 
structure and biogenesis 
QP84_02445 - transcriptional regulator FolI 438 NMB0693 folC -2.99 2.72E-03     Metabolism 
Coenzyme transport and 
metabolism 
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N. meningitidis L91543 MC58 orthologs BH-FDR* 
TRANSIT 
Resampling COG Categories 
Locus Gene Product Length (bp) NMB Gene 
Average 
Log2 FC  p-value Log2 FC p-value Process Description 
QP84_02450 - hypothetical protein 357 NMB0695 - -3.40 3.48E-04     NA NA 
QP84_02575 - ferrochelatase 1008 NMB0718 hemH -2.61 1.72E-02     Metabolism 
Coenzyme transport and 
metabolism 
QP84_02580 - queuine tRNA-ribosyltransferase 1113 NMB0719 tgt     -2.32 2.71E-02 
Information 
storage and 
processing 
 
Translation, ribosomal 
structure and biogenesis 
QP84_02690 - nucleotide-binding protein 852 NMB0738 - -2.97 2.97E-03 -3.23 6.90E-03 
Poorly 
characterized 
General function 
prediction only 
QP84_02770 xerD 
site-specific tyrosine recombinase 
XerD 873 NMB0751 xerD -2.60 1.72E-02     
Information 
storage and 
processing 
Replication, 
recombination and repair 
QP84_02795 - 
phosphoribosylaminoimidazole-
succinocarboxamide 861 NMB0757 purC -2.37 4.67E-02     Metabolism 
Nucleotide transport and 
metabolism 
QP84_02910 - uroporphyrin-III methyltransferase 1332 NMB0778 -     -3.96 3.60E-03 Metabolism 
Coenzyme transport and 
metabolism 
QP84_02940 - 
exodeoxyribonuclease V subunit 
beta 3612 NMB0785 recB -2.93 3.66E-03 -2.87 8.00E-04 
Information 
storage and 
processing 
Replication, 
recombination and repair 
QP84_02980 - VanZ family protein 360 NMB0794 - -3.45 2.60E-04     NA NA 
QP84_03175 - hypothetical protein 1518 NMB0531 - -2.83 5.55E-03     Metabolism 
Energy production and 
conversion 
QP84_03615 - membrane protein 336 NMB1943 - -4.26 1.11E-06     NA NA 
QP84_03620 - 
chromosome partitioning protein 
ParB 858 NMB1944 parB -3.26 6.95E-04 -3.26 6.00E-04 
Information 
storage and 
processing Transcription 
QP84_03740 - transporter 588 NMB1963 - -6.26 1.00E-14     Metabolism 
Secondary metabolites 
biosynthesis, transport 
and catabolism 
QP84_03740 - transporter 588 NMB1963 -     -8.43 1.42E-02 Metabolism 
Secondary metabolites 
biosynthesis, transport 
and catabolism 
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N. meningitidis L91543 MC58 orthologs BH-FDR* 
TRANSIT 
Resampling COG Categories 
Locus Gene Product Length (bp) NMB Gene 
Average 
Log2 FC  p-value Log2 FC p-value Process Description 
QP84_03750 - ABC transporter permease 774 NMB1965 - -4.15 2.77E-06     Metabolism 
Secondary metabolites 
biosynthesis, transport 
and catabolism 
QP84_03755 - 
toluene ABC transporter ATP-
binding protein 798 NMB1966 - -6.04 7.70E-14 -6.12 1.10E-03 Metabolism 
Secondary metabolites 
biosynthesis, transport 
and catabolism 
QP84_03790 - hypothetical protein 1515 NMB1971 - -3.60 9.74E-05     NA NA 
QP84_04055 - protein-PII uridylyltransferase 1908 NMB1822 pglD     -2.1 2.20E-03 
Cellular 
processes and 
signalling 
 
Cell 
wall/membrane/envelope 
biogenesis 
QP84_04095 - 
polysaccharide biosynthesis family 
protein 1422 NMB1818 - -3.54 1.43E-04 -3.21 <0.0001 
Poorly 
characterized 
General function 
prediction only 
QP84_04130 - pilin assembly protein 543 NMB1811 pilP -6.03 6.87E-14     
Cellular 
processes and 
signaling Cell motility 
QP84_04135 - pilus assembly protein PilO 645 NMB1810 pilO -4.39 4.73E-07     
Cellular 
processes and 
signaling Cell motility 
QP84_04145 - pilus assembly protein PilM 1113 NMB1808 pilM -5.40 4.57E-11     
Cellular 
processes and 
signaling Cell motility 
QP84_04175 - cytochrome C biogenesis protein 1185 NMB1803 - -3.14 1.25E-03     
Cellular 
processes and 
signaling 
Posttranslational 
modification, protein 
turnover, chaperones 
QP84_04355 prpB 2-methylisocitrate lyase 873 NMB0430 prpB -2.89 4.32E-03     Metabolism 
Carbohydrate transport 
and metabolism 
QP84_04430 - 
cytochrome C biogenesis protein 
CcmE 1644 NA NA -4.96 3.07E-09 -6.13 4.66E-02 NA NA 
QP84_04520 - exodeoxyribonuclease III 768 NMB0399 xthA -3.13 1.27E-03 -3.25 1.59E-02 
Information 
storage and 
processing 
Replication, 
recombination and repair 
QP84_04600 - hypothetical protein 294 NA NA -3.06 1.92E-03 -5.58 3.80E-03 NA NA 
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N. meningitidis L91543 MC58 orthologs BH-FDR* 
TRANSIT 
Resampling COG Categories 
Locus Gene Product Length (bp) NMB Gene 
Average 
Log2 FC  p-value Log2 FC p-value Process Description 
QP84_04690 - aminotransferase 1212 NMB1473 - -3.28 6.66E-04 -3.29 2.10E-03 Metabolism 
Amino acid transport and 
metabolism 
QP84_04700 - 
phosphoribosylglycinamide 
formyltransferase 804 NMB1475 - -4.14 2.75E-06 -2.74 3.42E-02 Metabolism 
Inorganic ion transport 
and metabolism 
QP84_04860 - 
amino acid ABC transporter 
permease 744 NMB1509 - -3.89 1.53E-05     Metabolism 
Amino acid transport and 
metabolism 
QP84_04930 - peptidylprolyl isomerase 480 NMB1522 slyD -2.66 1.34E-02 -3.86 2.97E-02 
Cellular 
processes and 
signaling 
Posttranslational 
modification, protein 
turnover, chaperones 
QP84_05040 - long-chain fatty acid--CoA ligase 1668 NMB1555 fadD-2 -2.36 4.86E-02 -2.09 1.49E-02 Metabolism 
Lipid transport and 
metabolism 
QP84_05060 - glutathione synthetase 954 NMB1559 gshB -3.40 3.47E-04     
Information 
storage and 
processing 
Translation, ribosomal 
structure and biogenesis 
QP84_05520 - transcription-repair coupling factor 4125 NMB1281 mfd -2.55 2.19E-02     
Information 
storage and 
processing Transcription 
QP84_05670 - cell division protein FtsK 2436 NMB1314 ftsK1 -3.22 8.30E-04     
Cellular 
processes and 
signaling 
Cell cycle control, cell 
division, chromosome 
partitioning 
QP84_05750 - major facilitator transporter 1215 NA NA -2.84 5.51E-03     NA NA 
QP84_05990 - hypothetical protein 135 NA NA -2.97 3.06E-03     NA NA 
QP84_06140 - 
crossover junction 
endodeoxyribonuclease RuvC 534 NMB1419 ruvC -4.48 2.35E-07     
Information 
storage and 
processing 
Replication, 
recombination and repair 
QP84_06260 - 
N5-carboxyaminoimidazole 
ribonucleotide mutase 483 NMB1439 purE -3.26 6.95E-04     Metabolism 
Nucleotide transport and 
metabolism 
QP84_06460 - 
ABC transporter substrate-binding 
protein 912 NMB0586 - -2.36 4.92E-02     Metabolism 
Inorganic ion transport 
and metabolism 
QP84_06685 - 1-(5-phosphoribosyl)-5-[(5- 735 NMB0629 hisA -3.94 1.08E-05 -4.45 2.61E-02 Metabolism 
Amino acid transport and 
metabolism 
QP84_06800 - hypothetical protein 249 NA NA -2.91 4.14E-03     NA NA 
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N. meningitidis L91543 MC58 orthologs BH-FDR* 
TRANSIT 
Resampling COG Categories 
Locus Gene Product Length (bp) NMB Gene 
Average 
Log2 FC  p-value Log2 FC p-value Process Description 
QP84_07245 - DNA-3-methyladenine glycosylase 549 NMB1673 tag -2.54 2.25E-02     
Information 
storage and 
processing 
Replication, 
recombination and repair 
QP84_07515 - peptidase M50 636 NA NA -2.70 1.11E-02     NA NA 
QP84_07545 - secretion protein 1308 NMB1737 - -3.72 4.52E-05     
Cellular 
processes and 
signaling 
Cell 
wall/membrane/envelope 
biogenesis 
QP84_07560 - hypothetical protein 510 NMB1740 - -3.87 1.76E-05 -4.07 4.40E-03 NA NA 
QP84_07795 guaA GMP synthase 1563 NMB1920 guaA -3.45 2.62E-04     Metabolism 
Nucleotide transport and 
metabolism 
QP84_07840 - phosphoribosyltransferase 525 NMB1912 -     -4.08 3.41E-02 
Poorly 
characterized 
General function 
prediction only 
QP84_08055 - hypothetical protein 273 NMB0361 - -3.33 4.81E-04     
Information 
storage and 
processing 
Replication, 
recombination and repair 
QP84_08070 - hypothetical protein 375 NA NA -2.36 4.86E-02     NA NA 
QP84_08095 - 
sugar ABC transporter substrate-
binding protein 528 NMB0355 lptA -3.75 3.76E-05 -5.97 1.50E-02 
Poorly 
characterized Function unknown 
QP84_08160 - intracellular septation protein A 528 NMB0342 - -3.10 1.51E-03     
Cellular 
processes and 
signaling 
Cell cycle control, cell 
division, chromosome 
partitioning 
QP84_08160 - intracellular septation protein A 528 NMB0342 -     -5.48 3.33E-02 
Cellular 
processes and 
signaling 
Cell cycle control, cell 
division, chromosome 
partitioning 
QP84_08220 - type II secretion system protein F 1230 NMB0333 pilG -5.52 1.33E-11 -5.41 <0.00001 
Cellular 
processes and 
signaling Cell motility 
QP84_08240 - pilus assembly protein PilF 1674 NMB0329 pilF -3.61 9.48E-05 -3.53 1.99E-02 
Cellular 
processes and 
signaling Cell motility 
QP84_08380 - 
tRNA delta(2)-
isopentenylpyrophosphate 939 NMB0935 miaA     -2.34 4.29E-02 
Information 
storage and 
Translation, ribosomal 
structure and biogenesis 
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N. meningitidis L91543 MC58 orthologs BH-FDR* 
TRANSIT 
Resampling COG Categories 
Locus Gene Product Length (bp) NMB Gene 
Average 
Log2 FC  p-value Log2 FC p-value Process Description 
processing 
QP84_08515 sucC 
succinyl-CoA synthetase subunit 
beta 1164 NMB0959 sucC -3.66 6.84E-05 -3.7 2.10E-03 Metabolism 
Energy production and 
conversion 
QP84_08565 - peptidase S41 1482 NMB1332 prc -3.14 1.24E-03 -5.78 1.37E-02 
Cellular 
processes and 
signaling 
Cell 
wall/membrane/envelope 
biogenesis 
QP84_08570 - hypothetical protein 1803 NMB1333 - -2.75 8.76E-03     
Cellular 
processes and 
signaling 
Cell cycle control, cell 
division, chromosome 
partitioning 
QP84_08580 - creA protein 558 NMB1335 creA -3.79 2.80E-05     
Poorly 
characterized Function unknown 
QP84_08585 - hypothetical protein 546 NMB1336 - -2.88 4.48E-03     
Information 
storage and 
processing Transcription 
QP84_08615 - 
dihydrolipoamide 
acetyltransferase 1599 NMB1342 aceF -3.24 7.52E-04     Metabolism 
Energy production and 
conversion 
QP84_08635 - inositol monophosphatase 783 NMB1347 suhB -5.15 4.36E-10 -5.63 3.50E-03 Metabolism 
Carbohydrate transport 
and metabolism 
QP84_08650 - 
SAM-dependent 
methlyltransferase 1254 NMB1351 -     -3.97 3.08E-02 
Information 
storage and 
processing 
 
Translation, ribosomal 
structure and biogenesis 
QP84_08725 - hypothetical protein 564 NMB0808 - -3.17 1.08E-03     
Poorly 
characterized Function unknown 
QP84_08745 - multidrug transporter 1377 NMB0812 norM -2.77 8.00E-03 -3.31 1.82E-02 
Cellular 
processes and 
signaling Defense mechanisms 
QP84_08760 - adenylosuccinate synthetase 1296 NMB0815 purA -3.39 3.52E-04     Metabolism 
Nucleotide transport and 
metabolism 
QP84_08795 - 
ADP-L-glycero-D-manno-heptose-
6-epimerase 1002 NMB0828 hldD -5.71 1.90E-12 -5.56 1.10E-03 
Cellular 
processes and 
signaling 
Cell 
wall/membrane/envelope 
biogenesis 
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N. meningitidis L91543 MC58 orthologs BH-FDR* 
TRANSIT 
Resampling COG Categories 
Locus Gene Product Length (bp) NMB Gene 
Average 
Log2 FC  p-value Log2 FC p-value Process Description 
QP84_09030 - hypothetical protein 852 NMB0906 - -2.66 1.35E-02     
Poorly 
characterized Function unknown 
QP84_09165 - hypothetical protein 423 NMB0872 - -2.85 5.14E-03     
Poorly 
characterized 
General function 
prediction only 
QP84_09275 - hypothetical protein 753 NMB1996 purL -3.98 9.56E-06 -5.36 2.62E-02 Metabolism 
Nucleotide transport and 
metabolism 
QP84_09550 - iron-regulated protein FrpA 2284 NMB1415 frpC -2.88 4.53E-03     
Cellular 
processes and 
signaling Cell motility 
QP84_09605 - hypothetical protein 753 NMB1624 - -2.57 1.98E-02     
Poorly 
characterized Function unknown 
QP84_09625 - sulfatase 1632 NMB1638 - -4.27 1.09E-06 -4.35 1.40E-03 
Poorly 
characterized 
General function 
prediction only 
QP84_09760 - 
hypoxanthine 
phosphoribosyltransferase 561 NMB2047 - -4.37 5.18E-07 -3.88 2.29E-02 Metabolism 
Nucleotide transport and 
metabolism 
QP84_09895 - hypothetical protein 120 NMB2073 - -3.15 1.24E-03     NA NA 
QP84_10135 - recombinase XerC 915 NMB1868 xerC -2.99 2.69E-03     
Information 
storage and 
processing 
Replication, 
recombination and repair 
QP84_10205 carB 
carbamoyl phosphate synthase 
large subunit 3213 NMB1855 carB -3.95 1.10E-05 -4 <0.00001 Metabolism 
Amino acid transport and 
metabolism 
QP84_10230 - hypothetical protein 258 NA NA -2.65 1.38E-02     NA NA 
QP84_10515 - membrane protein 342 NA NA -3.14 1.26E-03     NA NA 
QP84_10560 - hemolysin 606 NMB2091 -     -3.78 1.28E-02 
Poorly 
characterized 
General function 
prediction only 
QP84_10740 - glutaminase 225 NA NA -4.36 5.51E-07     NA NA 
QP84_11040 - lactoferrin-binding protein B 2175 NMB1541 lbpB -3.95 1.10E-05     NA NA 
Note: List of genes selected using both TRANSIT resampling and BH-FDR with a cut-off of fold change (FC) < -1.5, p ≤ 0.05 
* Calculated from the T-test comparing the average fold change difference of each biological repeat of the tested gene against the average fold change difference of the 
whole population 
NA – Information not available 
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Table 5-12 List of meningococcal genes showing reduced fitness in traversing across the epithelial cells 
N. meningitidis L91543 MC58 orthologs TRANSIT Resampling COG Categories 
Locus Gene Product Length (bp) NMB Gene Log2 FC p-value Process Description 
QP84_04055 - protein-PII uridylyltransferase 1908 NMB1822 pglD -4.06 1.65E-02 
Cellular 
processes and 
signaling 
Cell 
wall/membrane/envelope 
biogenesis 
QP84_00420 - gamma-glutamyl phosphate reductase 1260 NMB1068 - -4.07 3.66E-02 Metabolism 
Amino acid transport and 
metabolism 
QP84_11070 - acriflavine resistance protein B 3201 NMB1715 mtrD -5.44 2.49E-02 
Cellular 
processes and 
signaling Defense mechanisms 
QP84_09680 - dihydrolipoamide acyltransferase 486 NA NA -5.15 2.36E-02 NA NA 
QP84_03780 - peptidase S8 2697 NMB1969 - -0.33 2.41E-02 
Cellular 
processes and 
signaling 
Posttranslational 
modification, protein 
turnover, chaperones 
QP84_02940 - exodeoxyribonuclease V subunit beta 3612 NMB0785 recB -5.76 1.90E-03 
Information 
storage and 
processing 
Replication, recombination 
and repair 
QP84_00325 - anthranilate synthase component I 1473 NMB1021 trpE -4.94 7.90E-03 Metabolism 
Amino acid transport and 
metabolism 
QP84_09625 - sulfatase 1632 NMB1638 - -6.3 2.23E-02 
Poorly 
characterized 
General function prediction 
only 
QP84_09470 - transcriptional regulator 846 NMB1389 - -5.04 2.25E-02 
Information 
storage and 
processing Transcription 
QP84_06585 - 
putrescine/spermidine ABC transporter 
permease 963 NMB0611 potB -5.42 2.54E-02 Metabolism 
Amino acid transport and 
metabolism 
QP84_08440 - 5-methyltetrahydropteroyltriglutamate-- 2274 NMB0944 metE -4.55 4.68E-02 Metabolism 
Amino acid transport and 
metabolism 
QP84_04690 - aminotransferase 1212 NMB1473 - -4.85 2.38E-02 Metabolism 
Amino acid transport and 
metabolism 
QP84_10105 - hypothetical protein 1899 NMB2040 thiC -0.23 2.04E-02 Metabolism 
Coenzyme transport and 
metabolism 
QP84_07105 - membrane protein 972 NMB0012 - -5.56 9.80E-03 Metabolism 
Inorganic ion transport and 
metabolism 
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N. meningitidis L91543 MC58 orthologs TRANSIT Resampling COG Categories 
Locus Gene Product Length (bp) NMB Gene Log2 FC p-value Process Description 
QP84_00725 - sulfite reductase 1812 NMB1190 cysJ1 -0.23 3.01E-02 Metabolism 
Inorganic ion transport and 
metabolism 
QP84_05040 - long-chain fatty acid--CoA ligase 1668 NMB1555 fadD-2 -5.21 9.30E-03 Metabolism 
Lipid transport and 
metabolism 
QP84_02690 - nucleotide-binding protein 852 NMB0738 - -5.77 8.50E-03 
Poorly 
characterized 
General function prediction 
only 
QP84_09930 - methenyltetrahydrofolate cyclohydrolase 852 NA NA -5.23 2.01E-02 NA NA 
QP84_02415 - 
N-(5'-phosphoribosyl)anthranilate 
isomerase 624 NA NA -6.08 3.07E-02 NA NA 
Note: List of genes selected using both TRANSIT resampling and BH-FDR with a cut-off of fold change (FC) < -1.5, p ≤ 0.05. Data from BH-FDR not included as p >0.05 
NA – Information not available 
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The distribution of genes on the finalised list relative to the assay type (adherence, 
invasion, traversal) are shown in Figure 5.9, where the genes are also categorized 
according to the Clusters of Orthologous Groups (COG) functions (Tatusov et al., 
1997). The gene list is tabulated in Tables 5.10 to 5.12. 73% of the genes involved in 
adherence to epithelial cells were found to also have reduced fitness in the invasion 
assay, while almost 50% of mutants with reduced fitness during invasion were 
exclusive, i.e. not in the adhesion list. From the 19 finalized genes involved in 
traversing the epithelial cell, ~47% were also involved in adherence and 
internalization to the epithelial cells. Five genes were identified to be important in all 
three tested assays, of which three coded for hypothetical proteins (NMB1638, 
NMB1473 and NMB0738) in addition to pglD (NMB1822) and recB (NMB0785) 
genes. In general, the top two categories of genes identified were involved in 
metabolism (35 ±7%) or belonged to those with unknown or poorly categorized 
functions (26 ±10%).   
Next, we looked for interactions between selected genes using the STRING 
database (Szklarczyk et al., 2015). This software assesses protein-protein 
interactions (PPI) to find proteins that are predicted to have functional connectivity, 
and so is useful in visually identifying genes that are functionally linked (p value of 
≤0.05 indicates significance). This can provide additional confidence that a process 
or pathway is involved over and above that provided by a single gene, eg purine 
biosynthesis rather than purC on its own. Genes identified in the adhesion and 
invasion assays are shown in Figure 5.10. Clusters of genes involved in tfp 
biogenesis proteins (blue circle), nucleotide transport and metabolism (especially 
purine metabolism) (red circle) and secondary metabolite transport system (yellow 
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circle) can be discerned. However, genes in the other subsets, such as adhesion 
only (Figure 5.11) and internalization only (Figure 5.12), showed no significant PPI 
enrichments. No PPI enrichment were seen with genes identified in the traversal 
assays (p= 0.32) (Figure 5.13). The orthologs of N. meningitidis MC58 were used in 
the STRING analysis, with a loss of ~10% genes from the L91543 strain, as gene 
association files are not available for L91543. 
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Figure 5-9 Genes indicating reduced fitness in adhesion, invasion and traversal of 
epithelial cells form Tn-Seq data analysis  
A. Venn diagram showing overlap of genes found to be defective in adherence, invasion and 
traversal across epithelial cells. The genes found in the outside all overlaps are specific to the 
individual dataset. B.  Bar chart showing the COG categories of the identified genes. The detailed list 
of genes with the categories are tabulated in the appendix. 
A 
B 
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Figure 5-10 The STRING network view for genes present in both adhesion and invasion 
assays  
Protein-protein interaction network analysis of 47 genes that showed reduced fitness in both 
adhesion and internalization of 16HBE14o- epithelial cell line (PPI enrichment p value of 0.000292). 
Four networks of associated proteins were seen, tfp biogenesis proteins (blue circle), nucleotide 
transport and metabolism (especially purine metabolism) (red circle) and secondary metabolite 
transport system (yellow circle).The different coloured lines connecting the nodes represent the 
evidence type used in the prediction of the protein association (https://string-db.org)  
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Figure 5-11 The STRING network view for genes identified in only adherence to the 
epithelial cells  
Protein-protein interaction network analysis of 15 genes that showed reduced fitness in adhesion to 
16HBE14o- epithelial cell line (PPI enrichment p value of 0.0526). No specific protein association 
network was observed. The different coloured lines connecting the nodes represent the evidence 
type used in the prediction of the protein association (https://string-db.org)  
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Figure 5-12 The STRING network view for genes identified in only invasion of the epithelial 
cells  
Protein-protein interaction network analysis of 49 genes that showed reduced fitness in invasion of 
16HBE14o- epithelial cell line (PPI enrichment p value of 0.35). No specific protein association 
network was observed. The different coloured lines connecting the nodes represent the evidence 
type used in the prediction of the protein association (https://string-db.org)  
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Figure 5-13 The STRING network view for genes identified in the traversal assay   
Protein-protein interaction network analysis of 16 genes that showed reduced fitness in traversing 
across the 16HBE14o- epithelial cell barrier (PPI enrichment p value of 0.32). No specific protein 
association network was observed . The different coloured lines connecting the nodes represent the 
evidence type used in the prediction of the protein association (https://string-db.org)  
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5.3  Discussion 
The dynamics of the adherence, invasion and traversal assays using the Tn5 mutant 
library were similar to the wild type strain, N. meningitidis. Thus, the screening 
methods established in the previous chapters as well as the newly verified traversal 
assay (using 6mm inserts instead of 24mm inserts) were applicable to the mutant 
library and the vast majority of mutants continue to behave in a manner similar to 
wild type. Our screening approach relies on “negative selection” to identify 
meningococcal genes involved in adherence, internalization and traversal of the 
epithelial cells. Such a selection is relative (we are looking for change in fitness not a 
complete loss of adherence/invasion/traversal), and so it is important the mutants 
with fitness defects can be identified by comparison to a wider population of mutants 
that have no fitness cost as is apparent in our experiments. Thus, when we observed 
a bimodal distribution of recovered bacteria  in our traversal assay (evident by ‘low’ 
and ‘high’ cell counts (Figure 5.1), it was important that they were processed for Tn-
Seq analysis separately to avoid missing mutants with slower traversal kinetics, 
which would be overshadowed by the higher count mutants. We also filtered the 
sequence data according to the set quality measures mentioned previously, leaving 
approximately 35% of ‘reads’ that were used to identify relevant genes. Seeing that 
the biggest percentage of gene loss was during the alignment to the L91543 strain 
(Karlyshev et al., 2015) and the PCR de-duplication stage, the reads were also 
aligned against the more commonly used and studied reference strain N. 
meningitidis MC58 (Tettelin et al., 2000). However, this gave a similar percentage of 
reads suggesting that the loss was due to elimination of PCR de-duplication, and 
sequence misreads rather than a lack of sequence alignment.  
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Unlike Mariner transposition at TA sites, the random insertion of the Tn5 transposon 
meant that measures of insertion saturation are less meaningful than in a TA library, 
as the notional maximum saturation of the library would be the size of the entire 
genome. The insertion density of the Tn5 transposon was 1/22bp in the input pool. 
We did see higher insertion in certain sites; the reasons for this are unknown. Some 
studies have shown that the Tn5 transposition has a weak preference to GC rich 
regions (Chao et al., 2016, Green et al., 2012), nevertheless Tn5 libraries have been 
successfully used in Tn-Seq studies of other organisms in various selection 
conditions (Barquist et al., 2013b, Christen et al., 2011, Pickard et al., 2013, Teh et 
al., 2017).  
Adherence and internalization. Based on our Tn-Seq analysis, using a cut-off of 
>1.5 fold change and P<0.05 respectively, we found that 69 (4.5%) and 107 (7%) of 
the 1527 gene mutants that were represented in the library, showed reduced fitness 
in adherence and invasion of 16HBE14o-  cells respectively. Of these, 51 genes 
exhibited reduction in fitness in both adherence and invasion processes. Fourteen of 
these genes (27%) are shown to be defective in colonizing epithelial cells in 
previously published work (Cox et al., 2003, Hey et al., 2013, Jamet et al., 2013, Li et 
al., 2009, Monaco et al., 2006, Sviridova et al., 2017, Takahashi et al., 2008) 
including genes related to tfp, an important virulence factor in adherence to epithelial 
cells (Laver et al., 2015, Merz and So, 2000, Soriani, 2017), thus validating the 
selection conditions and demonstrating that the library and its selection is capable of 
identifying genes involved in adhesion. In addition, 17% of the genes that showed 
reduced fitness in our adherence and internalization assay was also shown to be 
153 
 
important in colonizing the epithelial cells in the transposon mutagenesis study using 
an in vitro laminar flow chamber experimental model (Capel et al. (2016)).  
In addition to the major and minor adhesins identified as virulence factors, nutritional 
virulence has also been shown to be significant in nasopharyngeal colonization 
(Schoen et al., 2007). Hey et al. (2013) and Capel et al. (2016) showed that the 
majority of genes that were differentially expressed and showed lowered fitness 
respectively in their studies were involved in metabolic pathways. Our results 
exhibited a similar trend, with the highest percentage of identified genes, ~31%, 
involved in nutrient transport and metabolism. Another large group of mutants 
showing reduced fitness belonged to those containing insertions in genes of 
unknown function. This was also reported by Exley et al. (2009) who found that  3 
out of 8 mutants defective in colonizing the nasopharynx contained inserts in genes 
of unknown function. These studies are consistent with the idea that some factors 
important in Neisserial pathogenesis have yet to be discovered and may be involved 
in currently undescribed activities. 
 Of the genes identified as important in both adhesion and invasion of epithelial cells,  
STRING analysis revealed enrichment in three gene networks; tfp machinery, 
secondary metabolite transport system and purine metabolism. We  detected 5 (pilF, 
pilG, pilM, pilO, pilP) of the 15 tfp genes involved in tfp pilus biogenesis (Carbonnelle 
et al., 2006)  attenuated, as well as  pglD which is involved in pilin glycolisation. The 
genes pilM, pilO and pilP are involved in the assembly of the tfp whilst pilF, a 
membrane associated ATPase is necessary for pili elongation and maturation of the 
prepilin (Carbonnelle et al., 2006, Carbonnelle et al., 2009). Exley et al. (2009) also 
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demonstrated that pilF was essential for colonization of upper airway epithelial using 
an organ culture model. Somewhat surprisingly, PilE, the major subunit of the tfp 
encoded by the pilE gene, was not identified in our screen. However, further 
investigation of the transposition counts data showed that even though the output 
pool was void of Tn5 insertion mutants in pilE, the low number of insertions in pilE in 
the input pool precluded significant fold-changes in frequency to be identified.  
The uptake of certain amino acids from the host has been implicated in 
meningococcal virulence (Schoen et al., 2014). Our data also indicated that amino 
acid metabolism and transport was important; up to 8% of genes within this category 
had lowered fitness values in the adherence and invasion assays. These included 
NMB1966, NMB1963 and NMB1965, which clustered in the STRING analysis 
(Figure 5.10). Monaco and colleagues assigned the name gltT (for L-glutamate 
transport) operon to the ORFs NMB1966 to NMB1958 and successfully 
demonstrated that the  NMB1965 and NMB1963 genes  were involved in glutamate 
transport, and were essential for growth in infected epithelial cells under low sodium 
concentrations (Monaco et al., 2006). In addition, Li et al. (2009) also showed that a 
NMB1966 knockout mutant (encoding a putative ABC transporter) was less adhesive 
and invasive to human bronchiol cells. These studies provide additional confidence 
in the utility of our assays to identify genes involved in Neisseria-epithelial cell 
interactions. 
Finally, in addition to the two networks of genes discussed above, genes involved in 
purine metabolism were also detected and shown to have significant PPI enrichment 
in the STRING analysis. Nucleotide metabolism is integral to core cellular functions 
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including DNA replication and transcription. Therefore, Tn5 insertions in these genes 
are likely to effect to general cellular metabolism of Neisseria rather than be directly 
involved in adherence and invasion. It is possible that under the conditions faced by 
the meningococci during colonization of the epithelial cells, the impact of these gene 
insertions is further enhanced, thus their loss in the library is exaggerated, explaining 
their loss from the mutant pool. 
STRING analysis provides one means to visualize the connection between genes 
that show reduced fitness. However, many other individual genes, accounting for 
approx. 81% of the identified genes, did not fit into any obvious cluster. These 
include genes in other metabolic pathways and transport, as well as core cellular 
functions such as nucleotide metabolism, cell division and control of cell cycle, repair 
and recombination  (Table 5.10 and 5.11). Future studies are needed to confirm 
whether these play a role in mediating epithelial cell interactions  
Traversal across the epithelial barrier. Statistical analysis revealed the mutant 
population in the output pools of the traversal assay was highly variable; R2 value = 
0.03 indicating very poor correlation between biological replicates. This may reflect 
stochastic selection of genes with fitness defects. In other words, in all of the repeats 
the mutant diversity was too low for a common set of mutants with fitness defects to 
be identified. This may also reflect differences in the kinetics of mutant transfer 
across the epithelial barrier as our assay used a single short time point. Increased 
reproducibility may be achieved by capturing the traversed meningococci over a 
longer sampling period. Regardless of this variability, we were still able to perform 
statistical analysis on the output population. 
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A total of 204 genes showed reduced fitness in traversing the epithelial barrier when 
differences between input and output pools (fold change) of the biological repeats 
were compared using a t-test. However, none of these genes were significant when 
corrected for multiple comparison to control for the false discovery rate using BH-
FDR (Benjamini and Yekutieli, 2005). We, therefore, used the genes identified using 
the TRANSIT resampling method to look for candidates with reduced fitness. This 
test will ignore variation due to biological variation, but will rather effectively average 
the reads, as if a single large experiment was performed. Using this approach we 
identified 19 genes involved in meningococci traversal of the epithelial barrier, of 
which 16 exhibited >1.5 fold change between the input and output pool. STRING 
analysis of these genes did not reveal any significant enrichment (Figure 5.13). 
Nevertheless, mutation in these genes may effect Neisseria host cell interaction and 
traversal. Similar to the adhesion and invasion assay, genes involved in metabolism 
as well as those of unknown function yielded the highest percentages of mutants 
with reduced fitness.  
This genome-wide screen has generated many genes worthy of further study and 
this work would extend well beyond the scope of this thesis. However, in order to 
establish the usefulness of the Tn5 screen, it is important to validate some of the 
identified candidates by creating individual knockout mutants and testing their 
response in single infection assays. Therefore, in Chapter 6 eight candidate genes 
were selected based on the gene meeting at least 2 of the 3 following criteria: i) 
there was a significant fold-change between frequency of the mutant in the input and 
output pools (p<0.05); ii) the candidate gene was identified as significant by both 
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statistical analysis pipelines - the TRANSIT resampling and BH-FDR methods; and 
finally iii) candidate genes were enriched in the STRING analysis.  
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6    VALIDATION OF TN-SEQ APPROACH TO IDENTIFY GENES INVOLVED IN 
NEISSERIA MENINGITIDIS ADHERENCE, INVASION AND TRAVERSAL OF THE 
EPITHELIAL BARRIER  
6.1  Introduction 
In the previous chapter, we utilized the adherence, internalization and traversal 
assays to identify factors that play a role in N. meningitidis interaction(s) with 
respiratory epithelial cells including those involved in enabling Neisseria to breach 
the epithelial barrier and enter the bloodstream. We used a previously published 
library (Mendum et al. (2011)) containing 14,500 Tn5 transposon insertion mutants, 
and high throughput sequencing methodologies to carry out this genome-wide 
screen. In total, 69 and 107 genes showed reduced fitness in adherence and 
invasion of epithelial cells respectively, whilst only 19 genes were found to affect 
Neisseria traversal of the epithelial barrier.  
Even though transposon mutagenesis studies provide a powerful, genome-wide 
approach for determining genes essential for a tested biological condition, the 
method has some limitations. Among these is the over-prediction of a genes’ 
requirement because the mutant is outcompeted by other mutants in the pool, 
absence of insertions in small genomic elements such as sRNAs and short open 
reading frames (ORF) as well as polar effects on genes downstream of the insertion 
site (Lourdault et al., 2016, van Opijnen et al., 2009). Thus, it is important to validate 
the findings from the Tn-Seq screen by performing single mutant phenotypic assays.  
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Thus, the aim of this chapter is to determine whether genes identified in the Tn-Seq 
analysis are attenuated when single gene deletion mutants are constructed and 
tested in single strain (rather than competition-style) assays. We selected 8 genes 
(using the criteria described at the end of Chapter 5), taking 6 putative adherence 
and invasion genes and 3 putative ‘traversal’ genes. The selected genes are 
summarized in Table 6.1. Single gene deletion mutants were constructed in the wild 
type Neisseria background and their fitness was tested in the adherence, invasion 
and traversal assays.  
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Table 6-1 Summary of selected genes used in Tn-Seq validation 
N. meningitidis 
L91543 locus 
N. meningitidis 
MC58 orthologs 
Gene Product description Genes showing reduced fitness in 
Tn-Seq analysis 
(Fold change >1.5, p <0.05) 
Selected to 
validate 
Previously published work 
using deletion mutant in 
regards to tested phenotype 
Adhesion Invasion Traversal 
QP84_08240 NMB0329 pilF Pilus assembly protein PilF √ √  Adherence and 
invasion assay 
Yes 
Exley et al. (2009) 
QP84_03755 NMB1966 - ABC transporter, ATP-binding 
protein 
√ √  Yes 
Li et al. (2009) 
QP84_00370 NMB1060 fbp Fructose 1,6-bisphosphatase √ √  No 
QP84_10205 NMB1855 carB Carbamoyl phosphate synthase, 
large subunit 
√ √  No 
QP84_06260 NMB1439 purE Phosphoribosylaminoimidazole 
carboxylase, catalytic subunit 
√ √  No 
QP84_09625 NMB1638 - Hypothetical protein √ √ √ Adherence, 
invasion and 
traversal assay 
No 
QP84_11070 NMB1715 mtrD Multiple transferable resistance 
system protein MtrD 
√  √ Traversal assay No 
QP84_06585 NMB0611 potB Putrescine/spermidine ABC 
transporter permease 
  √ No 
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6.2  Results 
6.2.1  Construction and verification of individual mutants  
In order to assess the accuracy of the Tn-Seq predictions, insertional knockout 
strains were constructed for each of the 8 selected genes. From this point 
onwards, the selected genes will be referred to by the N. meningitidis MC58 
orthologs instead of the L91543 strain. The mutants were created by 
transforming chromosomal DNA into N. meningitidis L91543 strain as described 
in section 2.10 The chromosomal DNA from the appropriate mutants were 
kindly provided by Dr Vladimir Pelicic, Faculty of Medicine, Imperial College 
London and Dr Yih-Ling Tzeng, Department of Medicine, Emory University 
School of Medicine as described in Table 2.4. The genomic DNA of the 
kanamycin resistant colonies from the transformation were screened for the 
inserts by PCR and putative knock out (K/O) mutants were stored in 15% 
glycerol at -80°C.  
The sequence of the knock out mutants was confirmed by amplifying the genes 
adjacent to the insertion sites. Chromosomal DNA from Dr Pelicic and Dr Tzeng 
was used as a positive control (specific for each mutant) and negative controls 
including genomic DNA of the L91543 strain and a non-template control, was 
used to check primer specificity. The PCR amplicon of the Himar1 insertion 
L91543 mutants are shown in Figure 6.1. All the expected bands were seen in 
the mutants and positive controls. The expected band size is described in 
Chapter 2 (Table 2.5). In addition to the expected band size, a non-specific 
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amplification product at ~ 350 bp was seen in the PCR reaction performed with 
NMB1060 mutant and its corresponding positive and negative control (wild type 
strain).  Unlike the other mutants, NMB1060 primer pairs also amplified the fbp 
gene in the wildtype. The amplicon size of ~978 bp reflected the fbp gene 
without the transposon insert. The corresponding K/O mutants showed 
amplification of the target gene flanking the Mariner transposon with the 
kanamycin resistance cassette (~2.5 kb) (Pelicic et al., 2000, Tzeng et al., 
2005). 
The sequence of the constructed mutants were further checked by Sanger 
sequencing before the mutants were used in subsequent phenotypic assays. 
The sequences obtained corresponded to the relevant genes of N. meningitidis 
using Basic Local Alignment Search Tool (BLAST) (data not shown) with a 95-
100% percentage of identity. Thus, both the PCR and the sequence results 
indicated the successful insertion of the mariner transposon mutant DNA by 
homologous recombination, disrupting the targeted gene in N. meningitidis 
L91543 and thus creating single gene knock out mutants.  
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Figure 6-1 Gel electrophoresis image of transposon-chromosome junction 
amplification of the knock out mutants using PCR 
A representative result (1% agarose gel) of the kanamycin resistant colonies screened by PCR. 
The predicted bands were seen in both the K/O and the positive controls. M: 1 kb marker; PC: 
positive control; K/O: knock out mutant; WT: L91543 strain (wild type strain); NC: no template 
control.  
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6.2.2  Adherence and internalization assay using knock out mutants  
In order to determine the adherence and invasion phenotypes of the mutants, 
all the 8 K/O mutants, including those selected using the traversal assay, were 
used to challenge 16HBE14o- cells grown to confluency in 24-well plates. The 
adherence and internalization assays were carried out as described in Section 
2.7 with a minor change; an overnight culture was used to infect the wells 
instead of a 4h culture as done in the previous chapters. This was necessary to 
fit in with the restricted working hours of the Neisseria laboratory. Three 
independent assays, each in duplicate, were carried out using the K/O mutants 
and the wild type (N. meningitidis L91543) as a control. The 2 genes with 
previously described attenuations, pilF (ΔNMB0329) (Exley et al., 2009) and 
ΔNMB1966 (Li et al., 2009) were shown to be defective in adhering to and 
invading the epithelial cells (Figure 6.2). These acted as positive controls and 
so validated the adherence and invasion assay. The other 4 mutants [NMB1060 
(fbp), NMB1855 (carB), NMB1439 (purE) and NMB1638] also demonstrated 
significant reductions in adhesion compared to the wild type, ranging from 56-
99 % of the wild type. In the invasion assay, these K/O mutants also showed 
lower numbers of internalized meningococci, but only ΔNMB1060 and 
ΔNMB1855 exhibited significantly lower levels when compared to the wild type 
(Figure 6.2). Though invasion by NMB1439 and NMB1638 K/O mutants was 
reduced (45.6±5.6% and 5.7±1.7%, respectively) compared to wild type N. 
meningitidis L91543, differences were not significant most likely because they 
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were considered as part of a multiple mutant comparison assay (one-way 
ANOVA with Bonferroni’s correction).   
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Figure 6-2 Measurement of N. meningitidis adhesion and invasion to epithelial cells 
for Tn-Seq-identified gene mutants 
16HBE14o- cell layers were infected with the parental wild type strain (L91543 strain) and the 
K/O mutants with a MOI of 200. The number of adhering and internalized (gentamicin 
protection assay) were enumerated using Miles and Misra after 6h incubation. Data is shown 
as mean ±SEM of the bacterial counts from 3 biological repeats. The significant difference 
between the wild type and each K/O mutant were determined using one-way ANOVA with 
Bonferroni’s correction, where *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 and **** p ≤ 0.0001. The 
red square depicts the genes that showed reduced fitness in the Tn-Seq analysis.   
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6.2.3  Traversal assay using knock out mutants  
The K/O mutants were further used to validate the traversal assay analysis. 
Three (3) genes; NMB1638, NMB1715 (mtrD) and NMB0611 (potB), which had 
reduced fitness in the traversal assay as well the 5 genes selected from the 
adhesion and invasion transposon mutagenesis study, were tested concurrently 
with the wild type strain. Polarized 16HBE14o- cells grown on the 6mm 
Transwell® inserts with transepithelial electrical resistance (TEER) of 2411 ± 
650Ω, were infected at the apical region with the respective strains at a MOI of 
200 as described in Chapter 2. This TEER correlates with the establishment of 
cell barrier as shown in Chapter 5 and in other published work (Kim et al. 
(2005). Again, an overnight culture grown on CBA (supplemented with 
kanamycin for the mutants) was used instead of 4h cultures. Three independent 
assays were set up in triplicate (including no-cell controls for each biological 
repeat).  
Meningococci traversal across the epithelial barrier occurred without a 
significant reduction (~25%) in TEER compared to the uninfected cells 
(p=0.549; one-way ANOVA). Moreover, no significant differences were 
observed in the amount of FITC-labelled 70 kDa dextran sampled from the 
basal chamber of the infected and uninfected wells (p=0.8766, one way 
ANOVA). Both these measures indicate that the epithelial barrier was still intact 
at the end of the experiment (Figure 6.3). 
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At the 12th hour of incubation, the inserts were transferred to new wells with 
fresh tissue culture medium in the basal chamber. The traversed meningococci 
were then enumerated after 2 h incubation from the basal chamber. All three of 
the putative traversal mutants were attenuated in crossing the epithelial barrier 
as significantly lower numbers were recovered in the basal chamber compared 
to the wild type strain, L91543 (Figure 6.4). Four of five of the other mutants 
also showed a reduced ability to traverse the epithelial barrier, with two K/O 
mutants, ΔNMB1638 and ΔNMB1060, completely absent from the basal 
chamber.  
 
 
 
 
 
 
 
 
 
 
 
 170 
 
 
 
Figure 6-3 Assessment of epithelial barrier integrity during traversal assay 
The epithelial barrier formed by the 16HBE14o- cells were assessed by measuring the TEER and 
the FITC-labelled 70kDA dextran permeability across the cell layer. The TEER was measured at 
time zero, post inoculation and at the 12th hour. The FITC-labelled 70 kDa dextran was added 
to the apical chamber at the end of the traversal assay, the 14th hour, and the fluorescence 
was measured after 2 h incubation. No significance differences were seen in all 3 
measurements using one-way ANOVA when the infected wells were compared to the 
uninfected wells. Data is shown as mean ± SEM of all inserts tested in all 3 independent assays. 
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Figure 6-4 Measurement of N. meningitidis traversal across the epithelial barrier for 
Tn-Seq-identified gene mutants 
Polarized 16HBE14o- cell layers were infected with the wild type, L91543 strain and K/O 
mutants with a MOI of 200. The number of meningococci that crossed the barrier was 
determined by Miles and Misra after 2h incubation in fresh basolateral media on the 12th hour 
post infection. Data is shown as mean ± SEM of all inserts tested in all 3 independent assays. 
The significant differences between the strains were determined using one-way ANOVA with 
Bonferroni’s correction, where *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 and **** p ≤ 0.0001. The 
red square depicts the genes that showed reduced fitness in the Tn-Seq analysis.   
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6.3  Discussion 
TN-Seq simultaneously determines the abundance of a large number of 
transposon mutants in a multi-faceted competition assay. By applying a 
selection pressure to one population of mutants and comparing the abundance 
of mutants to a control that has not been placed under the same selection 
pressure, the fitness of every mutant can be simultaneously determined. 
However the methodology has some limitations, therefore it is wise to challenge 
the predictions made by the Tn-Seq analysis to confirm that the genes actually 
play a role in the processes under study. Here we have successfully validated 
the Tn-Seq screening, showing that 6/6, 4/6 and 3/3 of the mutants exhibited 
the expected phenotypes for adherence, internalization and traversal of the 
epithelial cells respectively. In addition, one of the 2 mutants selected for 
validating the traversal assay, ΔNMB1715, which was attenuated in adhering to 
the 16HBE14o- cells, had also shown reduced fitness in our Tn-Seq screen with 
a fold change of -2.5 (p value of 0.0158) (Table 5.10).  
Consistent with the Tn-Seq data, mutants containing deletions in the genes 
NMB1638, NMB1715 and NMB0611 were found to be defective in crossing the 
epithelial barrier.  However, four other mutants were also found to be attenuated 
in the traversal assay. NMB1855 was one of the 19 genes that had shown 
reduced fitness in the Tn-Seq analysis (Table 5.12). Although the remaining 
mutants, with deletions in NMB0329, NMB1966 and NMB1060, were not 
identified as having reduced fitness based on the cut-off criteria established in 
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Chapter 5 (specifically p values were >0.05 in the TRANSIT sampling analysis), 
all 3 mutants exhibited fold changes of between -5.19 to -2.46. Further 
investigation revealed that 2 of these mutants, NMB0329 and NMB1966 do 
meet the cut-off criteria when the high and low count output pools were 
analysed separately (See Appendix A.3 for the separate analysis of these two 
pools). This suggests that analysing the combined reads of the 2 output pools 
may be overly stringent in predicting the genes that contribute to reduced 
fitness because of the large variability between the output pools.  Pujol et al. 
(1997) previously demonstrated the importance of pili in traversing the epithelial 
barrier using T84 colonic epithelial cells. We did not identify pilF as being 
important for Neisseria traversal using the selection criteria initially stated for 
our Tn-Seq analysis. However, pilF mutants did exhibit a significant reduction 
when we considered the reads from the low and high pools separately. Indeed, 
many more genes were identified when data from the high and low traversing 
population in the transposon mutagenesis experiment (Chapter 5) was 
separately analysed by TRANSIT resampling. Then, a total of 388 and 132 
genes were found to be of reduced fitness in the high and low traversal count 
output pool, respectively. Of these, 116 genes were identified in both the mutant 
pools. The gene lists are shown in Appendix A.3. It may be worthwhile to look 
again at the genes selected from the low and high counts output pool in order to 
identify additional genes involved in Neisseria traversal of the epithelial cell 
barrier.  
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One factor that may confound the interpretation of the study relates to the ability 
of the mutants to grow under the conditions of the experiment. Because we 
used CBA plates to produce the bacteria in the ‘input’ pool in Chapter 5, we did 
not fully test the ability of the mutants to grow in tissue culture medium. Mutants 
that grow less well in tissue culture media may be under-represented in the pool 
and appear attenuated.  To partially address this issue, we enumerated the 
number of viable bacteria at time zero as well as the tested time points, i.e. 6 h 
and 14 h incubation, in the media of the single strain experiments. The data 
showed that 3 of the tested mutants (ΔNMB1638, ΔNMB1855 and ΔNMB1060) 
demonstrated a growth defect in the tissue culture medium during the adhesion 
and invasion assays (Appendix A.4). This growth defect may thereby partly 
account for their attenuation. It is difficult in this assay to separate bacterial 
growth defects from adhesion/invasion defects as the meningococci interact 
with the epithelial cells from as early as 2 hours post-inoculation (Chapter 3). 
Ideally, phenotypes observed using single gene deletion mutants are further 
confirmed by complementing the mutants, thereby reverting the phenotypic 
defect of the mutant back to the wild type condition (Exley et al., 2009, Jamet et 
al., 2013). Unfortunately, achieving these next steps was beyond the time frame 
of this project, but this should be completed to further confirm the role of these 
newly-identified gene(s) in Neisseria pathogenesis.  
The remainder of this discussion will focus on discussing what is known about 
the genes that were identified in more detail.   
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NMB0329 (pilF gene) and NMB1966. The genes involved in type IV pilus 
assembly, namely protein PilF, NMB0329 (pilF gene) and a predicted ATP 
binding component of an ABC transporter system, NMB1966, have been 
previously demonstrated to be involved in colonization of epithelial cells (Exley 
et al., 2009, Li et al., 2009). The data from our Tn-Seq analysis confirms this 
finding, even though different experimental testing conditions were used in the 
two studies. We further demonstrated that both these genes also played a role 
in Neisseria traversal across the epithelial cell barrier. Type IV pili act as 
adhesins as well as promoting aggregation during colonization of the epithelial 
cells (Carbonnelle et al., 2009). Pileated strains are also shown to successfully 
cross the epithelial barrier by a transcellular pathway (Pujol et al., 1997, 
Sutherland et al., 2010). Even though the pilF gene has not been directly tested 
in the meningococci traversal across epithelial barrier, we infer its role to be 
similar based on the experiments using other Type IV pili mutants (Sutherland 
et al., 2010).  
Glutamate is an important nutrient for meningococci, as shown in in vitro growth 
experiments using chemically defined medium (Catlin, 1973), and during 
interactions with epithelial and endothelial cells (Monaco et al., 2006, Takahashi 
et al., 2011). NMB1966 forms part of the operon involved in the glutamate ABC 
transport system, GltT, (operon contains NMB1966 to NMB1958) (Monaco et 
al., 2006). Li et al. (2009) demonstrated that NMB glutamate uptake mutants 
were attenuated in both adhesion and invasion of 16HBE14o-  cells. However, 
despite a 35% reduction in adhesion compared to the wild type, this difference 
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was not found to be statistically significant in their study. We observed 
significantly lower levels of adhesion and invasion of the mutant, with a 
percentage of 27% and 0.2% respectively, compared to the wild type strain. 
Meningococcal traversal is closely related not only to the ability of the bacterium 
to colonize the cells, but also to its ability to survive in the host cell environment. 
Our results suggest that the ability of Neisseria to utilize glutamate in the host 
cell may be important and explain the poor recovery of the mutant. However, Li 
et al. (2009) also demonstrated that the NMB1966 mutant expressed less pili, 
which could also contribute to the attenuation of this mutant during adhesion, 
invasion and traversal of the epithelial cell. 
NMB1060 (fbp gene). NMB1060 encodes fructose 1,6-bisphosphatase, which 
catalyses the gluconeogenesis conversion of D-fructose 1,6-biphosphate to D-
fructose 6-phosphate (Hines et al., 2006). D-fructose 6-phosphate is an 
important branch point in metabolism that connects to the pentose phosphate 
pathway. We have shown that fructose 1,6-bisphosphatase is important in 
meningococcal colonization as well as traversal across the epithelial barrier, 
thus indicating glucose metabolism is also crucial. Only 3% and 1.8% of the 
NMB1060 mutants adhered and invaded the cells compared to the wildtype, 
and none breached the barrier. This gene also showed reduced fitness 
interacting with both the epithelial and endothelial cells in the transposon 
mutagenesis based screen conducted by Capel et al. (2016), but was not 
confirmed in a single mutant assay. The role of this gene has not been well 
studied in N. menigitidis or in other organisms except for its catalytic function. 
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One study by Tzeng et al. (2005) demonstrated that this gene played a role in 
cationic antimicrobial peptides (CAMP) resistance by altering cell permeability. 
Even though we demonstrated the importance of this gene, we cannot rule out 
other possible roles in addition to glucose metabolism, which directly or 
indirectly affect pathogenesis. Housekeeping enzymes have recently been 
reported as potential virulence factors with additional functions such as 
glyceraldehyde 3-phosphate dehydrogenase and fructose bisphosphate 
aldolase (Pancholi and Chhatwal, 2003, Tunio et al., 2010, Mendonça et al., 
2016). Even within glucose metabolism, it is not clear whether its role is in 
mediating anabolic or catabolic reactions, since the nasopharynx has available 
carbon sources such as glucose, amino acid and especially lactate (Schoen et 
al., 2014).  
NMB1855 (carB gene) and NMB1439 (purE gene). These nucleotide transport 
and metabolism genes are involved in arginine biosynthesis and pyrimidine 
metabolism (NMB1855) as well as purine metabolism (NMB1439). Carbamoyl 
phosphate synthase encoded by carB generates carbomyl phosphate which is a 
metabolic branch point for the arginine and pyrimidine pathway. Even though 
carbomyl phosphate is not unique to pyrimidine, it is an important regulatory 
step in pyrimidine biosynthesis (Moffatt and Ashihara, 2002). Our phenotypic 
assays show that carB mutants are defective in adhering to, invading and 
traversing the epithelial cells. Capel et al. (2016) also demonstrated that this 
gene showed reduced fitness in both meningococcal epithelial and endothelial 
colonization, based on findings from their mariner transposon mutant library 
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screen. This gene has also been reported to play a role in direct competition of 
P. aeruginosa with S. aureus in a study of cystic fibrosis pathogen and co-
colonizers (Beaume et al., 2015). This may also be applicable to the 
nasopharynx niche where S. aureus is a known commensal. As for the purE 
tested mutant, it was defective in adhesion but even though fewer invading and 
traversing mutant cells were recovered compared to the wild type strain, the 
levels obtained did not reach statistical significance. Both carB and purE were 
shown to be upregulated during biofilm formation (O'Dwyer et al. (2009). Biofilm 
formation may enable Moraxella catarrhalis to achieve long-term mucosal 
colonization of the host (Luke et al., 2007). In addition, both these genes were 
also shown to be critical for survival in human blood for Salmonella enterica and 
Bacillus anthracis (Samant et al., 2008). Finally, purE N. meningitidis was also 
shown to have reduced fitness in meningococcal growth in serum (Mendum et 
al., 2011). This shows that both purine and pyrimidine metabolism is important 
bacterial growth and survival in human body, as nucleotides have a central role 
in the physiology of organisms.  
NNMB1638. NMB1638 encodes a hypothetical protein which was  identified as 
lptA, a gene encoding LPS phosphoethenolamine transferase for lipid A (Cox et 
al., 2003). The attenuation of the NMB1638 mutants for colonization and 
especially traversal across the epithelium indicates that lipopolisaccharide 
(LPS) structural changes are important for bacterial interactions with epithelial 
cells. However, the mechanistic basis for this interaction is unclear. The lipid A 
region of the LPS is responsible for the toxicity of the LPS molecule and the 
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LPS is known to elicit an anti-adhesive effect mediated by outer membrane 
proteins (Virji, 2009). In addition, modification of the lipid A region can affect the 
overall charge of the molecule. Resistance to cationic antimicrobial peptide 
(CAMPs) such as polymyxin B, in N. meningitidis, N. gonnorhoea and E. coli 
has been reported to be due to phosphoethenolamine modification of the lipid A 
molecule (Lewis et al., 2009, Nummila et al., 1995, Sperandeo et al., 2007, 
Tzeng et al., 2005, Wanty et al., 2013). Studies using atomic force microscope 
on adhesion of E. coli with substrates showed that the presence of long O-
antigen chains reduces bacterial adhesion (Camesano et al., 2007, Lu et al., 
2011). Thus, modifications in LPS may act directly to affect bacterial adherence 
or indirectly to confer resistance to host defences, or both.  
NMB1715 (mtrD gene) and NMB0611 (potB gene) The NMB1715 and 
NMB0611 mutants were defective in traversing the epithelial cells. Attenuation 
in adhesion was also displayed by the NMB1715 mutant. MtrD is part of the Mtr 
efflux pump, MtrC/D/E which is responsible for Neisseria spp resistance to 
antimicrobial peptides (Cole and Nizet, 2016). Tzeng et al. (2005) and (Spinosa 
et al., 2007) have demonstrated that mtrD mutants were defective in CAMPs 
resistance. The mtrCDE operon was upregulated when the meningococci was 
exposed to CAMP or the cells were intracellular. Our work thereby suggests 
that the ability of meningococci to cross the epithelial barrier is directly related to 
their ability to evade host defence peptides. NMB0611 is part of the polyamine 
transport operon, potDABC, and all 4 proteins are necessary for spermidine 
uptake (Igarashi and Kashiwagi, 1999). Goytia et al. (2015) suggested that that 
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gonococci could use this ABC transporter to acquire polyamines present in the 
human urogenital tract. In addition, an intact PotABCD transport system was 
also shown to provide resistance to neutrophil killing in Streptococcus 
pneumoniea  (Rai et al., 2016). Polyamines are also implicated in biofilm 
formation, bacteriocin production, toxin activity and protection from oxidative 
and acid stress (Shah and Swiatlo, 2008). Thus, deletion of these genes in 
Neisseria may impact the ability of cells to withstand host cell defence 
mechanisms.  
In summary, we can conclude that the genes uncovered in the Tn-Seq assay 
and analysis described in Chapter 5 can correctly identify meningococcal genes 
involved in adhesion, invasion and traversal across epithelial cells. Our findings 
using single gene deletion mutants indicate that nutrient-based virulence, and 
escaping host defences, are important aspects governing the outcome of 
Neisseria-epithelial cell interactions.  
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7    FINAL DISCUSSION 
7.1  Final discussion 
N. meningitidis is the leading cause of bacterial meningitis worldwide, causing 
both endemic and epidemic infections with high mortality and morbidity. 
Meningococcal disease is treatable with antibiotics, penicillin and cephalosporin 
being the choice drugs, but often these come too late as the disease can 
progress quickly with rapid clinical deterioration (Corsini and Mishra, 2017). The 
clinical outcomes are further complicated by the difficulties in establishing an 
early diagnosis as the early symptoms are similar to non-serious other illnesses. 
Delays in diagnosis and the rapid onset of disease can lead to high mortality 
and morbidity, with serious sequale common.  
On average, one tenth of the human population carry N. meningitidis 
asymptomatically at any given time, making nasopharynx carriage a major 
factor in the prevalence and epidemiology of meningococcal disease. Since 
humans are the only known reservoir for meningococci, understanding its 
interaction with human epithelial cells is important, as meningococcal disease 
begins when the organism invades and crosses the epithelial barrier to reach 
the blood stream, and occasionally, the blood brain barrier (BBB). However, 
meningococci interaction with human epithelial cells is multi-factorial, beginning 
with bacterial adhesion to the apical cell surface, invasion of the cells, 
intracellular persistence, traversal across the epithelial cell and exit into the 
bloodstream (Merz and So, 2000). Even though some of the organism’s 
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colonisation factors are known, factors and processes that are important for 
survival and traversal across the epithelial cell barrier are poorly understood, 
and the trigger that initiates, or makes this process possible, remain unknown.  
Transposon mutagenesis methods allow genome-wide analysis of genes that 
affect an organisms’ fitness under a test condition. We applied this technology 
to gain a better understanding of N. meningitidis-epithelial cell interactions, 
focusing on genes involved in the organisms’ adherence, invasion and traversal 
of the epithelial barrier. Of the three respiratory cell lines we tested, 16HBE14o- 
cells demonstrated the highest levels of meningococcal adherence and 
internalized bacteria and so were used for the Tn-Seq experiments.  
TnSeq analysis predicted that 69 and 107 genes were critical for adherence and 
invasion of the epithelial cells, respectively. Using COG classification, we found 
that the highest percentage of genes (31%) with reduced fitness were involved 
in meningococcal metabolism. This agrees with the recently published 
transposon-based mutagenesis study of Capel et al. (2016) as well as 
transcriptomic assays by Hey et al. (2013). Genes involved in type IV pili 
biogenesis, and nucleotide transport and metabolism, were the two categories 
containing the greatest number of genes of reduced fitness in both adhesion 
and invasion of the epithelial cells. Genes involved in glucose metabolism, 
amino acid metabolism and defence mechanisms also showed reduced fitness 
as did a significant number of those of unknown function. The Tn-Seq based 
prediction was further validated using single mutant phenotypic assay, notably, 
we found that 6 of 6 (100%) genes identified in the adherence assays. 4 of 6 
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(67%) of genes identified by Tn-seq in the invasion assays exhibited the 
expected phenotypes with significant attenuation in the number of adherent and 
internalised bacteria, respectively.  
 Tn-Seq data generated from the traversal assays was less reproducible than 
that obtained from the adherence and invasion assays, most likely reflecting the 
complexity of the biological process and the low number of cells that were 
captured under our assay conditions. Regardless, we identified 19 genes as 
potentially important during meningococcus transveral of the epithelial barrier. 
These included genes mainly involved in amino acid transport and metabolism 
as well as genes of unknown functions. We further showed that 4 of 4 (100%) 
genes identified in the traversal assay were attenuated in traversing the 
epithelial barrier in our single mutant validation assays. To our knowledge, this 
is the first time meningococcal traversal has been studied at a genomic scale.   
The importance of type IV pili in adherence, internalization and traversal of the 
epithelial cells is further emphasized with our pilF K/O mutant assays. Mutants 
involved in glucose metabolism (ΔNMB1060), amino acid metabolism 
(ΔNMB1966), pyrimidine biosynthesis (ΔNMB1855) and host defence 
(ΔNMB1715) were attenuated in adhesion, invasion and traversal across the 
epithelial cells. The purE K/O mutant was attenuated in adhesion whilst the 
potB K/O mutant was attenuated in both invasion and traversal of the epithelial 
cell. The lptA mutant, was defective in adhesion and traversal of the epithelial 
cell. Even though the invasion counts of the lptA mutant were not statistically 
significant, it was reduced ~15 fold compared to the wild type strain. These 
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genes need to be further characterized to better understand the role and the 
mechanisms involved in the tested phenotype. The metabolic genes that we 
showed to have attenuation in adhesion, invasion and traversal further stresses 
the importance of nutritional virulence in meningococci. These housekeeping 
enzymes may be good targets for vaccine and antibiotic development as they 
often have lower mutation rates compared to typical virulent factors. 
Current limitations in the available models of infection hampers our ability to 
fully replicate complex in vivo physiology systems. For example, we used a 
single epithelial cell type in our assays but the nasopharynx is known to contain 
several  cell types, including mucus-producing cells (Laver et al., 2015). In our 
traversal assays, the number of cells recovered in the lower chamber ranged 
over four orders of magnitude. Whether this reflects true biological variation or 
is an artefact of our experimental set up is not known; however, it did 
significantly limit our ability to statistically analyse the data from these assays. 
Wide variation in traversing bacteria was also observed in other meningococcal 
traversal studies (Pujol et al., 1997). 
 Three dimensional (3D) bio-printed organs may overcome some of the 
limitations of current 2D cell monolayer models. Recently, a 3D system that 
mimics the human tracheo-bronchial mucosa with pseudostatified epithelium 
has been used to study the early stages of colonization of non-typeable 
Haemophilus influenzae (Marrazzo et al., 2016). Also, other models developed 
for cancer progression and environmental damage of the respiratory system 
may be adapted for meningococcal studies (Soriani, 2017). 
 186 
 
In conclusion, our work has uncovered many new putative adhesion, invasion 
and traversal factors. Many of these are associated in metabolism functions, 
providing important insights into meningococcal biology. Only further detailed 
characterization of the putative genes, including expression analysis and 
localization of their products, will uncover the multifactorial process of 
meningococci pathogenesis. In addition, we also have successfully optimized a 
high throughput infection model to study adhesion, invasion and traversal of 
meningococci in epithelial cells. 
7.2 Further avenues of investigation 
Further characterization of the genes identified in this study would provide 
further information and further elucidate the processes and the possibilities of 
different roles of these genes. For instance it would be helpful to determine the 
localization of the gene products which may also indicate a role in cell 
physiology. It would also be interesting to know the relationship between 
intracellular survival rate and the traversal of the organism. Immuno-staining of 
the infected Transwell® insert could also be used to determine if these genes 
are involved in subverting the polarized organization of the epithelial cells as 
reported by (Barrile et al., 2015).  
We had identified genes for further study that were predicted to have reduced 
fitness in both adhesion and invasion of the epithelial cells. It would be 
beneficial to phenotypically characterize those genes that are important only in 
invasion of the cells. As with any invasion data, the question arises whether the 
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attenuation is due to the mutant being defective in invasion or is a consequence 
of its inability to adhere to the cells. Although we attempted to control for this 
possibility, further work is required to completely separate adhesion from 
invasion. Similar criticisms can be applied to the traversal assay predicted gene 
list.  
Based on our traversal assay optimization, we observed a bimodal distribution 
of meningococcal numbers crossing the cells. This was surprising as all the 
cells were genetically identical but could be the consequence of epigenetic 
changes, such as phase variation. Comparing the mutant cells that traverse the 
barrier at earlier and later incubation times may allow us to determine if there is 
a real difference between the meningococci that invade early and late.  
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APPENDICES 
A.1  Growth curves of N. meningitidis L91543 (wild type) and phoP mutant 
in DMEM complete medium  
 
0 2 4 6 8
1
0
2
4
7
8
9
1 0
1 1
G ro w th  in  D M E M  (C F U /m l)
H o u r
B
a
c
te
r
ia
l 
c
o
u
n
t 
 (
lo
g
1
0
c
fu
/m
l)
L 9 1 5 4 3
 p h o P
****
****
****
****
**
 
20 ml DMEM was inoculated with 4 h culture of both wild type and mutant grown on 
CBA to an OD600nm of 0.05. The inoculated flasks were incubated at 37 ˚C in a shaking 
incubator at 200 rpm and sampled at hour 0, 2, 4, 6, 8, 10 and 24. The OD600nm and 
bacterial counts using Miles and Misra were determined at these time points.  Three 
biological repeats were performed. Data is shown as mean ±SEM. A significant 
difference was seen between the growth of both strains in the tissue culture media 
(p<0.0001).  The asterisk indicates the difference between the 2 strains in each time 
point. Two-way ANOVA test with  Tukey’s correction was used.   
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A.2  Assessment of epithelial barrier integrity using 6mm Transwell® 
inserts 
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The epithelial barrier formed by the 16HBE14o-  cells were assessed upto 6 
days post seeding by measuring the TEER and the FITC-labelled 70kDA 
dextran permeability across the cell layer after 2h incubation. The percentage of 
fluorescence in the basal chamber was calculated by comparing against the 
fluorescence in the no cell (blank) inserts. The experiments were carried out in 
2 biological repeats, and the data is shown as mean, with the error bars 
representing standard error of mean. No significant difference was seen in the 
fluorescence from day 3 onwards suggesting an intact barrier has been formed 
 205 
 
A.3  Genes showing reduced fitness when the Illumina sequencing reads 
for the traversal output pool (low count and high count) were analysed 
separately 
A.3.1 List of meningococcal genes showing reduced fitness in traversing across the 
epithelial cells in low traversal output  
 
N. meningitidis L91543 MC58 orthologs 
TRANSIT 
Resampling 
Locus Gene Product 
Length 
(bp) NMB Gene Log2 FC p-value 
QP84_00070 - N-acetylmuramoyl-L-alanine amidase 543 NMB0987   -2.96 0.0069 
QP84_00325 - anthranilate synthase component I 1473 NMB1021 trpE -4.02 <0.0001 
QP84_00415 - cell division protein FtsK 3030 NMB1067 ftsK-1 -1.51 0.0347 
QP84_00420 - gamma-glutamyl phosphate reductase 1260 NMB1068 proA -3.07 0.0001 
QP84_00425 - glutamate 5-kinase 1107 NMB1069 proB -2.42 0.0426 
QP84_00685 - 
UDP-N-acetylmuramate:L-alanyl-gamma-
D-glutamyl- 1374 NMB1183 mpl-2 -3.15 0.0407 
QP84_00715 - dihydroxy-acid dehydratase 1857 NMB1188 ilvD-2 -3.35 0.0139 
QP84_01150 - GTP-binding protein HflX 1176 NMB1041   -3.02 0.0406 
QP84_01170 - glutamate--cysteine ligase 1347 NMB1037 gshA -4.6 0.0056 
QP84_01175 - isopropylmalate isomerase 1407 NMB1036 leuC -2.06 0.0196 
QP84_01215 aspA aspartate ammonia-lyase 1395 NMB1029 aspA -2.6 0.0424 
QP84_01460 - capsule biosynthesis protein 1944 NMB0082 lipA -2.57 0.0075 
QP84_01465 - capsule biosynthesis protein 1257 NMB0083 lipB -3.35 0.0076 
QP84_01500 - pyruvate kinase 1470 NMB0089 pykA -2.79 0.0097 
QP84_02075 - sodium:alanine symporter 1425 NMB0194   -3.66 0.0461 
QP84_02175 - hypothetical protein 195 NA NA -5.05 0.0386 
QP84_02295 - 
N-acetyl-anhydromuranmyl-L-alanine 
amidase 570 NMB0668 ampD -3.29 0.0298 
QP84_02320 - hypothetical protein 579 NMB0673   -2.94 0.009 
QP84_02365 - Clp protease ClpB 609 NMB0680 cnp1 -3.16 0.0025 
QP84_02415 - 
N-(5'-phosphoribosyl)anthranilate 
isomerase 624 NA NA -5.08 0.002 
QP84_02550 - membrane protein 384 NMB0714   -2.08 0.0382 
QP84_02650 - exclusion suppressor FxsA 483 NMB0730 fxsA -3.68 0.0156 
QP84_02690 - nucleotide-binding protein 852 NMB0738   -4.92 <0.0001 
QP84_02795 - 
phosphoribosylaminoimidazole-
succinocarboxamide 861 NMB0757 hemH -3.8 0.0329 
QP84_02800 - 
polynucleotide 
phosphorylase/polyadenylase 2118 NMB0758 pnp -3.08 0.0206 
QP84_02940 - exodeoxyribonuclease V subunit beta 3612 NMB0785 recB -5.17 <0.0001 
QP84_02950 - 
amino acid ABC transporter substrate-
binding 822 NMB0787   -2.94 0.0167 
QP84_02955 - cysteine ABC transporter permease 714 NMB0788   -3.91 0.0426 
QP84_02970 - peptidylprolyl isomerase 507 NMB0791   -3.84 0.0157 
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N. meningitidis L91543 MC58 orthologs 
TRANSIT 
Resampling 
QP84_03020 - delta-aminolevulinic acid dehydratase 999 NMB0801 hemB -2.82 0.0313 
QP84_03060 - hemagglutinin 1500 NMB0502   -2.26 0.0075 
QP84_03080 - hemagglutinin 2499 NMB0497   -2.13 0.0087 
QP84_03105 - hypothetical protein 153 NMB1076   -4.12 0.0142 
QP84_03175 - hypothetical protein 1518 NMB0531   -2.56 0.0204 
QP84_03190 - endonuclease III 627 NMB0533 nth -1.64 0.0378 
QP84_03215 - sodium:proton antiporter 1377 NMB0536   -2 0.0247 
QP84_03235 - aromatic amino acid aminotransferase 1191 NMB0455   -2.34 0.0474 
QP84_03265 - chromosome segregation protein SMC 3483 NMB0545   -2.02 0.0019 
QP84_03270 adhP 
ethanol-active 
dehydrogenase/acetaldehyde-active 1038 NMB0546 adhP -3.17 0.0101 
QP84_03285 - macrolide transporter 1932 NMB0549 ybjZ -2.39 0.0034 
QP84_03490 - nitroreductase 603 NMB0292   -4.31 0.0223 
QP84_03655 - lytic murein transglycosylase 1845 NMB1949   -2.4 0.0189 
QP84_03955 - formate--tetrahydrofolate ligase 1674 NMB1839 fhs -3.32 0.0061 
QP84_03960 ychF GTP-binding protein 1089 NMB1838   -2.86 0.0461 
QP84_04015 - TonB-dependent receptor 2154 NMB1829   -1.68 0.0278 
QP84_04055 - protein-PII uridylyltransferase 1908 NMB1822 pglD -3.16 <0.0001 
QP84_04230 - histidine kinase 1248 NMB1792   -2.36 0.05 
QP84_04235 - ribonuclease G 1491 NMB1791 cafA -2.94 0.002 
QP84_04250 - ATP-dependent DNA helicase RecG 2037 NMB1788 recG -2.67 0.0121 
QP84_04365 - guanine permease 1308 NMB0428   -3.05 0.0272 
QP84_04505 - proline:sodium symporter PutP 1524 NMB0402 putP -3.21 0.017 
QP84_04535 - nicotinate-nucleotide pyrophosphorylase 879 NMB0396 nadC -2.41 0.0353 
QP84_04570 - maltose phosphorylase 2256 NMB0390 mapA -3.02 0.0097 
QP84_04575 - aldose epimerase 975 NMB0389 galM -2.22 0.0198 
QP84_04600 - hypothetical protein 294 NA NA -2.99 0.0341 
QP84_04685 - protein disaggregation chaperone 2577 NMB1472 clpB -2.99 0.0059 
QP84_04690 - aminotransferase 1212 NMB1473   -3.99 0.0009 
QP84_04705 - glutamate dehydrogenase 1263 NMB1476 gluD -1.94 0.0098 
QP84_04745 - stationary phase survival protein SurE 744 NMB1484 surE -4.97 0.0095 
QP84_05040 - long-chain fatty acid--CoA ligase 1668 NMB1555 
fadD-
2 -4.27 <0.0001 
QP84_05075 - membrane protein 900 NMB1562   -2.18 0.0363 
QP84_05150 - acetolactate synthase 3 catalytic subunit 1725 NMB1577 ilvI -3.1 0.0018 
QP84_05365 - O-succinylhomoserine sulfhydrolase 1167 NMB1609   -2.22 0.036 
QP84_05455 - conjugal transfer protein 1095 NMB1269   -1.75 0.0097 
QP84_05475 - alginate O-acetyltransferase 1434 NMB1273   -2.21 0.0123 
QP84_05495 - long-chain fatty acid--CoA ligase 1551 NMB1276 
fadD-
1 -2.18 0.0085 
QP84_05700 - membrane protein 804 NMB1319   -1.82 0.0187 
QP84_06010 - rRNA methylase 462 NMB0268   -2.44 0.0001 
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N. meningitidis L91543 MC58 orthologs 
TRANSIT 
Resampling 
QP84_06030 - hypothetical protein 267 NA NA -2.74 0.0332 
QP84_06160 - RNA helicase 1371 NMB1422   -3.81 0.0053 
QP84_06265 - tetratricopeptide repeat family protein 714 NMB1440   -2.06 0.0227 
QP84_06555 - deacetylase 1107 NMB0605 0 -5.47 0.0072 
QP84_06585 - 
putrescine/spermidine ABC transporter 
permease 963 NMB0611 potB -4.57 0.0015 
QP84_06670 prfC peptide chain release factor 3 1593 NMB0626 prfC -5.58 0.0088 
QP84_06880 - argininosuccinate synthase 1341 NMB2129 argG -2.75 0.0068 
QP84_06915 - major facilitator transporter 1455 NMB2136   -3.29 0.0104 
QP84_06955 - hypothetical protein 744 NMB1839 fhs -3.06 0.0162 
QP84_06995 - phosphoribosylamine--glycine ligase 1269 NMB2151 purD -3.4 0.012 
QP84_07105 - membrane protein 972 NMB0012   -4.78 <0.0001 
QP84_07230 - PqiA family protein 1302 NMB1670   -1.84 0.0348 
QP84_07290 - tRNA (uracil-5-)-methyltransferase 1101 NMB1679 trmA -3.2 0.0048 
QP84_07360 - 
3-octaprenyl-4-hydroxybenzoate carboxy-
lyase 1476 NMB1694   -2.71 0.0363 
QP84_07385 - transposase 609 NMB1411   -3.88 0.0275 
QP84_07420 - apbE family protein 657 0 0 -3.04 0.0118 
QP84_07705 - 
polyamine ABC transporter substrate-
binding 1140 NMB0462 
potD-
1 -4.74 0.0372 
QP84_07830 - hypothetical protein 249 NMB1914   -2.8 0.0497 
QP84_07855 - septum formation inhibitor Maf 588 NMB1909 maf -3.96 0.0074 
QP84_07975 - sulfurtransferase 321 NMB2064   -2.58 0.0373 
QP84_08120 - hypothetical protein 288 NA NA -4.39 0.0043 
QP84_08125 - glutamyl-Q tRNA(Asp) ligase 885 NMB0349   -1.8 0.0095 
QP84_08130 - tRNA-dihydrouridine synthase 1008 NMB0348   -2.47 0.0437 
QP84_08160 - intracellular septation protein A 528 NMB0342 ispZ -5.92 0.0483 
QP84_08275 rpmG 50S ribosomal protein L33 153 NA NA -2.58 0.0011 
QP84_08310 - peptidase M23 1290 NMB0315   -1.88 0.0342 
QP84_08440 - 5-methyltetrahydropteroyltriglutamate-- 2274 NMB0944 metH -3.63 0.0013 
QP84_08480 sdhB succinate dehydrogenase 705 NMB0951 sdhB -2.81 0.0322 
QP84_08515 sucC succinyl-CoA synthetase subunit beta 1164 NMB0959 sucC -2.88 0.0008 
QP84_08560 - excinuclease ABC subunit B 2025 NMB1331 uvrB -2.18 0.0329 
QP84_08570 - hypothetical protein 1803 NMB1333   -1.86 0.0372 
QP84_08635 - inositol monophosphatase 783 NMB1347 suhB -6.9 0.0023 
QP84_08705 - MFS transporter 1539 NMB1362 0 -3.03 0.0034 
QP84_08795 - 
ADP-L-glycero-D-manno-heptose-6-
epimerase 1002 NMB0828 rfaD -3.15 0.0108 
QP84_08800 clpA Clp protease ClpX 2295 NMB0836 clpA -2.68 0.0446 
QP84_08805 - Clp protease ClpS 312 NMB0837 clpS -2.2 0.007 
QP84_08835 - PcnB 1359 NMB0843 pcnB -2.8 0.0203 
QP84_09245 - 
phosphoribosylformylglycinamidine 
synthase 3960 NMB1996 purL -2.27 0.0004 
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N. meningitidis L91543 MC58 orthologs 
TRANSIT 
Resampling 
QP84_09250 - hydroxyacylglutathione hydrolase 756 NMB1997 gloB -2.33 0.0052 
QP84_09470 - transcriptional regulator 846 NMB1389   -4.68 0.0014 
QP84_09625 - sulfatase 1632 NMB1638   -7.8 <0.0001 
QP84_09670 - alanine glycine permease 1416 NMB1647   -2.35 0.0131 
QP84_09680 - dihydrolipoamide acyltransferase 486 NA NA -4.57 0.0001 
QP84_09760 - hypoxanthine phosphoribosyltransferase 561 NMB2047   -3.79 0.0355 
QP84_09765 - DNA ligase 822 NMB2048 ligA-2 -2.62 0.0312 
QP84_09775 - recombinase RmuC 1782 NMB2050   -1.83 0.0095 
QP84_09930 - methenyltetrahydrofolate cyclohydrolase 852 NA NA -4.37 0.0008 
QP84_09995 - iojap-like protein 384 NMB2023   -2.38 0.0218 
QP84_10135 - recombinase XerC 915 NMB1868 xerC -4.16 0.0054 
QP84_10145 - (dimethylallyl)adenosine tRNA 1326 NMB1866   -1.89 0.0109 
QP84_10325 - iron transporter 837 NMB0034   -2.36 0.0213 
QP84_10585 - malate:quinone oxidoreductase 1464 NMB2096 yojH -2.55 0.0258 
QP84_10745 - RNA helicase 1386 NMB1368   -2.35 0.0083 
QP84_10785 - pseudouridine synthase 930 NMB1374 truB -2.79 0.025 
QP84_10895 - 
phospho-2-dehydro-3-deoxyheptonate 
aldolase 1053 NMB0307 aroG -2.1 0.0201 
QP84_10965 - acyltransferase 1866 NA NA -2.64 0.0081 
QP84_10980 - alpha/beta hydrolase 639 NMB0868   -2.16 0.034 
QP84_11055 - lactate permease 312 NA NA -3.38 0.0111 
QP84_11070 - acriflavine resistance protein B 3201 NMB1715 mtrD -4.81 0.0009 
 
Note: List of genes selected using both TRANSIT resampling and BH-FDR with a cut-off of fold change 
(FC) < -1.5, p ≤ 0.05. Data from BH-FDR not included as p >0.05 
NA – Information not available 
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A.3.2 List of meningococcal genes showing reduced fitness in traversing across the 
epithelial cells in high traversal output  
 
 
N. meningitidis L91543 MC58 orthologs 
TRANSIT 
Resampling 
Locus Gene Product 
Length 
(bp) NMB Gene 
Log2 
FC p-value 
QP84_00070 - N-acetylmuramoyl-L-alanine amidase 543 NMB0987  -9.14 <0.00001 
QP84_00085 - hypothetical protein 234 NMB1086  -5.55 0.0099 
QP84_00090 - hypothetical protein 417 NMB0990  -6.88 <0.00001 
QP84_00095 - 
UDP-N-acetylmuramoylalanyl-D-
glutamate--2, 180 NMB1087  -2.24 0.0325 
QP84_00165 - lactate dehydrogenase 1689 NMB0997 dld -2.67 0.0018 
QP84_00175 - FAD-linked oxidase 3831 NMB0998 
 
-4.53 0.0028 
QP84_00325 - anthranilate synthase component I 1473 NMB1021 trpE -8.22 <0.00001 
QP84_00405 - chromosome condensation protein CrcB 357 NMB1065 crcB -9.31 0.0001 
QP84_00415 - cell division protein FtsK 3030 NMB1067 ftsK-1 -2.16 0.0083 
QP84_00420 - gamma-glutamyl phosphate reductase 1260 NMB1068 proA -5.5 <0.00001 
QP84_00425 - glutamate 5-kinase 1107 NMB1069 proB -6.72 0.0031 
QP84_00575 - ABC transporter ATP-binding protein 243 NA NA -6.66 0.0283 
QP84_00610 - phytoene synthase 870 NMB1168  -6.83 0.0027 
QP84_00625 - ankyrin 759 NMB1171  -6.72 0.0106 
QP84_00650 - tRNA synthetase RNA-binding protein 399 NMB1176  -7.24 0.0121 
QP84_00665 - RNA methyltransferase 783 NMB1327  -5.73 <0.00001 
QP84_00675 - hypothetical protein 351 NMB1181  -2.18 0.0332 
QP84_00685 - 
UDP-N-acetylmuramate:L-alanyl-gamma-
D-glutamyl- 1374 NMB1183 mpl-2 -6.88 0.0005 
QP84_00715 - dihydroxy-acid dehydratase 1857 NMB1188 ilvD-2 -5.19 0.0015 
QP84_00815 - hypothetical protein 237 NA NA -5.54 0.0022 
QP84_00850 - membrane protein 1068 NMB1219  -7.13 0.0123 
QP84_00915 - ABC transporter 1920 NMB1226  -3.86 0.0008 
QP84_00930 - membrane protein 432 NMB1229  -3.34 0.0046 
QP84_01000 - ATP-dependent DNA helicase RuvB 1029 NMB1243 ruvB -6.56 0.0357 
QP84_01015 - hypothetical protein 204 NMB1837  -8.54 0.0149 
QP84_01035 - ATPase 1770 NMB1249  -4.91 0.004 
QP84_01095 - recombination factor protein RarA 1308 NMB1258  -4.45 0.0172 
QP84_01105 - autotransporter 495 NA NA -7.09 0.0006 
QP84_01115 - membrane protein 1467 NMB1048  -7.61 0.0022 
QP84_01130 - hypothetical protein 780 NMB1045  -3.45 0.015 
QP84_01150 - GTP-binding protein HflX 1176 NMB1041  -5.12 0.0148 
QP84_01170 - glutamate--cysteine ligase 1347 NMB1037 gshA -7.98 0.0004 
QP84_01175 - isopropylmalate isomerase 1407 NMB1036 leuC -4.23 0.0011 
QP84_01205 - 3-isopropylmalate dehydrogenase 1068 NMB1031 leuB -6.59 0.008 
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N. meningitidis L91543 MC58 orthologs 
TRANSIT 
Resampling 
Locus Gene Product 
Length 
(bp) NMB Gene 
Log2 
FC p-value 
QP84_01215 aspA aspartate ammonia-lyase 1395 NMB1029 aspA -5.32 0.0031 
QP84_01280 - twitching motility protein PilT 1041 NMB0052 pilT-1 -4.78 0.0087 
QP84_01285 - alanine racemase 684 NMB0053 
 
-7.89 <0.00001 
QP84_01345 - molecular chaperone DnaJ 1119 NMB0623 
potD-
2 -6.7 0.0489 
QP84_01350 - peptide transporter 2016 NMB0060 
 
-6.69 0.0422 
QP84_01385 - alpha-2,9-polysialyltransferase 1476 NMB1200 
 
-6.9 0.0001 
QP84_01400 - UDP-N-acetylglucosamine 2-epimerase 1131 NMB0070 synX -7.09 0.0358 
QP84_01425 - transcription accessory protein 2271 NMB0075 
 
-3.1 0.004 
QP84_01460 - capsule biosynthesis protein 1944 NMB0082 lipA -5.31 0.0001 
QP84_01465 - capsule biosynthesis protein 1257 NMB0083 lipB -7.32 <0.00001 
QP84_01470 - sel1 repeat family protein 1404 NMB1327 
 
-6.42 <0.00001 
QP84_01500 - pyruvate kinase 1470 NMB0089 pykA -6.95 <0.00001 
QP84_01600 - aspartate carbamoyltransferase catalytic 918 NMB0106 pyrB -3.53 0.0435 
QP84_01610 - membrane protein 663 NMB0108  -7.84 0.0252 
QP84_01615 - peptidoglycan-binding protein LysM 1215 NMB0109  -3.43 0.0041 
QP84_01640 - hypothetical protein 597 NMB0113  -6.52 0.0006 
QP84_01680 - ribonuclease T 375 NMB0121  -3.12 0.0326 
QP84_02010 - zinc metalloprotease 1338 NMB0183  -2.5 0.0317 
QP84_02035 - membrane protein 1125 NMB0188  -4.62 0.0015 
QP84_02055 - chromosome partitioning protein 771 NMB0191  -5.52 0.0326 
QP84_02075 - sodium:alanine symporter 1425 NMB0194  -5.57 0.0015 
QP84_02110 - hypothetical protein 408 NMB0532 htrA -8.41 0.0002 
QP84_02175 - hypothetical protein 195 #N/A #N/A -7.35 0.0099 
QP84_02190 - serine dehydratase 621 NMB0211 sdaA -3.22 0.0014 
QP84_02230 - catalase 1512 NMB0216 kat -5.33 0.0195 
QP84_02285 - DNA ligase 2460 NMB0666 ligA-1 -4.66 0.0045 
QP84_02295 - 
N-acetyl-anhydromuranmyl-L-alanine 
amidase 570 NMB0668 ampD -5.4 0.0027 
QP84_02320 - hypothetical protein 579 NMB0673 
 
-7.56 0.0019 
QP84_02355 - tryptophan synthase alpha chain 783 NMB0678 trpA -4.39 0.0243 
QP84_02365 - Clp protease ClpB 609 NMB0680 cnp1 -6.81 0.0001 
QP84_02375 - hypothetical protein 603 NA NA -5.79 0.0017 
QP84_02415 - 
N-(5'-phosphoribosyl)anthranilate 
isomerase 624 NA NA -4.19 0.0015 
QP84_02475 - tryptophan synthase subunit alpha 1200 NMB0699 trpB -5.64 0.0069 
QP84_02550 - membrane protein 384 NMB0714  -2.45 0.0334 
QP84_02555 - hypothetical protein 297 NMB0714  -6.27 0.0025 
QP84_02560 - potassium/proton antiporter 318 NMB0715  -4.95 0.0076 
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N. meningitidis L91543 MC58 orthologs 
TRANSIT 
Resampling 
Locus Gene Product 
Length 
(bp) NMB Gene 
Log2 
FC p-value 
QP84_02580 - queuine tRNA-ribosyltransferase 1113 NMB0719 tgt -3.01 0.0159 
QP84_02650 - exclusion suppressor FxsA 483 NMB0730 fxsA -7.3 0.0037 
QP84_02665 - dethiobiotin synthetase 645 NMB0733 bioD -4.23 0.0212 
QP84_02690 - nucleotide-binding protein 852 NMB0738 
 
-8.1 <0.00001 
QP84_02720 - oxidoreductase 1617 NMB0741  -2.27 0.0016 
QP84_02725 - hypothetical protein 366 NMB0742  -7.5 0.007 
QP84_02795 - 
phosphoribosylaminoimidazole-
succinocarboxamide 861 NMB0757 hemH -7.77 0.002 
QP84_02800 - 
polynucleotide 
phosphorylase/polyadenylase 2118 NMB0758 pnp -5.24 0.0129 
QP84_02810 - lipoprotein 294 0  -6.45 0.0051 
QP84_02870 - DNAase 777 NMB0771  -6.39 0.0289 
QP84_02880 - glutaredoxin 309 NMB0773  -7.6 0.0318 
QP84_02915 - heme biosynthesis protein HemY 1215 NMB0779  -2.68 0.0224 
QP84_02940 - exodeoxyribonuclease V subunit beta 3612 NMB0785 recB -6.77 <0.00001 
QP84_02950 - 
amino acid ABC transporter substrate-
binding 822 NMB0787  -4.4 0.0123 
QP84_02955 - cysteine ABC transporter permease 714 NMB0788  -7.11 0.0019 
QP84_02965 - phosphoglucomutase 1380 NMB0790 pgm -4.21 0.0105 
QP84_02975 - anion:sodium symporter 1413 NMB0792 
 
-2.7 0.0064 
QP84_03020 - delta-aminolevulinic acid dehydratase 999 NMB0801 hemB -6.71 0.0013 
QP84_03025 - cystathionine gamma-synthase 1155 NMB0802 metB -3.67 0.0002 
QP84_03040 - hemagglutinin 6078 NMB0497  -2.73 0.0162 
QP84_03050 - hemagglutinin 1941 NMB0497  -6.49 0.0027 
QP84_03060 - hemagglutinin 1500 NMB0502  -7.82 <0.00001 
QP84_03080 - hemagglutinin 2499 NMB0497  -4.85 0.0001 
QP84_03095 - hypothetical protein 618 NMB0515  -6.67 0.0021 
QP84_03105 - hypothetical protein 153 NMB1076  -3.14 0.0178 
QP84_03130 - ribonuclease BN 1224 NMB0524 rbn -5.49 0.0067 
QP84_03135 - hypothetical protein 423 NA NA -7.03 0.0025 
QP84_03175 - hypothetical protein 1518 NMB0531 
 
-3.61 0.0039 
QP84_03190 - endonuclease III 627 NMB0533 nth -5.91 <0.00001 
QP84_03195 - membrane protein 411 NMB0534 
 
-6.89 0.0063 
QP84_03205 - major facilitator transporter 1221 NMB0535 gluP -6.54 0.0026 
QP84_03210 - hypothetical protein 195 NA NA -6.75 0.0205 
QP84_03215 - sodium:proton antiporter 1377 NMB0536 
 
-2.37 0.0208 
QP84_03230 - porphobilinogen deaminase 933 NMB0539 hemC -5.43 0.0006 
QP84_03235 - aromatic amino acid aminotransferase 1191 NMB0455  -4.26 0.0089 
QP84_03250 - lactate permease 1584 NMB0543  -3.1 0.0137 
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Log2 
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QP84_03265 - chromosome segregation protein SMC 3483 NMB0545  -3.88 <0.00001 
QP84_03270 adhP 
ethanol-active 
dehydrogenase/acetaldehyde-active 1038 NMB0546 adhP -3.1 0.0133 
QP84_03285 - macrolide transporter 1932 NMB0549 ybjZ -4.88 <0.00001 
QP84_03295 - primosome assembly protein PriA 2187 NMB0551 priA -2.73 0.0111 
QP84_03300 - membrane protein 1071 NMB0552 
 
-5.64 0.0187 
QP84_03375 - 
Na(+)-translocating NADH-quinone 
reductase 774 NMB0567 nqrC -4.27 0.001 
QP84_03385 - 
Na(+)-translocating NADH-quinone 
reductase 1341 NMB0569 nqrA -4.03 0.0312 
QP84_03410 - glycine cleavage system protein T 1098 NMB0574 gcvT -6.74 0.0001 
QP84_03470 - hypothetical protein 4368 NMB0585  -2.51 0.0328 
QP84_03485 - TonB-dependent receptor 2109 NMB0293  -3.37 0.0023 
QP84_03490 - nitroreductase 603 NMB0292  -3.41 0.0015 
QP84_03505 - deoxyribodipyrimidine photolyase 1299 NA NA -5.78 0.0007 
QP84_03545 - lacto-N-neotetraose biosynthesis glycosyl 825 NMB1928 lgtB -2.3 0.0228 
QP84_03555 - glycyl-tRNA synthetase subunit beta 2061 NMB1930 glyS -6.66 0.0021 
QP84_03620 - chromosome partitioning protein ParB 858 NMB1944 
 
-1.61 0.0206 
QP84_03630 - aromatic acid decarboxylase 567 NMB1945 ubiX -6.25 0.0095 
QP84_03635 - membrane protein 861 NMB1946  -6.32 <0.00001 
QP84_03645 - hypothetical protein 771 NMB1948  -7.08 0.0056 
QP84_03655 - lytic murein transglycosylase 1845 NMB1949  -3.65 0.0001 
QP84_03705 - UDP-3-o 378 NMB1957  -4.39 0.0099 
QP84_03720 - thioesterase 381 NMB1959  -5.59 0.0042 
QP84_03755 - 
toluene ABC transporter ATP-binding 
protein 798 NMB1966  -6.93 0.0006 
QP84_03845 - hypothetical protein 417 NMB1980  -4.1 0.0186 
QP84_03900 - FetA 2139 NMB1988 frpB -6.48 0.0003 
QP84_03955 - formate--tetrahydrofolate ligase 1674 NMB1839 fhs -6.66 <0.00001 
QP84_04010 - phosphatase 657 NMB1830  -6.18 0.0011 
QP84_04015 - TonB-dependent receptor 2154 NMB1829  -3.43 0.0005 
QP84_04020 - esterase 930 NMB1828  -6.58 <0.00001 
QP84_04050 - valine--pyruvate aminotransferase 1290 NMB1823 avtA -2.47 0.0375 
QP84_04055 - protein-PII uridylyltransferase 1908 NMB1822 pglD -6.95 <0.00001 
QP84_04085 - glycosyl transferase family 1 1170 NA NA -2.99 0.0015 
QP84_04095 - polysaccharide biosynthesis family protein 1422 NMB1818  -5.25 <0.00001 
QP84_04230 - histidine kinase 1248 NMB1792  -4.06 0.0118 
QP84_04235 - ribonuclease G 1491 NMB1791 cafA -4.03 0.0002 
QP84_04250 - ATP-dependent DNA helicase RecG 2037 NMB1788 recG -7.1 0.0005 
QP84_04255 - 
N-acetyl-gamma-glutamyl-phosphate 
reductase 1041 NMB1787 argC -4.15 0.0494 
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Log2 
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QP84_04270 - cupin 1152 NMB1786 
 
-6.95 0.0018 
QP84_04280 - hypothetical protein 351 NA NA -6.12 0.0079 
QP84_04315 - Rrf2 family transcriptional regulator 441 NMB0437  -5.12 0.0001 
QP84_04320 - hypothetical protein 618 NMB0388  -5.98 0.0031 
QP84_04365 - guanine permease 1308 NMB0428  -4.87 0.0014 
QP84_04505 - proline:sodium symporter PutP 1524 NMB0402 putP -7.66 0.0017 
QP84_04535 - nicotinate-nucleotide pyrophosphorylase 879 NMB0396 nadC -6.42 0.0007 
QP84_04545 - quinolinate synthetase 1110 NMB1877 
 
-4.45 0.0072 
QP84_04565 - beta-phosphoglucomutase 663 NMB0391 pgmB -2.28 0.0188 
QP84_04570 - maltose phosphorylase 2256 NMB0390 mapA -7.81 <0.00001 
QP84_04625 - coproporphyrinogen III oxidase 1419 NMB0423 murC -4.3 0.0019 
QP84_04640 - anhydro-N-acetylmuramic acid kinase 1101 NMB0377 anmK -6.2 0.0017 
QP84_04685 - protein disaggregation chaperone 2577 NMB1472 clpB -4.95 0.0008 
QP84_04690 - aminotransferase 1212 NMB1473  -7.37 <0.00001 
QP84_04700 - 
phosphoribosylglycinamide 
formyltransferase 804 NMB1475  -6.46 0.0002 
QP84_04705 - glutamate dehydrogenase 1263 NMB1476 gluD -2.8 0.0006 
QP84_04715 - phosphoglycolate phosphatase 708 NA NA -7.66 0.0294 
QP84_04720 - recombinase RecX 459 NMB1479 recX -3.66 0.0207 
QP84_04745 - stationary phase survival protein SurE 744 NMB1484 surE -7.79 0.0011 
QP84_04825 - heme biosynthesis protein HemY 774 NMB1501  -7.06 0.0201 
QP84_04850 - membrane protein 1416 NMB1508  -7.37 0.0031 
QP84_04860 - amino acid ABC transporter permease 744 NMB1509  -2.85 0.0406 
QP84_04970 - cysteine methyltransferase 750 NMB1528  -5.7 0.0077 
QP84_05040 - long-chain fatty acid--CoA ligase 1668 NMB1555 
fadD-
2 -8.86 <0.00001 
QP84_05050 - hypothetical protein 471 NMB1557 
 
-3.08 0.0094 
QP84_05125 - bifunctional aconitate hydratase 2583 NMB1572 acnB -2.21 0.0176 
QP84_05135 - ketol-acid reductoisomerase 1011 NMB1574 ilvC -3.67 0.0033 
QP84_05150 - acetolactate synthase 3 catalytic subunit 1725 NMB1577 ilvI -6.68 <0.00001 
QP84_05210 - membrane protein 681 NMB1586 
 
-6.55 0.0199 
QP84_05255 - hypothetical protein 420 NMB1822 pglD -4.28 0.0256 
QP84_05265 - AraC family transcriptional regulator 903 NMB1591 mtrA -7.22 0.0384 
QP84_05280 - 
polyamine ABC transporter substrate-
binding 1143 NMB1594 
potD-
3 -3.23 0.0207 
QP84_05290 - restriction endonuclease 1020 NMB0188  -4.33 0.0008 
QP84_05365 - O-succinylhomoserine sulfhydrolase 1167 NMB1609  -2.25 0.0403 
QP84_05440 - cation uptake regulator 474 NMB1266  -3.9 0.0331 
QP84_05475 - alginate O-acetyltransferase 1434 NMB1273  -2.23 0.013 
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QP84_05480 - periplasmic protein 984 NMB1274  -5.31 0.0146 
QP84_05495 - long-chain fatty acid--CoA ligase 1551 NMB1276 
fadD-
1 -2.61 0.0035 
QP84_05505 - recombinase 2004 NMB1278 gcr -6.86 0.003 
QP84_05580 - 5-hydroxymethyluracil DNA glycosylase 825 NMB1295 mutM -4.53 0.0008 
QP84_05590 - murein transglycosylase 1974 NMB1297 
 
-4.04 0.0068 
QP84_05595 - pseudouridine synthase 690 NMB1298 rsuA -7.09 0.0221 
QP84_05625 - 
S-(hydroxymethyl)glutathione 
dehydrogenase 1134 NMB1304  -2.77 0.0009 
QP84_05635 - ATPase 1149 NMB1306  -3.91 0.0043 
QP84_05660 - Clp protease ClpP 612 NMB1312 clpP -7.41 0.0006 
QP84_05670 - cell division protein FtsK 2436 NMB1314 ftsK-2 -6.19 0.0144 
QP84_05675 - uracil transporter 1209 NMB1315 uraA -4.64 0.0251 
QP84_05700 - membrane protein 804 NMB1319 
 
-5.22 <0.00001 
QP84_05735 uvrC excinuclease ABC subunit C 1884 NMB1326 uvrC -4.39 0.0017 
QP84_05755 - bile acid:sodium symporter 951 NMB0705 
 
-4.08 0.0005 
QP84_05790 - hypothetical protein 471 NMB0222 
 
-6.25 0.0005 
QP84_05800 - hypothetical protein 333 NA NA -7.39 0.0035 
QP84_05805 - glutamine-synthetase adenylyltransferase 2688 NMB0224 glnE -7.76 <0.00001 
QP84_05810 - hypothetical protein 690 NMB0226  -7.11 0.0027 
QP84_05820 - LamB/YcsF family protein 735 NMB0228  -2.63 0.0199 
QP84_05825 - hypothetical protein 927 NA NA -5.08 0.0098 
QP84_05870 - membrane protein 618 NMB0239 
 
-7.47 0.0473 
QP84_05900 - NADH dehydrogenase 471 NMB0245 nuoE -7.49 0.0342 
QP84_05940 - cell division protein Fic 573 NMB0255 
 
-4.96 0.0016 
QP84_05960 - 
NADH:ubiquinone oxidoreductase subunit 
N 1443 NMB0259 nuoN -4.26 0.0003 
QP84_05970 - geranyl transferase 894 NMB0261 ispA -6.11 <0.00001 
QP84_05995 - ATP-dependent DNA helicase RuvA 582 NMB0265 ruvA -1.73 0.0265 
QP84_06000 - peptidase 324 NMB0266  -5.79 0.0002 
QP84_06010 - rRNA methylase 462 NMB0268  -5.65 <0.00001 
QP84_06015 - competence protein 495 NMB0269  -6.46 <0.00001 
QP84_06030 - hypothetical protein 267 NA NA -5.47 0.0021 
QP84_06035 - membrane protein 294 NA NA -6.11 0.0041 
QP84_06040 - hypothetical protein 423 NMB0273 
 
-7.08 0.0019 
QP84_06050 trpC indole-3-glycerol-phosphate synthase 780 NMB0275 trpC -2.15 0.0135 
QP84_06055 - alpha/beta hydrolase 954 NMB0276  -4.64 0.0001 
QP84_06080 - peptidylprolyl isomerase 1212 NMB0281  -8.01 0.0003 
QP84_06125 - 3'-5' exonuclease 792 NMB1417  -4.98 0.0002 
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QP84_06140 - 
crossover junction 
endodeoxyribonuclease RuvC 534 NMB1419 ruvC -7.23 0.0095 
QP84_06160 - RNA helicase 1371 NMB1422  -5.26 0.0001 
QP84_06190 - membrane protein 1251 NMB1426  -2.71 0.02 
QP84_06210 - membrane protein 1155 NMB1429 porA -6.5 0.0018 
QP84_06240 - major facilitator transporter 1404 NMB1435  -6.13 0.0025 
QP84_06265 - tetratricopeptide repeat family protein 714 NMB1440  -3.33 0.0019 
QP84_06270 - methyltransferase 666 NMB1441  -7.57 0.0019 
QP84_06325 - 3-dehydroquinate dehydratase 762 NMB1446 aroD -6.5 0.009 
QP84_06330 - ATP-dependent DNA helicase Rep 2013 NMB1447 rep -4.27 0.0036 
QP84_06335 - DNA polymerase IV 1056 NMB1448 dinP -8.84 0.0039 
QP84_06375 - 2-nitropropane dioxygenase 1173 NMB1452  -6.25 0.0003 
QP84_06495 - CoA-binding protein 2424 NMB0593  -4.93 0.0003 
QP84_06510 - polymerase 1812 NMB0596  -2.83 0.0124 
QP84_06520 - septum formation inhibitor Maf 606 NMB0598  -2.73 0.013 
QP84_06550 - butanediol dehydrogenase 1062 NMB0604  -2.52 0.0399 
QP84_06555 - deacetylase 1107 NMB0605  -7.88 0.0001 
QP84_06585 - 
putrescine/spermidine ABC transporter 
permease 963 NMB0611 potB -7.75 0.0001 
QP84_06595 - oxidoreductase 1293 NMB0614 
 
-6.05 0.0229 
QP84_06600 - ammonia channel protein 1302 NMB0615 
 
-4.43 0.0484 
QP84_06615 - phosphoenolpyruvate synthase 2382 NMB0618 ppsA -2.56 0.0136 
QP84_06620 - PEP synthetase regulatory protein 819 NMB0619 
 
-3.7 0.0101 
QP84_06670 prfC peptide chain release factor 3 1593 NMB0626 prfC -7.86 0.0004 
QP84_06680 - imidazole glycerol phosphate synthase 765 NMB0628 hisF -4.52 0.0126 
QP84_06685 - 1-(5-phosphoribosyl)-5-[(5- 735 NMB0629 hisA -4.85 0.0027 
QP84_06690 hisH imidazole glycerol phosphate synthase 636 NMB0630 hisH -7.46 0.0097 
QP84_06700 - 
peptide ABC transporter substrate-
binding 1056 NMB0632 fbpC -9.17 0.0004 
QP84_06705 - Fe3+ dicitrate ABC transporter permease 1515 NMB0633 fbpB -7.14 <0.00001 
QP84_06880 - argininosuccinate synthase 1341 NMB2129 argG -6.52 <0.00001 
QP84_06895 - membrane protein 1491 NMB2132  -6.82 <0.00001 
QP84_06900 - serine/threonine protein kinase 1227 NMB2133  -6.47 0.0021 
QP84_06915 - major facilitator transporter 1455 NMB2136  -6.36 0.0005 
QP84_06950 - hypothetical protein 840 NMB2142  -3.46 0.0317 
QP84_06955 - hypothetical protein 744 NMB1839 fhs -7.92 <0.00001 
QP84_06960 - RNA polymerase sigma factor 585 NMB2144  -6.63 0.0154 
QP84_06980 - hypothetical protein 438 NMB2149  -6 0.0312 
QP84_06995 - phosphoribosylamine--glycine ligase 1269 NMB2151 purD -7.87 <0.00001 
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QP84_07005 - thymidylate synthase 609 NMB2153 
 
-7.44 0.0006 
QP84_07040 - DNA mismatch repair protein MutS 2556 NMB2160 mutS -4.66 0.001 
QP84_07065 - arsenate reductase 351 NMB0005 arsC -8.32 0.0461 
QP84_07070 - thioredoxin 480 NMB0006  -6.23 0.0411 
QP84_07080 - cell division protein FtsX 915 NMB0008  -2.18 0.0367 
QP84_07105 - membrane protein 972 NMB0012  -7.4 <0.00001 
QP84_07120 - 6-phosphogluconate dehydrogenase 1446 NMB0015 gnd -5.23 0.0014 
QP84_07195 - protease 1353 NMB1664 
 
-3.64 0.0206 
QP84_07235 - paraquat-inducible protein B 1638 NMB1671 pqiB -3.79 0.0148 
QP84_07265 - glycine dehydrogenase 2850 NA NA -8.71 <0.00001 
QP84_07275 - cytochrome 837 NMB1677 0 -6.01 0.0046 
QP84_07290 - tRNA (uracil-5-)-methyltransferase 1101 NMB1679 trmA -3.35 0.0053 
QP84_07330 - hydrolase 768 NMB1687  -5.96 0.0037 
QP84_07360 - 
3-octaprenyl-4-hydroxybenzoate carboxy-
lyase 1476 NMB1694  -6.75 <0.00001 
QP84_07365 - hypothetical protein 513 NA NA -5.89 0.0006 
QP84_07380 - beta-ketoacyl synthase 420 NMB1699  -4.77 0.0133 
QP84_07385 - transposase 609 NMB1411  -5.96 0.0096 
QP84_07390 - 3-oxoacyl-ACP synthase 1134 NMB1703 fabF-2 -3.9 0.0003 
QP84_07405 - alpha 1,2 N-acetylglucosamine transferase 1062 NMB1705 rfaK -8.36 0.002 
QP84_07415 - transporter 1335 NMB1707 
 
-6.83 0.0034 
QP84_07435 - hypothetical protein 372 NA NA -4.68 0.0191 
QP84_07455 - aminobenzoyl-glutamate transporter 1566 NMB1719 mtrF -6.21 <0.00001 
QP84_07490 - peptidase 1746 NMB1726 
 
-7.91 <0.00001 
QP84_07505 - biopolymer transporter ExbB 660 NMB1729 exbB -7.53 0.0016 
QP84_07510 - energy transducer TonB 834 NA NA -7.5 0.0003 
QP84_07665 - C4-dicarboxylate ABC transporter 1464 NMB0470 
 
-6.96 0.0024 
QP84_07705 - 
polyamine ABC transporter substrate-
binding 1140 NMB0462 
potD-
1 -3.16 0.0057 
QP84_07725 - 3-hydroxyisobutyrate dehydrogenase 492 NMB0286 
 
-8.31 0.0001 
QP84_07745 - restriction endonuclease Eco57I 2502 NA NA -4.18 0.0175 
QP84_07800 - ABC transporter permease 1863 NMB1919 
 
-4.43 <0.00001 
QP84_07805 - malonyl CoA-ACP transacylase 924 NMB1918 fabD -7.35 0.0006 
QP84_07830 - hypothetical protein 249 NMB1914 
 
-4.31 0.0142 
QP84_07855 - septum formation inhibitor Maf 588 NMB1909 maf -5.88 0.0001 
QP84_07900 - polyphosphate kinase 2055 NMB1900 ppk -5.39 0.0165 
QP84_07930 - hypothetical protein 552 NA NA -7.11 0.0023 
QP84_07970 - 
protein-L-isoaspartate O-
methyltransferase 654 NMB1885 pcm -6.18 0.0005 
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QP84_07975 - sulfurtransferase 321 NMB2064  -6.66 0.0086 
QP84_07985 - TonB-dependent receptor 2175 NMB1882  -4.39 <0.00001 
QP84_07990 - cupin 321 NMB1881  -6.15 0.0418 
QP84_08015 - MJ0042 family finger-like domain protein 432 NMB1876 argA -7.99 0.0056 
QP84_08030 - acetyltransferase 438 NMB1872  -8.33 0.0025 
QP84_08055 - hypothetical protein 273 NMB0361  -6.85 0.0037 
QP84_08060 - hypothetical protein 1281 NMB0360  -9.22 0.004 
QP84_08075 aroE shikimate dehydrogenase 807 NMB0358 aroE -6.72 0.0053 
QP84_08120 - hypothetical protein 288 NA NA -5.35 0.0019 
QP84_08130 - tRNA-dihydrouridine synthase 1008 NMB0348 
 
-6.34 <0.00001 
QP84_08135 - D-tyrosyl-tRNA(Tyr) deacylase 489 NMB0983 purH -7.88 0.0001 
QP84_08140 - peptidylprolyl isomerase 756 NMB0346 0 -6.41 <0.00001 
QP84_08160 - intracellular septation protein A 528 NMB0342 ispZ -5.03 0.0298 
QP84_08170 - tspA protein 2523 NMB0341  -2.23 0.0386 
QP84_08195 - 
branched-chain amino acid 
aminotransferase 996 NMB0337  -7.79 0.0034 
QP84_08210 - hypothetical protein 228 NMB1613 fumB -8.43 0.0391 
QP84_08220 - type II secretion system protein F 1230 NMB0333 pilG -1.76 0.0202 
QP84_08240 - pilus assembly protein PilF 1674 NMB0329 pilF -3.43 0.0133 
QP84_08275 rpmG 50S ribosomal protein L33 153 #N/A #N/A -6.2 0.0001 
QP84_08295 - hemolysin D 1170 NMB0318 farA -5.73 0.0006 
QP84_08440 - 5-methyltetrahydropteroyltriglutamate-- 2274 NMB0944 metH -7.73 <0.00001 
QP84_08455 - dihydrolipoamide dehydrogenase 1401 NMB0947 
 
-7.67 <0.00001 
QP84_08460 - hypothetical protein 210 NA NA -5.81 0.0342 
QP84_08465 - succinate dehydrogenase 375 NMB0948 sdhC -3 0.0107 
QP84_08515 sucC succinyl-CoA synthetase subunit beta 1164 NMB0959 sucC -5.86 0.0008 
QP84_08560 - excinuclease ABC subunit B 2025 NMB1331 uvrB -6.22 <0.00001 
QP84_08570 - hypothetical protein 1803 NMB1333 NA -6.46 0.0001 
QP84_08590 - Holliday junction resolvase 453 NMB1337 NA -2.98 0.0421 
QP84_08610 aceE pyruvate dehydrogenase 2661 NMB1341 aceE -4.15 0.0004 
QP84_08620 - dihydrolipoamide dehydrogenase 1785 NMB1344 lpdA2 -5.3 0.0111 
QP84_08625 - hypothetical protein 1548 NMB1345 
 
-5.75 0.0081 
QP84_08630 - ligand-gated channel protein 2121 NA NA -6.75 0.002 
QP84_08635 - inositol monophosphatase 783 NMB1347 suhB -6.38 0.0126 
QP84_08640 - RNA methyltransferase 813 NMB1348  -4.27 0.0007 
QP84_08665 - membrane protein 651 NMB1354  -7.77 0.043 
QP84_08705 - MFS transporter 1539 NMB1362  -6.29 <0.00001 
QP84_08710 - NAD(P)H nitroreductase 663 NMB0804  -7.67 0.0016 
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QP84_08725 - hypothetical protein 564 NMB0808  -5.51 0.0327 
QP84_08730 - hypothetical protein 774 NMB0809  -4.7 0.0077 
QP84_08735 - TetR family transcriptional regulator 648 NMB0810  -7.96 0.0004 
QP84_08755 hisZ ATP phosphoribosyltransferase regulatory 1149 NMB0814 hisZ -7.54 0.02 
QP84_08795 - 
ADP-L-glycero-D-manno-heptose-6-
epimerase 1002 NMB0828 rfaD -9.05 <0.00001 
QP84_08800 clpA Clp protease ClpX 2295 NMB0836 clpA -3.71 0.0102 
QP84_08805 - Clp protease ClpS 312 NMB0837 clpS -6.38 <0.00001 
QP84_08815 pmbA peptidase PmbA 1329 NMB0839 pmbA -2.11 0.0435 
QP84_08835 - PcnB 1359 NMB0843 pcnB -5.39 0.0011 
QP84_08845 - phosphate starvation protein PhoH 951 NMB0845  -3.97 0.0163 
QP84_08850 - glycosyl transferase 606 NMB0846  -7.5 0.0254 
QP84_08935 - membrane protein 270 NA NA -5.45 0.002 
QP84_08975 - hypothetical protein 378 NMB0897 
 
-7.74 0.0054 
QP84_08985 - hypothetical protein 183 NA NA -6.81 0.0494 
QP84_09030 - hypothetical protein 852 NMB0906 
 
-8 0.0316 
QP84_09065 - hypothetical protein 207 NA NA -6.66 0.0269 
QP84_09105 - phage tail protein 639 NA NA -2.73 0.0238 
QP84_09165 - hypothetical protein 423 NMB0872  -5.85 0.0108 
QP84_09215 - iron ABC transporter permease 966 NMB1990  -4.29 0.0052 
QP84_09230 - iron ABC transporter ATP-binding protein 747 NMB1993  -6.02 <0.00001 
QP84_09245 - 
phosphoribosylformylglycinamidine 
synthase 3960 NMB1996 purL -7.13 <0.00001 
QP84_09250 - hydroxyacylglutathione hydrolase 756 NMB1997 gloB -6.37 <0.00001 
QP84_09270 - molecular chaperone Hsp33 906 NMB2000 hslO -5.18 0.0131 
QP84_09290 - murein hydrolase transporter LrgB 690 NMB2004 
 
-4.6 <0.00001 
QP84_09295 argJ ornithine acetyltransferase 1218 NMB2005 argJ -1.85 0.029 
QP84_09330 - molecular chaperone 1644 NA NA -2.11 0.0214 
QP84_09340 - hypothetical protein 144 NA NA -6.77 0.0394 
QP84_09470 - transcriptional regulator 846 NMB1389 
 
-5.52 0.0015 
QP84_09505 - adenine glycosylase 1038 NMB1396 mutY -7.22 0.0335 
QP84_09510 - superoxide dismutase 558 #N/A #N/A -7.99 0.0102 
QP84_09585 - nitric oxide reductase large subunit 1968 NMB1622 norB -3.41 0.0119 
QP84_09625 - sulfatase 1632 NMB1638  -5.58 0.0005 
QP84_09655 - GTP-binding protein 1392 NMB1644  -4.59 0.0099 
QP84_09660 - membrane protein 1338 NMB1645  -4.95 0.0101 
QP84_09670 - alanine glycine permease 1416 NMB1647  -2.01 0.0469 
QP84_09680 - dihydrolipoamide acyltransferase 486 NA NA -6.13 <0.00001 
QP84_09700 - hypothetical protein 1353 NMB1652  -6.85 0.0429 
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QP84_09720 - hypothetical protein 591 NMB1656  -7.55 0.0307 
QP84_09760 - hypoxanthine phosphoribosyltransferase 561 NMB2047  -2.21 0.012 
QP84_09765 - DNA ligase 822 NMB2048 ligA-2 -5.07 0.006 
QP84_09775 - recombinase RmuC 1782 NMB2050  -3.71 <0.00001 
QP84_09795 - hypothetical protein 747 NMB2054  -3.31 0.0296 
QP84_09800 - LysR family transcriptional regulator 927 NMB2055  -3.68 0.0207 
QP84_09850 - sodium:proton antiporter 1386 NMB2064  -7.8 0.0004 
QP84_09930 - methenyltetrahydrofolate cyclohydrolase 852 NA NA -7.72 <0.00001 
QP84_09995 - iojap-like protein 384 NMB2023  -7.04 <0.00001 
QP84_10010 - ABC transporter permease 1539 NMB2026  -3.57 0.0014 
QP84_10035 - tryptophan permease 1239 NMB2031 mtr -3.15 0.0021 
QP84_10130 - fructose-1,6-bisphosphate aldolase 1062 NMB1869 cbbA -5.46 0.0006 
QP84_10135 - recombinase XerC 915 NMB1868 xerC -6.6 <0.00001 
QP84_10145 - (dimethylallyl)adenosine tRNA 1326 NMB1866  -3.17 0.0008 
QP84_10200 - LysR family transcriptional regulator 897 NMB1856  -4.53 0.0022 
QP84_10205 carB 
carbamoyl phosphate synthase large 
subunit 3213 NMB1855 carB -4.07 0.0016 
QP84_10325 - iron transporter 837 NMB0034  -6.92 0.0004 
QP84_10405 - DNA methylase 1140 NMB0455  -7 0.0103 
QP84_10425 - sulfite exporter TauE/SafE family protein 765 NMB0451  -8.22 0.0077 
QP84_10490 - TspB 1503 NMB1628  -8.58 0.0018 
QP84_10520 - exodeoxyribonuclease III 777 NMB2082 exoA -6.65 0.0053 
QP84_10525 - cysteinyl-tRNA synthetase 1419 NMB2083 cysS -3.97 0.0262 
QP84_10540 - cytochrome B561 351 NA NA -7.12 0.0027 
QP84_10545 - 16S rRNA methyltransferase 873 NMB2088  -6.86 0.0266 
QP84_10550 - hypothetical protein 345 NMB2089  -5.73 0.0139 
QP84_10585 - malate:quinone oxidoreductase 1464 NMB2096 yojH -6.59 0.001 
QP84_10590 - acetyltransferase 588 NMB2098 
 
-5.6 0.0199 
QP84_10640 - 50S ribosomal protein L25 570 NMB0876 rplY -6.48 0.0074 
QP84_10715 - exodeoxyribonuclease VII large subunit 1353 NMB1363 xseA -3.66 0.0118 
QP84_10745 - RNA helicase 1386 NMB1368 
 
-3.11 0.0007 
QP84_10765 - phospholipase 153 NA NA -6.94 0.0492 
QP84_10770 argD acetylornithine aminotransferase 1194 NMB1371 argD -2.82 0.0212 
QP84_10785 - pseudouridine synthase 930 NMB1374 truB -7.52 0.0058 
QP84_10895 - 
phospho-2-dehydro-3-deoxyheptonate 
aldolase 1053 NMB0307 aroG -4.07 0.0013 
QP84_10955 - methionyl-tRNA formyltransferase 630 NMB0283 
 
-4.61 0.0289 
QP84_10965 - acyltransferase 1866 NA NA -5.12 <0.00001 
QP84_10980 - alpha/beta hydrolase 639 NMB0868  -6.76 0.0036 
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QP84_11010 - TPR repeat family protein 1836 NMB0872  -2.18 0.0144 
QP84_11035 - ligand-gated channel 2829 NMB1540 lbpA -5.56 0.0011 
QP84_11055 - lactate permease 312 NA NA -5.01 0.0029 
QP84_11070 - acriflavine resistance protein B 3201 NMB1715 mtrD -6.56 <0.00001 
QP84_11090 - ligand-gated channel 2274 NMB0964 
 
-7.54 0.0001 
QP84_11095 - anthranilate synthase component II 588 NMB0966 pabA -6.79 0.0043 
QP84_11260 - identified by metageneannotator 405 NMB0371  -2.24 0.0316 
QP84_11265 - identified by metageneannotator 375 NMB0371  -6.93 0.0112 
Note: List of genes selected using both TRANSIT resampling and BH-FDR with a cut-off of fold change 
(FC) < -1.5, p ≤ 0.05. Data from BH-FDR not included as p >0.05 
NA – Information not available 
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A.4  Growth of K/O mutant and the wild type strain, L91543 in the tissue 
culture medium during adherence and invasion assay 
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Free living meningococci in the tissue culture medium during infection was determined. 
Bacterial counts were set up using Miles and Misra at time zero and the end of the incubation 
period for the adhesion and invasion assays, i.e. 6 h.  Results are shown as mean ± SEM of the 
3 biological repeats experiments carried out as explained in 6.2.2. 
 
 
 
 
 
 
